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Zusammenfassung
Schlaganfall ist eine der Hauptursachen für erworbene Behinderungen im Erwachsenenalter
weltweit und die aktuell verfügbaren therapeutischen Möglichkeiten sind begrenzt. Das liegt
unter anderem daran, dass wir immer noch nur unzureichend die Pathologie des Schlaganfalls
verstehen, insbesondere Reorganisations- und Regenerationsprozesse, die im Gehirn nach dem
Insult stattfinden um funktionelle Erholung zu ermöglichen. Gerade unser Wissen um das
Zusammenspiel von intrinsischen Wachstumsprozessen nach Schlaganfall und externen thera-
peutische Interventionen, wie z.B. Rehabilitationstraining, Elektrostimulation (TMS) oder der
Gabe von Wachstums fördernden Substanzen, ist immer noch sehr lückenhaft.
Die hier vorgelegte Arbeit beschäftigt sich mit der Untersuchung von intrinsisch plastischen
Mechanismen nach Schlaganfall, um neue Möglichkeiten für das Design von optimierten Reha-
bilitationstherapien zu finden, die direkt positiv auf interne Wachstumsmechanismen einwirken
und damit ein grösseres Potential für die Wiederherstellung von verlorenen, insbesondere mo-
torischen Funktionen eröffnen können.
Im ersten Kapitel fassen wir das aktuelle Verständnis von Mechanismen, die an spontanen
Erholungsprozessen beteiligt sind, zusammen. Wir präsentieren Beispiele für experimentelle In-
terventionen, die die Wachstumsprozesse im Gehirn nach Schlaganfall beschleunigen könnten,
wie z.B. eine Antikörpertherapie gegen den stärksten Wachstumshemmer im zentralen Ner-
vensystem, das Nogo-A Protein. Weil es Hinweise für ein kritisches Zeitfenster für Wachstum
und die Anwendung von Rehabilitationstraining gibt, diskutieren wir verschiedene Ansätze für
kombinierte Therapieoptionen.
Im zweiten Kapitel legen wir mögliche methodische Hindernisse in der aktuellen experi-
mentellen Schlaganfallforschung dar: Bisherige Studien waren im Hinblick auf das Verständnis
des Zusammenhangs von Reorganisationsprozessen nach Schlaganfall und dem Grad der funk-
tionellen Erholung vor allem korrelativ. Deshalb stellen wir neue Technologien vor, die in den
letzten Jahren im Bereich der Neurowissenschaften entwickelt wurden und die der Schlagan-
fallforschung neue Möglichkeiten eröffnen könnten, um kortikale Reorganisation zu studieren,
neuronale Schaltkreise zu manipulieren und die zu Grunde liegenden molekularen Mechanismen
zu verstehen.
Kapitel 3 fasst unsere Ergebnisse über Reorganisationsprozesse in der Region um den Schla-
ganfall, der sogenannten Penumbra, zusammen, die wir nach einem kleinen Schlaganfall im
Mausmodell, der das kortikale Hirnareal für die Handfunktion zerstört hatte, beobachtet haben.
Wir haben in einer Kombination von Licht-basierter kortikaler Stimulation zur Kartierung der
funktionellen Hirnareale für die Vorder-und Hinterpfote und detaillierter kinematischer Anal-
yse festgestellt, wie wichtig die Reorganisation innerhalb der Penumbra ist, um die durch den
Schlaganfall zerstörte Greiffunktion wiederherzustellen: In der Penumbra entsteht ein neues
Zentrum der Handrepräsentation, die auch das Motor-Engramm für die Greiffunktion enthält.
Das spontane Erholungspotenzial nach einem grossen Schlaganfall ist begrenzt. Im Kapitel
4 haben wir vier verschiedene Rehabilitationsparadigmen in einem Rattenmodell nach einem
grossen photothrombotischen Schlaganfall im sensomotorischen Cortex angewendet. Wir haben
dabei herausgefunden, dass der richtige Zeitpunkt entscheidend ist für den Grad der funk-
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tionellen Erholung, wenn zwei mögliche Therapieoptionen kombiniert werden: Ratten, die
zunächst für zwei Wochen eine Immuntherapy mit einem Antikörper gegen Nogo-A erhiel-
ten und nachfolgend für zwei Wochen intensives Training der Handfunktion, erholten sich fast
vollständig, im Gegensatz zu Ratten, die ihr Training parallel zur Antikörpertherapie innerhalb
der ersten zwei Wochen nach Schlaganfall durchführten. Diese zeigten kaum eine Erholung
der Greiffunktion und waren damit schlechter als die Kontrolltiere. Anatomisch spiegelte sich
der unterschiedliche Grand der Erholung in komplett verschiedenen Wachstumsmustern von
neu aussprossenden corticospinalen Fasern wieder, die ihren Ursprung von Neuronen in der
gesunden Hemisphäre nahmen. Während corticospinale Fasern von Tieren mit guter Erhol-
ung ein normales Verzweigungmuster aufwiesen und vorwiegend im motorischen Vorderhorn
der grauen Substanz endeten, war das Faserwachstum von Tieren mit schlechter Erholung
der Greiffunktion, die parallel zur Immuntherapie trainiert worden waren, überschiessend, mit
einer Ueberzahl an Synapsen, wobei die Fasern zum Teil falsche Regionen des Rückenmarks
ansteuerten. Als wir in den gut erholten, d.h. nach Antikörpertherapie trainierten Ratten,
temporär corticospinale Fasern aus einer bestimmten Region im pre- und primärmotorischen
Cortex der gesunden Hemisphäre abschalteten, die auf Rückenmarksebene über die Mittellinie
von der gesunde auf die kranke Rückenmarksseite hinüberwuchsen, war die wiedergewonnene
Handfunktion der Ratten erneut verloren. Damit zeigte sich diese Gruppe von im Rückenmark
die Mittellinie kreuzenden corticospinalen Fasern als entscheidend für die Wiederherstellung
der Feinmotorik in der Vorderpfote nach Schlaganfall.
Ein Kandidaten-basiertes Screening gab erste Hinweise (wie in Kapitel 5 beschrieben), dass
verschiedene Rehabilitationsparadigmen definierte örtliche und zeitliche Expressionsmuster von
Wachstums fördernden Faktoren und Neurotrophinen einleiten. Insbesondere die erhöhte Ex-
pression des Brain-derived neurotrophic factor (BDNF) Gens in der denervierten Seite des
zervikalen Rückenmarks war mit einer guten Erholung der motorischen Funktion in den Tieren
korreliert. Im Gegensatz dazu waren Anzeichen von Gliose und überschiessende Synapsenbil-
dung die vorrangigen Merkmale im Gehirn und Rückenmark von Tieren mit schlechter Er-
holung, die gleichzeitig zur Anti-Nogo A Antikörpertherapie Rehabilitationstraining erhalten
hatten.
Diese Arbeit gibt Hinweise darauf, dass genau orchestrierte, akkurat durchgeführte, zeitab-
hängige interne Reparaturmechanismen die neuronale Reorganisation als Grundlage für die
Wiederherstellung verlorener Funktionen kontrollieren. Weiterhin zeigen wir, wie wichtig es
für die funktionelle Erholung ist, sorgfältig über die Konzeption von Rehabilitationsschemata
nach Schlaganfall nachzudenken, insbesondere, wenn verschiedene Therapieoptionen kombiniert
werden, wie z.B. Trainung und Substanzen, die das Nervenfaserwachstum fördern. Ein Rehabil-
itationsansatz hat dann vor allem Erfolg, wenn er in einem ersten Schritt zunächst intrinsische
Wachstumsprozesse weiter unterhält und ankurbelt (z.B. durch die Gabe von Anti-Nogo A An-
tikörpern) und Training in einem zweiten Schritt erfolgt, das die Stabilisierung von bedeutsamen
neuen Nervenschaltkreisen unterstützt, während funktionslose Schaltkreise verschwinden. Im
Gegensatz dazu können Rehabilitationsansätze nicht förderlich sein für die Wiedererlangung
und Erholung von verlorenen Funktionen, wenn der Rehabilitationsansatz zum falschen Zeit-
punkt oder in zu hoher Intensität erfolgt. Gerade initial nach Schlaganfall scheint das Gehirn in
einer besonders sensitiven Phase zu sein. Zu intensive, erzwungene Rehabilitationsmassnahmen
sollten in dieser Phase, in der erhöhte Umbauvorgänge im Gehirn stattfinden, nur mit grösster
Vorsicht angegangen werden.
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Summary
Stroke is a major cause of adult disability worldwide and the treatment options available are
limited so far - in part, because we are still lacking detailed knowledge about stroke pathology
and reorganization processes taking part in the brain after the ischemic insult to enable the
recovery of lost function. In particular, we do not understand the interplay between intrinsic
growth-promoting processes induced by stroke and external therapeutical interventions such as
rehabilitative training, electrical stimulation or plasticity-boosting therapies.
The present work aims at understanding intrisic plastic mechanisms after stroke in order to
optimize the design of rehabilitation schedules which enhance these plastic processes and thus
provide restoration of lost function.
In chapter 1 we provide a general overview concidering the current understanding of mecha-
nisms involved in spontaneous recovery after stroke. Furthermore we introduce experimental
interventions to enhance growth and plasticity, with an emphasis on Anti-Nogo A immunother-
apy. As there is evidence for a critical window of growth and rehabilitative training, we discuss
different approaches of combinatorial rehabilitative schedules.
In chapter 2 we highlight the caveats of current experimental stroke research emphasizing
that our understanding of rewiring processes after stroke in relation to functional outcome lev-
els have been merely correlative so far. We therefore review new technologies recently developed
for neuroscientific applications which are also powerful tools to study cortical reorganization,
to manipulate rewiring neuronal circuits and to identify the underlying molecular profiles.
Chapter 3 summarizes our results of examining reorganization in the peri-infarct area after
a small focal stroke destroying the mouse forelimb motor cortex. Here we used a combination
of light-based motor mapping measuring cortical map shifts and detailed kinematic analysis to
reveal the functional relevance of the peri-infarct cortex for the organization of a new center
for forelimb function and the re-establishment of motor engrams lost due to the stroke.
Spontaneous recovery after large strokes is very limited. In chapter 4 we thus applied four
different rehabilitation paradigms in a rat model for large photothrombotic strokes targeting
the sensorimotor cortex. We found that timing is crucial when two treatment strategies are
combined: Rats receiving first Anti-Nogo A immunotherapy for two weeks after stroke followed
by two weeks of intensive rehabilitative training of the forelimb showed almost full restoration
of lost function while simultaneous training to Anti-Nogo-A immunotherapy resulted in very
poor outcome levels, which were found to be even below control groups. Anatomically these
distinct outcome levels were reflected by distinct growth patterns of newly out-sprouting corti-
cospinal fibers originating in the healthy contralesional hemisphere. While in the well recovered
group of rats, these fibers formed a near normal branching and termination pattern in the ven-
tral horn of the spinal cord, aberrant branching and too high numbers of synapses, in part
in wrong areas of the spinal cord were apparent in rats with poor functional recovery having
received simultaneous training with Anti-Nogo A immunotherapy. Temporarily silencing cor-
ticospinal fibers which originated from a distinct area within the premotor and rostral motor
cortex of the healthy hemisphere, crossed the midline at the level of the cervical spinal cord
and targeted the denervated grey matter, resulted in a decline of regained forelimb function in
rats with good functional outcome (after sequential training application), thus demonstrating
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the crucial relevance of these newly outsprouting fibers for the restoration of skilled motor
function. A candidate-based screening provided first insights (as described in Chapter 5)
that different rehabilitation paradigms induce distinct spatio-temporal expression patterns of
growth-promoting genes and neurotrophic factors. Induction of the brain-derived neurotrophic
factor (BDNF) gene in particular in the denervated cervical hemi-spinal cord was associated
with good functional outcome. In contrast, signs for gliosis and extensive synpatogenesis were
predominant characteristics in the brains and spinal cords of animals, which had concurrent
training to Anti-Nogo A antibody application.
In summary, this work provides evidence for precisely orchestrated time-dependent internal
repair processes controlling mechanisms of neuronal rewiring for the restoration of lost motor
functions after stroke. Furthermore we show here the importance of carefully designing reha-
bilitation schedules after stroke, in particular if different therapeutic options such as training
and growth enhancing agents are combined: A rehabilitative approach which first supports
and enhances the intrinsic potential of the brain and spinal cord to reinforce lost functions by
boosting the growth of new fibers (e.g. through growth-promoting therapies such as Anti-Nogo
A antibody application) followed by a phase of stabilization of the meaningful newly formed
circuits and pruning of non-functional ones through training, may result in robustly enhanced
recovery of motor function. In contrast, rehabilitative schedules may become less beneficial if
applied at the wrong time and intensity. In particular in the early phase after the injury, the
brain seems to be in a delicate vulnerable state. Forced rehabilitative therapies should therefore
be initiated with great caution during this period of circuit plasticity.
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Chapter 1
Finding an optimal rehabilitation
paradigm after stroke: enhancing fiber
growth and training of the brain at the
right moment
Anna-Sophia Wahl1and M.E. Schwab1
1Brain Research Institute, University of Zurich, and Dept. of Health Sciences and Technology, ETH Zurich,
Switzerland.
published in Frontiers in Human Neuroscience 2014; 8: 381. doi:10.3389/fnhum.2014.00381
A.S.W. conducted literature research, wrote the manuscript and prepared the figure. M.E.S.
complemented the manuscript.
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Abstract
After stroke the central nervous system reveals a spectrum of intrinsic capacities
to react as a highly dynamic system which can change the properties of its cir-
cuits, form new contacts, erase others, and remap related cortical and spinal cord
regions. This plasticity can lead to a surprising degree of spontaneous recovery.
It includes the activation of neuronal molecular mechanisms of growth and of ex-
trinsic growth promoting factors and guidance signals in the tissue. Rehabilitative
training and pharmacological interventions may modify and boost these neuronal
processes, but almost nothing is known on the optimal timing of the different pro-
cesses and therapeutic interventions and on their detailed interactions. Finding
optimal rehabilitation paradigms requires an optimal orchestration of the internal
processes of re-organization and the therapeutic interventions in accordance with
defined plastic time windows.
In this review we summarize the mechanisms of spontaneous plasticity after stroke
and experimental interventions to enhance growth and plasticity, with an emphasis
on anti-Nogo-A immunotherapy. We highlight critical time windows of growth and
of rehabilitative training and consider different approaches of combinatorial reha-
bilitative schedules. Finally, we discuss potential future strategies for designing
repair and rehabilitation paradigms by introducing a ’3 step model’: determina-
tion of the metabolic and plastic status of the brain, pharmacological enhancement
of its plastic mechanisms, and stabilization of newly formed functional connections
by rehabilitative training.
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The human brain works wonders to fulfill the requirements of every-day life. These unique
capacities are then fully esteemed when all of a sudden even simple activities fail or become a
problem: Cerebral strokes leave the victims with often large psychical and physical impairments
- from vision problems to aphasia and motor deficits – leading to the number one cause of adult
disability worldwide with great impact on public health. In the acute phase, ’time is brain’ –
ruptured blood vessels (hemorrhagic stroke) or aggregates of platelets and blood cells that clog
cerebral blood vessels (ischemic stroke) cause acute shortage of glucose and oxygen resulting
in metabolic distress and long-term neuronal cell loss. The destruction process is complex and
can only be dampened in the case of the ischemic stroke by very early intervention (within 4-6
hrs) with thrombolysis, (Hacke et al. 2008). Currently, only about 10% of all stroke patients
reach a hospital early enough or fulfill the criteria for being able to receive thrombolysis in the
therapeutic time window. Prognosis and recovery then depend on the location and extent of the
stroke lesion.Clinically, the most successful therapy to further enhance this recovery of function
is rehabilitative training. Rehabilitation as a term ’to reach and maintain optimal functioning
in physical, intellectual, psychological and/or social domains’(WHO. International classification
of functioning disability Health ICF. Geneva: WHO; 2001) is evidence based medicine and does
not exclude a specific subgroup of patients.
Nevertheless, for many rehabilitative interventions, in particular those for long-term or chronic
rehabilitation, robust data or adequately controlled studies are lacking (Quinn et al., 2009):
E.g. comparisons between different training methods in current use could not show that any
particular physiotherapy or stroke rehabilitation strategy is superior to another (Johansson et
al., 2000).
Consequently optimal rehabilitation strategies can only be defined if we understand the way in
which training and the rehabilitation protocol influences the neurobiology of the central nervous
system with priority on the aspects of timing, kind and intensity of rehabilitative training.
Measurable endpoint criteria for rehabilitative outcome are required in order to achieve two
purposes: The adjustment of the ideal rehabilitative strategy to the individual patient, and the
choice of the optimal therapy protocol.
In this review we focus on mechanisms of spontaneous recovery after stroke, on rehabilitative
designs to enhance plasticity, on growth promoting mechanisms with an emphasis on Anti-Nogo
A immunotherapy, and on the time windows of rehabilitative training and pharmacological
interventions and the combination of both.
1.1 Mechanisms of spontaneous recovery after stroke –
from human patients to animal models
For many years people have thought that the hardware of the brain is that ’hard’, that once an
incident such as stroke happens, brain areas and functions are lost forever. The old paradigm of
the adult CNS as a stable and static structure, consisting of billions of nerve cells and circuits,
has now been replaced by a much more dynamic view of the CNS which includes processes of
growth, connectivity changes and areal remodeling that can occur after CNS injury or stroke
and plays an important role in recovery and functional repair.
Spontaneous recovery is seen in stroke patients weeks to months after the incident. However,
due to variability across subjects and across neurological domains efforts of summarizing this
process with precision have been frustrating. Among the most obvious factors that contribute
to the extent of spontaneous recovery are infarct size, infarct location, age and pre-stroke
disability (Cramer, 2008). Most spontaneous recovery tends to occur within the first three
months. While patients with milder deficits achieve spontaneous recovery more quickly than
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patients with more sever deficits, the pattern of spontaneous recovery can also differ within the
same patient for different functions (Cramer, 2008).
1.1.1 Spontaneous recovery of sensorimotor function in humans
Motor recovery has been among the most often examined because motor impairments belong
to the symptoms that are most frequently and precisely diagnosed after stroke (Rathore et al.,
2002; Gresham et al., 1995, Langhorne et al., 2009). Motor impairment can be regarded as a loss
or limitation of function in muscle control or movement or a limitation in mobility. It is a focus
of physiotherapy or occupational therapy in terms of stroke rehabilitation (Langhorne et al.,
2009). The natural history of motor recovery is considerably heterogeneous: The first voluntary
movements can be seen anywhere from 6 to 33 days after a hemiplegic stroke (Twitchell 1951).
The largest improvement occurs in the first 30 days after stroke, though significant progress
is still found in patients with more severe deficits up to 90 days after stroke (Wade et al.,
198; Duncan et al., 1992, Duncan et al., 1994, Duncan et al., 2005). Studies on arm disability
revealed that a maximum of function is reached by 80% of the patients within 3 weeks and by
95% of patients within 9 weeks (Nakajama et al., 1994). Still significant long-term improvement
is found if arm function starts to ameliorate 16 weeks after stroke onset (Broeks et al., 1999).
Insights into the underlying remodeling and re-organization processes for functional recovery in
the brain after stroke can be obtained in human patients via functional neuroimaging methods
and brain mapping. These data suggest that recovery of motor function after stroke leads to
brain-wide modifications in neuronal activity patterns and connectivity (Rehme and Grefke,
2012). While initially tissue function and neurophysiological responses are diminished within
the injured primary neocortex, cortical function increases over time (Marshall et al, 2000;
Calautti et al. 2001, Feydy et al., 2002; Grefkes and Fink, 2011). In terms of good functional
outcome one of the major correlates is the degree of recovery of neurophysiological activity
in the affected primary cortical areas (Cramer 2008). In other terms: the best behavioral
outcomes are associated with the greatest restoration/remodeling of brain function towards
the normal state of organization (Ward et al., 2003; Zemke et al., 2003; Ward 2004; Murphy
and Corbett 2009). This is true even if the post-stroke behaviour is far from being identical
to the pre-stroke motor kinematics. In particular the extent of corticospinal tract integrity
is positively correlated to functional recovery as revealed by transcranial stimulation of the
motor cortex and its efferents after stroke (Talelli et al., 2006). In general, if an ischemic event
occurs, those areas are recruited for structural and functional modification which are either
close or functionally related and connected or both. Therefore, after a small stroke, peri-infarct
tissue is mainly involved that has similar function. By contrast, after a large stroke, tissue
that has similar functions might be only found at more distant sites or in unaffected regions
of the contralateral hemisphere, where still enough capacity for structural remodeling remains
(Murphy and Corbett, 2009).
1.1.2 The role of the premotor and contralesional motor cortex
Which areas are activated and what they contribute in terms of beneficial re-organization for
functional recovery is still under debate: A meta-analysis revealed that activation of premotor
areas and the contralesional primary motor cortex are consistent findings (Rehme et al., 2012,
Rehme et al., 2013). Interactions between premotor areas and the lesioned primary motor cortex
(M1) are directly related to recovery and functional outcome. For example, Johansen-Berg
showed that disruption of dorsal premotor cortex activity by transcranial magnetic stimulation
(TMS) over both the ipsi- and contralateral hemisphere lead to a deterioration of performance
in stroke patients, but not in healthy controls (Johansen-Berg et al., 2002). The exact role of
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the activation of contralesional M1 is a subject to controversy: Longitudinal functional MRI
studies revealed enhanced neuronal activity in motor-related areas in both hemispheres after a
large stroke. But then during the first 12 months post-stroke this activity returns to unilateral
levels similar to those of healthy controls for those patients with good motor recovery (Ward
et al., 2003). Remaining increased activity in the contralesional M1 was often associated with
poor outcome. Further studies have demonstrated that inhibition of contralesional M1 activity
using repetitive TMS may lead to ameliorated motor performance of the stroke-affected hand
in the subacute and chronic phase (Nowak et al., 2008; Takeuchi et al., 2012). In contrast,
Rehme et al., 2010 found that increases in contralesional M1 activity over the first 10 days
after stroke correlate with the amount of spontaneous motor improvement in initially more
impaired patients. These data suggest a supportive role for functional recovery in the early
phase after stroke for the contralesional motor cortex. In addition, disrupting contralesional
M1 activity with TMS resulted in a deterioration of motor-performance of the stroke-affected
hand of stroke patients with capsula interna infarcts (Lotze et al., 2006). A clear time-, size or
lesion-location- dependent influence of the contralesional M1, be it either beneficial or harmful
for functional recovery, remains to be demonstrated.
1.1.3 Changes in cortical excitability, lateralized activation and so-
matotopic re-mapping
For the above described remodeling and recruitment of areas three main forms of reorganization
have been described: (1) Increased cortical excitability in cortical regions distant from, but con-
nected to the stroke core; (2) reduced lateralized activation and (3) somatotopic modifications
within intact cortical regions.
Increased activity, as a first form of reaction to stroke in areas which before stroke formed a
distributed network, has been described many times (Brion et al., 1989; Chollet et al. 1991).
This phenomenon occurs in several cortical areas which include motor, language, attention and
visual functions (Cramer 2008). Widespread areas of cortical hyperactivity appear days after
stroke and diminish within months post incident (Ward 2004). This form of modification in
cortical excitability is thought to be a result of the down-regulation of the α1 γ-amino butyric
acid receptor subunit and a decrease in γ-amino butyric acidergic inhibition (Neumann-Haefelin
et al. 1998).
The second form of reaction to stroke – reduced lateralized activation – reflects the increased
activity in the contralesional hemisphere, which reduces the extent of interhemispheric balance
as demonstrated in many stroke studies (Weiller et al., 1993, Seitz et al., 1998). Reduced
lateralized activation is a common brain response not only seen in stroke but also in other
neurological contexts such as epilepsy, traumatic brain injury and multiple sclerosis (Cramer,
2008). The exact function of this reduced laterality remains to be elucidated: It may be just
a subtype of the described increased activity as described in (1) or a passive event reflecting
a reduced interhemispheric inhibition resulting from the stroke. Another interpretation is that
the contralesional hemisphere has to take over functions that were previously based in the
ipsilesional hemisphere. Both phenomena, increased cortical excitability and reduced laterality,
are related to spontaneous functional recovery (Cramer, 2008). Both are time dependent,
increasing in the early weeks after stroke and decreasing over months thereafter. This decrease
is greater among stroke patients with stronger functional recovery while the persistent increased
activity over both hemispheres is greatest in those patients with the poorest outcome (Cramer
et al. 2006; Ward et al., 2003). A relation to increased susceptibility for seizures and phantom
pain is possible.
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The third response to ischemic injury – somatotopic reorganization – implies that intact cortical
regions – in particular within the perinfarct area – reassign their functions which they subserved
before stroke and take over function, which have been affected or lost by the ischemic event.
Some studies suggest that the largest degree of somatotopic reorganization is associated with
very large stroke injuries (Cramer et al., 2006). Such map shifts occur in primary and secondary
cortical areas (Byrnes et al., 2001).
1.1.4 Animal models to study stroke induced cortical re-organization
on the anatomical and molecular level
As studies in stroke patients have limitations, animal models of stroke have been used to de-
scribe remodeling and reorganization processes on the macro and molecular level. Although
spontaneous recovery in animals tends to occur earlier (depending on stroke size), imaging and
mapping data show a number of analogues between recovery in animals and in humans: Con-
nectivity changes between sensorimotor cortex and deep grey matter structures after middle
cerebral artery occlusion (MCAO) in rats were comparable to results in human stroke patients
(Van der Zijden et al., 2007). fMRI studies concentrating on the affected upper limb in rats
have described a shift in laterality of activation after stroke such that early after stroke, brain
activation during affected paw stimulation is mainly in the contralesional cortex, later after
stroke activity shifts toward the normal pattern, that is the ipsilesional cortex (Dijkhuzen et
al. 2001; Dijkhuzen et al., 2003). Hsu et al., 2006 found that the larger the ischemic insult the
stronger the activity in the contralesional motor cortex. In accordance with human studies Van
Meer et al., 2012 could show that functional recovery after MCAO in rats was correlated with
the extent of preservation or restoration of the ipsilesional corticospinal tract in combination
with reinstatement of interhemispheric neuronal signal synchronization and normalization of
focal network organization.
New mapping methods allow describing somatotopic map shifts in animals in greater detail:
A recent study using light based motor mapping in transgenic mice expressing light-sensitive
channelrhodopsin-2 before and after focal ischemic lesions of the forelimb sensorimotor areas
revealed decreased motor output in the infarcted area and spatial displacement of sensory and
motor maps (Harrison et al., 2013). While strokes in sensory cortex caused the sensory map
to move into the motor cortex, a stoke in the motor cortex lead to a compensatory increase
in peri-infarct cortical motor output, but did not affect the position or excitability of the sen-
sory maps. In vivo 2-photon calcium or voltage sensitive dye imaging furthermore opens up
new possibilities to study the reorganization of complex neuronal networks and their functional
relevance for stroke recovery (Winship and Murphy, 2008; Stetter, 2013). Anatomically, differ-
ent studies have demonstrated that map-shifts and re-mapping can be accompanied by axonal
sprouting (Carmichael, 2003), and dendritic spine turnover (Brown et al., 2008, 2009; 2010).
Using different tracing techniques, Starkey et al., 2012 could show which neurons take over
when functional map shifts occur: If the forelimb motor cortex in rats was destroyed, neurons
in the hindlimb area took over to enable functional recovery of the forelimbs. This functional
shift was based on sprouting of new axon branches from hindlimb corticospinal fibers into the
cervical spinal cord, followed by retraction of the original lumbar projecting axon and thus a
conversion of a hindlimb into a forelimb projecting neuron.
Animal studies have also provided first insights on underlying molecular changes. A unilateral
infarct is associated with a number of growth related processes, in some cases bilaterally. These
events include the induction of inflammatory markers, grow-promoting and inhibiting genes,
cell-cycle regulatory genes and genes involved in synaptogenesis, dendritic branching and neu-
ronal sprouting as reviewed elsewhere (Li and Carmichael, 2006; Popa-Wagner et al., 2007).
Three major phases of stroke reaction and repair are often distinguished (Cramer 2006): The
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first epoch is the acute reaction to the injury and takes place in the initial hours when modifi-
cations become apparent in blood flow, edema, metabolism and inflammation. A second epoch
is related to repair, starts in the first days post stroke and is on-going for several weeks. During
this epoch spontaneous recovery is seen and endogenous repair related events reach their peak
levels. The third epoch begins weeks to months after stroke when spontaneous recovery has
reached a plateau and represents a stable but still modifiable chronic phase.
On the molecular level stroke induces neuronal growth-promoting genes in sequential waves
post insult to initiate axonal sprouting in the peri-infarct cortex, as initially shown in a rat
somato-sensory cortex (barrel field) infarct model (Carmichael et al., 2005): In the early phase
immediate early genes and growth related mRNAs such as SPRR1 are induced 3 to 7 days after
stroke. Typical growth cone constituents such as GAP43, CAP23 and MARCKS as well as the
transcription factor c-Jun are expressed from day 3 onward. Subsequently, the cell adhesion
molecule L1, cyclin-dependent kinase inhibitor p21 and embryonic tubulin isoform alpha1 tubu-
lin are induced, followed by the expression of cytoskeletal reorganization genes such as SCG10
and SCLIP. This pattern of growth gene expression described is unique for axonal sprouting
as a stroke response compared to expression profiles in neuronal development, peripheral or
other CNS injuries (Li et al., 2010). Furthermore, in an early response to stroke (Mattson,
2008; Carmichael, 2012), several neurotrophic factors such as brain-derived neurotrophic factor
(BDNF), nerve growth factor (NGF) and neurotrophin 3 (NT-3) as well as fibroblast growth
factor (FGF)-2 and insulin-like growth factor (IGF-1), epidermal growth factor (EGF) and
glial cell line-derived neurotrophic factor (GDNF) are up-regulated. Each neurotrophic factor
species shows a different temporal and cellular distribution pattern(Abe et al., 2000): While
GDNF is mainly expressed by neurons, CNTF induction was predominantly observed in as-
troglia of the marginal region and VEDF gene expression was found in both non-neuronal and
neuronal cell types after stroke.
Axonal sprouting not only requires the induction of growth-promoting programs within perin-
farct neurons, but also a reduction in the growth inhibitory environment (Carmichael, 2006):
Axonal growth inhibition in the adult CNS is mediated through three general classes of proteins:
myelin associated proteins (NogoA, myelin-associated glycoprotein, oligodendrocyte myelin gly-
coprotein), extracellular matrix proteins (e.g. chondroitin sulfate proteoglycans) and repulsive
cues for growth cones known mainly from development (e.g. ephrins, semaphorins). Interest-
ingly, messenger RNAs for the chondroitine sulfate proteoglycans aggrecan, phosphacan and
versican were found to be induced later after stroke than the early and middle phase of the
growth-promoting gene expression. A small number of growth inhibitory proteins including
Nogo A (Jiang et al., 2009), ephrin A5, semaphoring IIIa and neuropilin 1are induced in the
early phase, however, but down-regulation of Nogo receptor components were also seen (Li et
al., 2010).
Not only a temporal expression pattern of growth promoting and inhibiting genes can be de-
tected, but also the spatial distribution plays a role to induce the brain´s self-repair processes at
the right location: Axonal sprouting e.g. in the peri-infarct cortex takes place in a distinct envi-
ronment close to but larger than the glial scar. Thus, within the glial scar representing the wall
that separates the stroke core from the surviving per-infarct tissue both, growth-promoting and
growth inhibiting factors are induced while the growth-permissive and peri-infact cortex shows a
reduction of the levels of growth inhibiting molecules such as chondroitin sulfate proteoglycans.
In contrast, neurotrophins such as BDNF are highly up-regulated in the growth-permissive
penumbra und repressed in the stroke core (Lanfranconi, 2011).
Taken together, the data on the time and space dependent processes of intrinsic repair mecha-
nisms after stroke suggest a critical period or time window, in which the CNS recruits factors
for plasticity that enhance functional recovery. One of the most crucial questions that has to
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be addressed from a clinical perspective is whether this period characterized by map shifts,
fiber growth and major functional and structural changes is also the time window in which
rehabilitative interventions should be initiated. We now give an overview on rehabilitative and
repair strategies with an emphasis on timing, kind and intensity.
1.2 Strategies to enhance plasticity after stroke
1.2.1 Growth and plasticity enhancing treatments
Since the discovery of nerve growth factors and factors that prevent neuronal outgrowth and
survival, it became a goal in experimental animal studies to apply or induce growth-promoting
factors and inhibit the inhibiting ones. Several preclinical studies have examined various
growth factors, hormones and cytokines with the aim to enhance motor rehabilitation – in-
cluding prominent candidates such as nerve growth factor, glia (GDNF) and brain derived
neurotrophic factor (BDNF), insulin-like growth factor, erythropoietin and the granulocyte
colony-stimulating factor. All have met with variable levels of success in animal models; some
initial clinical studies have started (The BDNF study group, 1999; Nagahara and Tuszynski,
2011).
In adult rats with large strokes, the administration of BDNF resulted in improved recovery
rates (Schabitz et al., 2004), while the beneficial effect of rehabilitation on the improvement
of forelimb function was prevented in animals treated with a BDNF antisense oligonucleotide
(Ploughman et al., 2009). The translation of these results into clinical trials remains challeng-
ing and is a matter of safety concerns: In the case of BDNF applied as a neuro-protective
agent after stroke, the administration of very large quantities would be necessary as well as
repeated dosing to overcome the limited amount of protein that reaches the CNS, even with
transient disruption of the blood-brain barrier after stroke. The adverse effects of these high
dosages have not been extensively studied in animal models (Nagahara and Tuszynski, 2011).
Furthermore, the largest clinical trial of erythropoietin therapy revealed that, compared with
placebo, erythropoietin administration was associated with an increased risk of mortality in
patients with acute stroke (Ehrenreich et al., 2009).
Other experimental approaches to enhance the intrinsic regeneration ability of CNS axons in-
clude injecting cAMP analogs to influence intracellular signaling pathways (Hannila and Filbin
2008), knock down of the protein synthesis inhibitor PTEN (Liu et al., 2010) or blocking the
small GTPase RhoA (Ellezan et al., 2002).
Promising results have also been gained if inhibition of neuronal plasticity and outgrowth was
decreased either by (1) digesting growth restricting ECM proteoglycans with enzymes such as
chondroitinase ABC or (2) by blocking the growth inhibitory protein Nogo A (3) or by grafting
growth permissive cells. The bacterial enzyme chondroitinase ABC digests the glycosaminogly-
can chains of the chondroitin sulfate proteoglycans (CSPGs) which are part of the extracellular
matrix and usually up-regulated in astrocyctes and oligodendrocytes after CNS injury (Garcia-
Alias and Fawcett, 2012). Chondroitinase ABC treatment reduces scar formation and enhances
axonal regeneration and sprouting as first shown in several studies after experimental spinal
cord injury (Moon et al., 2001; Bradbury et al., 2002; Huang et al., 2006). After stroke,
chondroitinase ABC administration promoted functional recovery (Hill et al., 2012; Starkey et
al., 2012). Furthermore, Soleman et al., 2012 could demonstrate that delayed chondroitinase
ABC microinjections into the cervical spinal cord induce localized plasticity of the forelimb
sensorimotor spinal circuitry without effects on the cortical peri-infarct region.
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Inhibition of Nogo-A Signaling in animal models of stroke
The well-studied protein Nogo-A, a transmembrane protein of about 1200 amino acids includ-
ing a C-terminal 200 amino acid reticulon (RTN) domain, is involved in several cellular and
molecular events contributing to the failure of CNS axons to sprout and reconnect after CNS
injury. Function-blocking antibodies against Nogo-A, Nogo receptor (NgR1)-blocking peptides,
antibodies against the Nogo receptor subunit Lingo-1, or pharmacological blockade of the sig-
nal transducer RhoA and ROCK have been administered in various laboratories in different
stroke and spinal cord injury models in rodents and primates (Pernet and Schwab, 2012 for
review). Enhancement of behavioral recovery in a variety of sensory-motor tasks as well as
anatomical evidence of fiber growth, increased plasticity and re-organization within the cortex,
brain stem and spinal cord have been reported (Zörner and Schwab 2010 for review). Despite
different approaches to interrupt Nogo-A signaling, a high degree of similarity in terms of func-
tional recovery and hardware changes in the CNS was found among research groups and injury
models. Acute intrathecal anti-Nogo A antibody infusion over 2 weeks after stroke, with an
application starting early after incident (Wiessner et al., 2003; Tsai et al., 2007), or delayed
application starting 9 weeks after stroke in adult rats (Tsai et al., 2011) significantly improved
forelimb function and was correlated with a significant increase of midline crossing corticospinal
fibers originating in the unlesioned sensorimotor cortex. Robust sprouting of new projections
from contralesional brain regions into subcortical structures as well as functional reorganiza-
tion of contralateral sensorimotor areas were reported after anti-Nogo-A immunotherapy in rats
(Markus et al., 2005; Cheatwood et al., 2008). Those newly sprouting cortico-efferent axons
terminated in the red nucleus, pontine nuclei and spinal cord. A similar effect was found by
down-regulation of the Nogo receptor NgR using adenovirus-mediated RNA interference (Wang
et al., 2010) or NgR or Nogo-A/B knockout mice (Lee et al. 2004). Anti-Nogo-A immunother-
apy was also associated with increases in dendritic length, complexity, and spine density, both
in the lesioned and contralesional hemisphere (Papadopoulos et al., 2006). Functional MR-
imaging 8 weeks after unilateral middle cerebral artery occlusion revealed adaptations in the
somatosensory system of rats in the anti-Nogo-A antibody treatment group (Markus et al.,
2005). Nevertheless anti-Nogo-A immunotherapy is not neuroprotective in the sense that it
would reduce stroke lesion size as reported for anti-MAG immunotherapy (Irving et al., 2005).
This opens the therapeutic window for anti-Nogo-A immunotherapy in the subacute and even
chronic phase.
The described in vivo experiments represent essential preclinical tests to validate the efficiency
and safety of intrathecal Nogo-A antibody administration. Three different anti-Nogo-A anti-
bodies (IN-1, 11C7, 7B12) have proved efficient in enhancing axonal regeneration and outgrowth
both in vitro and in vivo. In collaboration with Novartis Pharma, a human anti-human Nogo-
A antibody has been developed and tested in extensive toxicological studies with intrathecal
antibody application in rodents and primates.
In a Phase I clinical trial (http://clinicaltrials.gov/ct2/show/NCT00406016) with 52 acutely
injured para- and tetraplegic patients in Europe (European Multicenter Study about Spinal
Cord Injury, EMSCI, www.emsci.org) and Canada pharmacokinetics, safety, tolerance and
dosing of intrathecal delivery of the antibody were investigated. The tolerance has been excel-
lent without any adverse effects ascribed to the anti-Nogo-A antibody (Abel et al., 2011). A
placebo-controlled Phase II clinical trial is currently in preparation. Anti-Nogo antibodies are
also in clinical trials or in preparation for clinical trials for other neurological indications such
as multiple sclerosis and amytrophic lateral sclerosis (ALS). For ALS GlaxoSmithKline (GSK)
has also developed a humanized anti-Nogo-A antibody (GSK1223249). In a Phase I clinical
trial, the intravenous injections of GSK1223249 were well tolerated by the 76 patients enrolled
in the study (Pradat et al., 2011).
Several additional molecules restricting axonal growth in vitro have been identified including
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ephrins, netrins, semaphorins and OMgp (oligodendrocyte myelin glycoprotein)(Schwab et al.,
1990, Schwab et al., 1993; Schwab, 2010). Their role in vivo after stroke has to be evaluated.
How much growth and plasticity of the adult, stroke-injured CNS can be enhanced by single
or combined manipulations of growth promoting or inhibitory mechanisms, and if there is a
danger of chaotic growth and formation of wrong connections is currently unknown.
Finally, grafting growth permissive cells, such as bone-marrow mesenchymal cells, cord blood
cells, fetal cells and embryonic cells as a form of restorative therapy have been studied in
animals (Chopp and Li, 2002). E.g. cultivated bone-marrow stromal cells from donor rats were
stereotaxtically implanted into the peri-infarct area in rats resulting in significant recovery of
somatosensory behaviour. In a first small study, 5/30 stroke patients who received autologous
bone-marrow mesenchymal cell transplantation showed beneficial effects in clinical stroke scores
(Bang et al., 2005). Such cell-based therapies could influence endogenous neurogenesis, axonal
sprouting and synaptogenesis in ischemic brain tissue (Zhang and Chopp. 2009), although their
effects may be primarily immune-modulatory or neurotrophic. More detailed and systematic
studies are certainly needed.
1.2.2 Rehabilitative training in clinical and experimental studies
The brain, including the motor system, learns by repetition and training. Many basic mecha-
nisms, however, are still poorly understood, and rehabilitative training is largely evidence-based
medicine (European Stroke Organization Guidelines 2008). Nevertheless there are no generally
accepted guidelines and no definite recommendations concerning the timing, kind and intensity
of rehabilitative training. Clear end point data and randomized controlled clinical trials are
often lacking. Furthermore, stroke recovery is a complex process that probably occurs through
a combination of restoration, substitution and compensation of functions. For this reason it
has been also difficult to translate results from rehabilitative studies in animals to recommen-
dations for rehabilitative schedules in human stroke patients. A majority of clinical studies has
been conducted in chronic stroke patients (>6 months after the stroke) as recruitment of these
patients was easier and baseline performance had stabilized (Krakauer et al., 2012). These
circumstances lead to functional outcome measurements probably gained largely from compen-
satory techniques to improve skills for daily living. In contrast, animal studies had a stronger
focus on enhancing impairment with more or less detailed analysis how much of the functional
recovery was restoration of baseline (motor) function or compensation. Furthermore, the time
courses of motor recovery differ among animal and human studies: While recovery in rodent
models reaches its maximum around 4 weeks after stroke, human stroke survivors complete
most of their recovery within 3 months (Dimyan and Cohen, 2011; Krakauer et al., 2012).
Early versus delayed training
A consensus exists that the effects of early training, - whereby ’early’ should be starting at
1-2 weeks in animals, not earlier (see below), - exceed effects of delayed training in terms of
functional recovery in both, animals and humans (Nudo, 2006; Murphy and Corbett, 2009;
Langhorne et al., 2011; Krakauer et al., 2012). In animal studies, behavioral training after
ischemic injury is most effective for restoring behavioral performance, peri-infarct neurophysio-
logical maps and enhanced neuroanatomical changes in the ipsi- and contralesional hemisphere
when introduced within the first week of injury (Nudo 2006). In a rat middle cerebral artery
occlusion (MCAO) stroke model it was demonstrated that functional outcome and dendritic
branching patterns in the contralesional hemisphere were restricted when rehabilitative training
was initiated 14 and 30 days post insult (Biernaskie et al., 2004). In another study by Hsu
and Jones 2005, rats were trained in a skilled forelimb reaching tasking starting 4 or 25 days
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post stroke. Reaching performance was significantly enhanced in the early trained group. In
a small ischemic insult in M1 in squirrel monkeys delayed training resulted in a large decrease
in spared hand representation during the spontaneous recovery period that persisted following
the delayed training (Barbay et al., 2006).
Concerns about initiating therapy too early following stroke arose from studies where lesion
size and cell death rate were seen to be exaggerated after early excessive use of the impaired
forelimb in rats while the unimpaired forelimb was casted (Kozlowski et al., 1996). One cause
for increased lesion size following early excessive limb training might be NMDA-mediated ex-
citotoxicity in the already hyperexcitable peri-infarct region (Humm et al., 1999). In closer
resemblance to clinical practice were animal studies, where training or enriched rehabilitation
was initiated a few days after stroke. In these cases early intervention (1-3 days post stroke)
again was associated with increased cell-death but also with much improved motor performance
on the long-term (Risedal et al., 1999; Farrell et al. 2001). Here, neuronal cell death may be
part of a pruning effect in which non- or dysfunctional neurons are eliminated early due to a
use-dependent selection. In summary, the overall consensus from animal data is that initiating
rehabilitative training 5 or more days after stroke is mostly beneficial and has no adverse effects
(Krakauer et al., 2012).
CIMT, robot assisted training and electrical devices to stimulate the rehabilitation
process
For human stroke patients two advanced rehabilitative approaches have proven beneficial for
functional outcome: constraint-induced movement therapy (CIMT) and robot-assisted training
for upper limb function (Langhorne et al., 2009; Mehrholz et al., 2012; Liao et al., 2012). Ex-
tensive preclinical studies in rodents and primates have preceded both rehabilitative strategies
(Taub et al., 2002). When somatic sensation is surgically abolished from a single forelimb
in a monkey, the animal avoids the usage of this forelimb in the free situation, but monkeys
can be induced to use the de-afferented extremity by restricting movement of the intact limb
continuously for a period of days. This concept was successfully brought into the clinics when
chronic stroke patients wore a sling or cast on their less affected arm during 90% of their waking
hours for 14 days (Taub et al., 1993). These patients showed a significant increase in the skill
and quality of movement as measured by two laboratory tests and a much larger increase in
real-world arm use over the period of these two weeks than the unrestricted control group.
Two studies addressed the question of intensity and timing for CIMT: In the VECTORS study
(Dromerick et al., 2009), 52 stroke patients were randomized at about 10 days post stroke to
two levels of intensity of CIMT or standard upper extremity therapy. Intense meant 3 hours
of CIMT versus 2 hours of shaping therapy. After 90 days the motor outcome was worse for
the more intensive CIMT group, although there had been no difference at 30 days. This result
reflects the fact that too intensive CIMT can turn into an adverse situation for both the pa-
tient and the therapist. In the much larger EXCITE study (Wolf et al., 2006) patients started
CIMT therapy 3 to 9 months post stroke and showed greater motor recovery than the usual
care group. In addition Lang et al., 2013 revealed that improvements in existing motor abilities
were possible with both early (3 to 9 months post stroke) and delayed (15 to 21 months post
stroke) application of CIMT. However, significant reacquisition of the ability to complete tasks
was only detected with early CIMT treatment.
A number of arm and also hand training robots have been developed recently with the aim to
allow very intense training without continuous, costly physiotherapy assistance. In the most
modern set-ups, training devices are combined with interactive video games that can boost the
motivation of the patient for the training and facility e.g. precision movements (e.g. grasping
eggs and putting them into a basket). The number of well controlled and standardized outcome
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studies is still very limited. However, differences are discriminated between recovery of specific
movements under ‘laboratory conditions’ and functional gains for daily life activities (Mehrholz
et al., 2012). Such studies are needed to exactly know the specific advantages (and potential
drawbacks) of robot assisted rehabilitation in stroke (Aisen et al., 1997; Balasubramanian et
al., 2010; Mehrholz et al., 2012).
Therapeutic approaches which directly stimulate the PNS or CNS electrically or by magnetic
pulses may enhance neuroplasticity during poststroke rehabilitation (Dimyan and Cohen, 2011).
Numerous research groups have examined the stimulation of the CNS, specifically the primary
motor cortex (M1), by noninvasive approaches such as transcranial magnetic stimulation (TMS)
and direct current stimulation as well as experimentally in animals by the implantation of
electrodes. Several studies showed that an increase of the excitability in the stroke-affected
ipsilesional M1 by electrical devices resulted in improved motor outcome (Hummel et al., 2005;
Malcolm et al., 2007, Ameli et al., 2009; Koganemaru et al., 2010). The mechanisms of action
of these techniques are under investigation but might involve changes in synaptic activity, gene
expression and increases in neurotransmitter, receptor and neurotrophin levels (Dimyan and
Cohen, 2011) or even enhanced fiber sprouting (Martin 2012). Understanding these mechanisms
may provide the basis for novel approaches using closed-loop brain machine interfaces (BMIs)
that define optimal stimulation parameters from a priori developed experimental models and
correctly modulate ionic currents and extracellular electric fields to provoke and guide plastic
changes of the CNS (Gonzalez Andino et al., 2011).
1.3 Combination of different repair and rehabilitation
strategies
To maximize the effectiveness of rehabilitative therapies after stroke, it is critical to define
when the brain is most responsive to sensorimotor input or extrinsic application of plasticity
promoting reagents. This becomes particularly important if different rehabilitative approaches
are combined.
In one of the first proof of concept studies for a critical period of heightened neuroplasticity,
stroke rats were exposed to an enriched environment in combination with daily sessions of
grasping training. The most significant gains in the recovery of forelimb reaching ability were
achieved when rehabilitation was initiated early, i.e.5 days after stroke as compared to 14 and
30 days after stroke. Recovery was associated with increased dendritic branching of layer V
motor cortex neurons in the unlesioned hemisphere – a response that was not detected when
rehabilitation was delayed by 30 days (Biernaskie et al., 2004).
A few recent studies in which regenerative therapies and rehabilitation have been combined have
been conducted since then. These experiments suggest that designing the combination and their
temporal pattern of administration are not going to be trivial (Garcia-Alias and Fawcett, 2012;
Starkey and Schwab, 2012).The different experiments have revealed a beneficial combinatorial
effect, a detrimental effect, no effect at all, or an effect that depends on the relative timing of
plasticity treatment and rehabilitation. Beneficial effects were described in spinal cord injury
rat models when agents against inhibitory molecules in the CNS were combined with growth
promoting reagents: Garcia-Alias et al., 2011 reported that the combination of Chondroitinase
ABC with neurotrophin NT-3 and an increased expression of the NR2D subunit of the NMDA
receptor resulted in better body stability and interlimb coordination compared with the single
treatment groups. The behavioral data were correlated with the highest number of sprouting
axons in the spinal cord and multisynaptic responses in the motor-neurons. Similar results could
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be found if anti-Nogo-A antibodies were combined with NT-3 and the NMDA-NR2D subunit
(Schnell et al., 2011). Furthermore, the combinatorial treatment of acutely applied anti-Nogo-
A antibody followed by delayed Chondroitinase ABC treatment starting 3 weeks after spinal
cord injury, and forelimb grasp training starting at 4 weeks was much more effective in terms of
functional recovery, sprouting and axonal regeneration than the single treatments (Zhao et al.,
2013). In rats with large cortical strokes, inosine, a substance which was shown to improve fine
motor control after stroke (Zai et al., 2009), augmented the effects of the Nogo receptor blocker
NEP1-40 in the restoration of skilled reaching abilities in rats. Similar functional improvements
were seen when inosine was combined with environmental enrichment (Zai et al., 2011).
Several recent experiments – mainly in spinal cord injury - have combined growth-promoting
agents with rehabilitative training with somewhat different results: Garcia-Alias et al., 2009
investigated whether chondroitinase-induced plasticity combined with physical rehabilitation
promotes recovery of manual dexterity in rats with cervical spinal cord injury. While CSPG
digestion combined with forelimb-specific rehabilitation lead to improved manual dexterity,
animals treated with chondroitinase ABC in combination with environmental enrichment im-
proved in ladder walking but performed much worse in skilled forelimb tasks than untreated
control animals. In a second investigation by Maier et al., 2009 adult rats with large but in-
complete cervical spinal cord injury received anti-Nogo A antibodies and simultaneous daily
forced treadmill training. The simultaneous rehabilitative therapy clearly worsened the func-
tional outcome compared with either treatment alone. When the forced treadmill training was
delayed, however, for two weeks after the end of the antibody treatment a very good functional
outcome was obtained (Marsh et al., 2010). In contrast to these results in spinal cord injured
rats, combination of Nogo receptor blockade with skilled forelimb training in stroke lead to a
greater degree of recovery than when either of the treatments were applied alone (Fang et al.,
2010).
No additive or adverse effects were reported by Boyce et al., 2007 when neurotrophins were
combined with rehabilitative training in spinal cord injured cats. Administration of pharma-
cological neuromodulators such as amphetamine and cholinergic agonists in combination with
rehabilitative training are a matter of debate: Early animal research had suggested a beneficial
effect of amphetamine in recovery of motor function after stroke which could not be sufficiently
reproduced in recent human and animal studies (Krakauer et al., 2012). Only for the anti-
depressant fluoxetine, a serotonin-selective reuptake inhibitor, which was applied from 9 days
post stroke to 3 months in a human stroke study, an impressive degree of increased motor recov-
ery was found when combined with rehabilitative training (Chollet et al., 2011). For all these
studies and their quite diverse outcomes, better knowledge of the neurobiological phenomena
and mechanisms triggered by the injury, the spontaneous reaction of the nervous tissue to it,
and by the different pharmacological and behavioral interventions is urgently required.
1.4 Future directions for designing optimal rehabilita-
tion schedules
How can we better understand the neurobiology of rehabilitation? What can we learn from the
above mentioned animal and clinical studies to improve current rehabilitation schedules for the
best possible recovery after stroke? The presence of critical time windows for the application
of growth and plasticity promoting agents and of training-dependent plasticity suggests that
careful consideration of rehabilitation onset times, tailored training to the type and extent of
stroke and the patient´s history are required. Potential future rehabilitation schedules after
stroke may therefore include the following ’3 step model’ (Figure 1):
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(1) Determination of the metabolic and plastic status of the brain by using state-
of-the-art imaging technologies and metabolic markers
(2) Enhancement of the plastic status of the brain by the application of growth
and plasticity-promoting factors
(3) Selection and stabilization of newly formed functional connections by rehabili-
tative training
One obstacle of the implementation of the optimal restorative therapies is the heterogeneity
of stroke as injury location and size differ widely from one patient to another. The ability
to assign the right therapy to the right patient would maximize treatment effects. Although
clinical scores and a number of imaging methods exist for evaluating the state of the central
nervous system and its function after stroke as reviewed elsewhere (Burke and Cramer, 2013),
these approaches are often insensitive, cost intensive and have logistical difficulties. Neverthe-
less, neuroimaging is not only essential for the establishment of acute stroke diagnosis but can
also serve as a powerful tool for the characterization of disease progression and monitoring of
the response to rehabilitative interventions. Diffusion-weighted imaging (DWI) and perfusion-
weighted MRI(PWI) are widely available MRI modalities that provide valuable information
about the tissue characteristics of the ischemic core but also of the tissue at risk in the penum-
bra (Merino and Warach et al., 2010; Fisher and Bastan et al., 2012). Further work is needed to
optimize the characterization of penumbra imaging for patient triage into adjusted treatment
groups. In the near future we expect to learn if penumbra imaging or other early imaging
features provide predictive value of critical time windows in which therapeutic interventions
should be initiated or maintained and allow stratification of patients into groups for specific
types of therapies.
Biomarker profiles in blood and CSF samples could bring a tremendous advance and are cur-
rently a focus of genomic and proteomic profiling studies and of systems biology in several
laboratories (Stuart et al., 2010; Hemphill et al., 2011, Whitley et al., 2012). In this regard, a
biomarker or a specific combination and profile of biomarkers may not only speed up diagnosis
and initiation of acute stroke treatment but may also help to classify and categorize patient
groups for prediction of outcome and target the right rehabilitative approach to those stroke
patients who would benefit the most.
Why do we suggest a temporal sequence of first enhancing the plastic state by growth promoting
agents followed by a phase of rehabilitative training in our ’3 Step Model’?
The current data suggest that the CNS reacts to the injury by an activation of growth and
plasticity mechanisms which, however, seem to also represent a vulnerable phase in which forced
activity can be harmful: This phase includes a period of GABA-mediated tonic inhibition, which
may also be necessary in the first days after the stroke to limit an expansion of the infarct size
(Clarkson et al., 2010), as well as homeostatic plasticity mechanisms, which ensure that neurons
receive an balanced amount of synaptic input (Murphy and Corbett, 2009). Intrinsic growth
and plasticity as well as exogenous enhancement of growth will lead to the formation of a large
number of new connections within and between different areas of the injured CNS. In analogy
to the situation in early postnatal development, many of these connections may be weak and
imprecise. The functionally meaningful ones will now have to be selected and stabilized, while
the malfunctional ones should be pruned, in the next, activity-dependent phase of the recovery
process.
In the last step of recovery that is based mainly on rehabilitative training the spared and the
new circuitry of the CNS is shaped by selection and stabilization of functional connections and
pruning of the non-functional ones. Hebbian learning rules might play a crucial role in this
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Fig. 1: Schematic overview of the ’3 step model’ - as a possible roadmap for designing future
rehabilitation schedules: (1) Determination of the metabolic and plastic status of the brain by using
state- of the art imaging technologies (image taken by the Akashi Municipal Hospital, Japan) and biomarker
profiles in the blood and CSF. (2) Enhancement of intrinsic repair and plasticity mechanisms in the ispi-
and contralesional hemisphere as well as the spinal cord by application of growth and plasticity-promoting
factors such as anti-Nogo-A antibody or Chondroitinase ABC. (3) Selection and stabilization of newly formed
functional connections and pruning of non-functional ones by rehabilitative training.
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step in the sense that Hebbian plasticity mechanisms redistribute synaptic strength to favor the
wiring of pathways that are coincidently active (Murphy and Corbett, 2009). Motor learning in
development is a very protracted process, requiring huge numbers of repetitions over a period
of many weeks and months. Much too less is known today on the optimal time and intensity
requirements for rehabilitation learning. To distinguish optimal rehabilitation schedules from
less beneficial ones, strict criteria for functional outcome have to be defined that discriminate
compensation and substitution from real restoration of previously impaired function. Much
remains to be learned and applied in this fascinating and medically most important field of
stroke rehabilitation at the interface between basic neuroscience and clinical neurology.
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Abstract
Current stroke research faces the same challenge as neuroscience: To transform
correlative findings in causative ones. Research of recent years has shown the
tremendous potential of the central nervous system to react to noxious stimuli such
as a stroke: Increased plastic changes leading to re-organization in form of neuronal
rewiring, neurogenesis and synaptogenesis, accompanied by transcriptional and
translational turn-over in the affected cells, have been described both clinically and
in experimental stroke research. However, less attempts have been made to connect
distinct plastic remodeling processes as causative features for specific behavioral
phenotypes. In this chapter we review current state-of the art techniques for
the examination of cortical reorganization and for the manipulation of neuronal
circuits as well as techniques which combine anatomical changes with molecular
profiling. These tools may be useful to close the loop from our understanding of
stroke pathology to behavioral outcome and may allow to discover new targets for
therapeutical approaches.
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Although huge efforts have been made in recent years, both by clinicians and by basic re-
searcher, we still have limited insights into a disease such as stroke (the second most common
cause of death after heart diseases worldwide) preventing us from developing specific cures and
resulting in poor statistical numbers: Of 15 million people suffering from a stroke every year,
a third dies, a third remains permanently disabled and a third recovers as the stroke itself has
not been too devastating. On the clinical side stroke units have been created, which combine
experts in intensive care medicine, neurology, physiotherapy and speech therapy, to accelerate
and coordinate the diagnostic and therapeutical processes aiming at improving recovery rates
for the patients. According to the neurologists’ saying ’time is brain’ even mobile units have
been established to bring the hospital to the patient (Walter et al., 2012) in order to increase
the number of patients being eligible for the only currently approved treatment option, the ap-
plication of the enzyme tissue plasminogen activator (tPA) within a time window of 4.5 hours
after stroke onset (Hacke et al., 2008).
On the side of basic research, studying the neurobiology of stroke, we seem to be stuck in a
’black box’ situation: we have accumulated data showing the brain’s tremendous capacities
to reorganize by synaptogenesis and even neurogenesis, by neuronal circuit rewiring and new
circuit formation. We find cortical map shifts and hyperactive brain regions after stroke, we
detected genetic and proteomic turn-over within a distinct spatiotemporal profile and sequence
of events. However, we have failed so far, to transform pure correlative data into causative ones,
meaning, we have to be able to causatively connect plastic remodeling processes in the brain
to distinct behavioral outcomes. This will not only allow us to form a new understanding of
the brain’s functional status after stroke, but also opens up possibilities to develop and test the
efficiency of new therapeutic approaches. Today’s basic stroke research is part of neuroscience
that faces the challenges to first describe the broad morphological features, then study fine
cellular and molecular events, find genes which are active in one neuron or cell-type but not
in another and bring it back to the behavioral phenotype. But as the philosopher of science
Karl Popper might have argued, before we can provide answers, we need the power to ask new
questions. In recent years new technology has been designed which is starting to fill the gap
between correlative and causative research.
The aim of this chapter is to introduce state-of the art technology for the examination of cor-
tical reorganization, manipulation of neuronal circuits and techniques which combine cytology
with molecular profiles - all tools, which may elucidate not only our understanding of stroke
pathology but also help to identify crucial anchor points for new therapeutic interventions.
2.1 State-of the art techniques to study cortical reorga-
nization after experimental stroke
A classical approach to study cortical reorganization and to find first hints if projections in the
motor cortex are functionally relevant, is intracortical microstimulation (ICMS) and surface
stimulation with electrode arrays. This technique applies electrical stimulation of cortical sites
to induce e.g. stimulus-evoked movement responses, which can be detected visually, by EMG
responses or by usage of accelerometers. Several studies have used this technique to either
examine cortical map shifts after spontaneous recovery or different therapeutical applications
(Emerick et al., 2003; Starkey et al., 2012; Lindau et al., 2014), or used the stimulation it-
self as a method to increase plastic processes (Brus-Ramer et al., 2007). However, ICMS has
its disadvantages such as the inability to selectively target neuronal subtypes as well as the
indiscriminate activation of axons of passage. Furthermore, due to electrode penetration intra-
cortical electric stimulation remains an invasive procedure causing tissue damage (Ayling et al.,
2009). ICMS is limited to perform cortical representation of body function at a distinct time
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point after stroke constraining longitudinal experiments within the same animal.
Another technique to study in particular sensory map shifts is millisecond-timescale voltage-
sensitive dye (VSD) imaging which unlike functional fMRI and intrinsic optical signal imaging
measures electrical activity with relatively high spatial and temporal resolution (Mohajerani
et al., 2013). VSD imaging has recently be applied to measure spontaneous activity over large
regions of the mouse cortex to reveal fast, complex, localized and bilaterally synchronized pat-
terns of depolarization (Mohajerani et al., 2010). In a study by Ghosh et al., 2010 VSD imaging
was used to show the expansion of the forelimb sensory map towards parts of the hindlimb cor-
tex after a large thoracic spinal cord injury, indicating incorporation of axotomized hindlimb
neurons into sensory circuits of the forelimb. In another study by Brown et al., 2009 the
function of the sensorimotor cortex was visualized with VSD imaging. The mouse forelimb
sensory cortex was targeted by stroke leading to a new sensory representation in the territory
previously occupied by the forelimb motor cortex. VSD imaging revealed slower kinetics in
remapped sensory circuits accompanied by high levels of dendritic spines as visualized with
two-photon microscopy.
A new non-invasive strategy to study the reorganization of the motor cortex after stroke in the
same animal over time is light-based motor mapping: This technique makes usage of the possi-
bility to stimulate neurons by light, either by uncaging neurotransmitters (Shepherd et al., 2003;
Luo et al., 2008) or by directly activating light-sensitive channels, such as channelrhodopsin-2
(ChR-2). Ayling et al., 2009 used transgenic channelrhodopsin-2 mice which express ChR-2
in layer 5B pyramidal neurons of the motor cortex. Thus, light-based stimulation directly
targets corticofugal cells, enabling the analysis of their contribution to motor cortex topogra-
phy. Light-based motor mapping has the advantage of sampling stimulus-evoked movements
at hundreds of cortical locations in mere minutes objectively and in a reproducible manner
(Harrison et al., 2012). It is faster and less invasive than electrode-based mapping and can be
combined with intrinsic signal imaging in animals with cranial window preparations (Harrison
et al., 2013). In addition it enables repeated mapping of the motor cortex over a timescale
of minutes to months, opening up possibilities to examine the dynamics of movement repre-
sentations at distinct conditions such as learning over time, pharmacological intervention or
reorganization before, during and after cortical damage. In a first study by Harrison et al.,
2012, light-based motor mapping revealed a functional subdivison of the forelimb motor cortex
based on the direction of movement evoked by brief light pulses (10ms), while prolonged stimu-
lation (100-500ms) resulted in complex movements of the forelimb to specific positions in space.
In a follow-up study (Harrison et al., 2013) light-based mapping was for the first time used to
perform a longitudinal experiment studying the reorganization of the sensorimotor cortex after
a focal sensory stroke. The sensory stroke caused the establishment of a new sensory map in
prior parts of the forelimb motor cortex, which preserved its center position but became more
dispersed.
However, although all described mapping approaches are powerful tools, they can only provide
information about map shifts and representation of general movement dynamics. They stay far
beyond cellular resolution and do not allow to study local neuronal circuitry or single neuron
contribution to neuronal networks. In particular after stroke it is not clear how activity in single
neurons changes in relation to cortical map shifts. The analysis of single neurons in relation
to the neuronal circuit in which they are embedded may elucidate whether stroke-induced
plasticity is a result of the capacity of surviving neurons to process multiple functional streams.
In vivo two-photon calcium imaging is a potent method which allows not only to study activity
of a single neuron or ensembles of neurons in a network, it also enables cell type and neuronal
sub-type specific analysis. Only a few in vivo two-photon calcium imaging studies focusing on
neuronal reorganization and circuit rewiring after stroke have been conducted so far. In an
acute in vivo calcium imaging experiment during the induction of a transient global ischemia
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model in mice, Murphy et al., 2008 saw a wide spread loss of mouse somatosensory cortex
apical dendritic structure during the phase of ischemic depolarization. This was accompanied
by increased intracellular calcium levels which coincidently occured with the loss of dendritic
structure. In a second study by Winship and Murphy, 2008 in vivo two-photon calcium imaging
was used to study how response properties of individual neurons and glia cells in reorganized
forelimb and hindlimb functional somatosensory maps modified during the recovery period from
ischemic damage in the sensory cortex. However, all studies have been conducted in animals
under anesthesia which itself influences neuronal activity. An experiment which examines single
neuron activity in the behaving animal before stroke and during the recovery phase after insult
is lacking so far.
2.2 State-of the art techniques for the manipulation of
neuronal circuits
In a 1979 Scientific American article Nobel laureate Francis Crick stated that the major chal-
lenge facing neuroscience was the need to control one type of cell in the brain while leaving
others unaltered. And in a lecture from 1999 he further confined: ’One of the next requirements
is to be able to turn the firing of one or more types of neuron on and off in the alert animal in a
rapid manner. The ideal signal would be light, probably at an infrared wavelength to allow the
light to penetrate far enough. This seems rather farfetched but it is conceivable that molecular
biologists could engineer a particular cell type to be sensitive to light in this way’ (Crick, 1999).
Manipulation of neuronal circuits or single neurons has two prerequisites: Manipulation has to
be quick and very specific. Over the years a very diverse set of tools has been developed to
manipulate the activity of individual cells and subtypes in the alert behaving animal. The first
constraint for specific manipulation implies a high spatial control allowing to selectively mod-
ulate a particular cell type (e.g. a parvalbumin positive interneuron) or a distinct anatomical
region (e.g. layer 5 pyramidal cells in the sensorimotor cortex). To achieve this aim researchers
have either created transgenic mouse lines or locally injected viruses with cell-type specific
promotors (Rogan and Roth, 2011). These promotors induce gene expression directly - as in
the case of transgenic mice - or indirectly via tet-on/off or Cre-flox systems.
The Tet system uses at least two viral vectors plus an antibiotic drug which in a sequential
way like a domino effect activate each other to induce the transcription and translation of the
gene of interest: a tissue specific promoter initiates the expression of a transcription factor,
either the tetracycline transactivator (tTA) or the reverse tetracycline transactivator (rtTA).
The tTA or rtTA then becomes the key player for the transciption of a tetracyclin response
element (TRE) promotor, which in dependence of the presence of tretracycline or doxycycline
drives the expression of the gene of interest. Expression of the gene of interest is fully reversible
as administration or removal of tetracycline or doxycycline will turn expression on or off. In a
study by Kinoshita et al., 2012 a Tet-on system was used to selectively express the synaptotoxin
tetanus toxin in propriospinal (PN) neurons innervated by the motor cortex. The researchers
could show that upon doxycycline administration in the drinking water reaching performance of
monkeys significantly declined due to temporal blockade of the motor cortex–PN–motor neuron
pathway.
The Cre-flox system functions similarly requiring two transgenes: A tissue specific promotor
regulates the expression of Cre recombinase, an bacteriophage enzyme which recombines DNA
at specific recognition sequences called loxP sites. Cre recombinase then excises DNA whithin
two loxP sites (’floxed’). As in most cases floxed-stop constructs are knocked-in by homologous
recombination to a gene of interest(Rogan and Roth, 2011), the stop signal is excised in the
presence of Cre and the transgene expression can be initiated. As Cre-mediated expression
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only occurs in cells expressing Cre, which are also those in which the tissue-specific promotor
is active, this technique has a high cell-type specificity.
As the second prerequisite for specific neuronal manipulation in addition to a high degree of
spatial resolution, temporal resolution and directional modulation of signaling are required for
remotely controlling neuronal firing. Temporal resolution implies the precise control when a
receptor or pathway is active or inactive and for how long it should be in a specific active
status. Temporal resolution can vary from milliseconds (see ’opsins’ described below) to hours
(e.g. DREADDs). Important are also ’onset’ kinetics (the time between the experimental ma-
nipulation and the modulation of the receptor or signaling pathway) and ’offset’ kinetics (the
time between the initiation of the signaling modulation and the termination of the modulation,
Rogan and Roth, 2011). Directional regulation describes the effect of the tool on neuronal
activity (either activating or inhibiting), while bidirectional control would be the optimal case:
Turning on and off the same cell population would elucidate the full spectrum of function that
a cell provides within a particular network for perception or execution of a distinct behavior.
For manipulation of neuronal networks for minutes to hours designer G protein-coupled recep-
tors have been developed. G protein-coupled receptors pathways are involved in a multitude
of cellular functions. Unlike opsins, which are functionally silent without excitation in vivo,
as they are not directly activated by endogenous compounds, G protein-coupled receptors
(GCPRs) are constantly modulated by endogenous ligands in vivo or reveal ligand-independent
activity (Seifert and Wenzel-Seifert, 2002; Smith et al., 2007). In vitro and in vivo pharma-
cological studies have described GPCRs as the most important class of druggable targets in
the human genome (Giguere et al., 2014), through which 50% of precribed therapeutics act
(Overington et al., 2006). These facts made the development of highly selective orthologous
ligand-receptor pairs, which would enable a high spatio-temporal control over GPCR signaling
pathways in vivo, challenging (Conklin et al., 2008). In recent years mutations to more than a
dozen native GPCRs have opened the field for the development of selectively activated designer
receptors. Most of these receptors are divided in two classes: the first -generation RASSLs (re-
ceptors activated solely by synthetic ligands) and the second-generation DREADDs (designer
receptors exclusively activated by designer drugs), which were evolved through directed molec-
ular evolution in yeast (Rogan and Roth, 2011). RASSLs were first engineered on the basis
of serotonin-receptors (Kristiansen et al., 2000), histamine receptors (Bruysters et al., 2005)
and melanocortin-4 receptors (Srinivasan et al., 2003). However, these first generation of or-
thologous ligand-GPCR pairs revealed potential shortcomings: Although the receptors were
activated solely by the synthetic ligands, the ligands themselves did not solely activate the
designer receptors (as reviewed by Rogan and Roth, 2011). Thus, for the development of
second-generation DREADDs Armbruster et al., 2007 took a designer ligand, clozapine-n-oxide
(CNO), which was known to be inert at endogenous targets and highly bioavailable and blood-
brain-barrier-permeant in both humans and mice (Chang et al., 1998; Weiner et al., 2004). As
CNO had a modified structure of clozapine, which was known to be a weak partial agonist at
muscarinic receptors, Armbruster et al., 2007 tested mutations induced in the five members
of the muscarinic cholinergic receptor family upon their selective responsiveness to CNO ap-
plication. Introducing two mutations transformed the hM3 receptor into a designer receptor
which was insensitive to its native ligands, but highly sensitive to the designer ligand CNO. In
smooth muscles cells the Gq-coupled hM3 DREADD receptor stimulated a cascade of inositol
phosphate hydrolysis, calcium release and ERK1/2 activation, while the hM4Di DREADD re-
ceptor, derived from the Gi-coupled human muscarinic M4 receptor, inhibited forskolin-induced
cAMP formation and activation of GIRK causing hyperpolarization and inhibition of neuronal
firing (Armbruster et al., 2007).
Since the first development of DREADD receptors reports of their usage in vivo are now ap-
pearing: The pharmacokinetic properties of the DREADD ligands and the particular route
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of administration (oral administration, subcutaneous, intraperitoneal or even local stereotaxic
infusion) determine how quickly neurons response to experimental manipulation by ligand ap-
plication. Responses typically emerge 5 to 15 min after systematic application e.g. of CNO and
usually last for 2h - but this time period can be further enlarged upon dose-dependent increase
of CNO (Guettier et al., 2009). When Ferguson et al., 2011 used virus-mediated expression
of the hM4Di receptor in the direct and indirect pathway neurons of the striatum they found
altered behavioral plasticity associated with repeated drug treatment. In particular decreas-
ing striatopallidal neuronal activity facilitated behavioral sensitization to drug treatment. In
another study by Krashes et al., 2011 the activation of agouti-related protein (AgRP) neurons
in the hypothalamus by DREADD receptors was used to manipulate feeding behavior, energy
expenditure, and ultimately fat stores.
Although manipulation of GPCR signaling pathways by DREADD receptor induction and
activation is highly efficient and shows a very specific spatial resolution (depending on the con-
structs or transgenic mouse lines used), the temporal resolution remains limited to an activation
within minutes - due to the slower nature of GPCR signaling and the necessary ligand delivery
to the location of neuronal manipulation. In contrast, high-temporal (milliseconds) and cellular
precision within intact mammalian neural tissue for fast, specific excitation or inhibition even
within a freely moving animal can only be achieved with optogenetics (Fenno et al., 2011).
Early approaches to use light to stimulate neuron activity included the selective photostimula-
tion of neurons in Drosophila by coexpression of the drosophila photoreceptor genes encoding
arrestin-2, rhodopsin and the alpha subunit of the cognate heterotrimeric G protein which en-
abled the sensitization of neurons to light (Zemelman et al., 2002). In a second approach action
potentials in hippocampal neurons were induced in a reliable and temporarily precise manner by
uncaging a caged capsaicin derivate by light (Zemelman et al., 2003). However, depolarization
occured within 5 s after a 1 s light pulse, lasting for 2-3 s and did not attenuate with multiple
light pulses. Other approaches such as UV light-isomerizable chemicals linked to genetically
encoded channels (Szobota et al., 2007; Gorostiza and Isacoff 2008) had also shown limitations
due to reduced speed, targeting, tissue penetration or applicability because of their multicom-
ponent nature (Fenno et al., 2011). In 2003, Nagel et al., cloned channelrhodopsin-2 (ChR2),
a cation channel from the green alga Chlamydomonas reinhardtii which depicted similarities
to the vertebrate rhodopsin which opens in response to blue light allowing potassium ions to
enter the cell. Two years later, the first optogenetic experiment in neuroscience was conducted
by expressing ChR2 using a lentiviral vector in cultured rat hippocampal neurons (Boyden et
al., 2005). Illumination of these cultures with shorter wavelength blue light (450-490nm) initi-
ated large and rapid depolarization, while light with longer wavelengths (490-510nm) induced
smaller currents. Light stimulation of neurons was selective to those neurons expressing ChR2.
Since then neuroscientists rapidly adapted the possibilities of this new technology to in vivo
experiments. In addition, the palette of available light-sensitive channels and ion pumps for
neuronal inhibition and activation, for fast and slow acting opsins and opsins activated at dis-
tinct wavelengths has been extensively augmented in recent years (Yizhar et al., 2011; Schmidt
et al., 2014; Chuong et al., 2014; Klapoetke et al., 2014).
However, although the numerous advantages of optogenetics are evident - such as the highest
specificity, the ultrafast millisecond time scale dissection and basically no adverse effects due
to the light (unless the light sourse is not too strong or applied too long) - for many in vivo
experiments optogenetics stays an invasive procedure: As the light sourse has to be brought
close to the neuronal tissue, targeting deep brain areas or diffuse neuronal populations remains
challenging. New opsin developments such as Jaws - an inhibitory opsin, which is activated by
light of infrared wavelength (Chuong et al., 2014) - opens up new possibilities for non-invasive
manipulation in vivo using optogenetics.
Only very few studies have been applied optogenetics in experimental stroke research so far,
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mostly in the context of light-based motor mapping as described above (Harrison et al., 2013).
In a first study by Cheng et al., 2014 optogenetic stimulation of the ipsilateral primary mo-
tor cortex in ChR2 transgenic mice promoted functional recovery and the induction of growth
promoting genes after stroke induction in the striatum and somatosensory cortex.
2.3 State-of the art techniques to combine anatomy and
molecular biology
We have described in the last paragraphs how stroke reorganization can be studied on the mar-
cro level of map shifts, as well as by studying single neurons in neuronal circuits using 2-photon
calcium imaging approaches. We have discussed how individual neurons and whole neuronal
populations can be manipulated with high spatio-temporal resolution disclosing new possibili-
ties of causally linking individual neuronal activity with a distinct behavioral phenotype. What
is now missing, is the understanding of the underlying molecular crosstalk inducing anatomical
and ultimately behavior changes. Classically, tracing techniques (e.g. dextran tracers) have
been applied to visualize cells involved in structural reorganization after stroke (Starkey et al.,
2012; Lindau et al., 2014). Li et al., 2010 found a way to exclusively study molecular changes in
newly outsprouting neurons (’the sprouting transcriptom’) in the peri-infarct cortex by injecting
two different fluorescent conjugates of the tracer cholera toxin B (CTB) into forelimb sensori-
motor cortex at different times points: One CTB tracer was injected at the time of stroke, the
second differently labeled one either 7 or 21 days afterwards. Neurons which expressed only
the second tracer were those that had not had an axonal projection to the injection site at
the time of the injection of the first tracer, and thus represented neurons which established a
new projection pattern after stroke. Both neuron types (single- and double labeled ones) were
laser captured to identify the distinct transcriptional profile of an outsprouting neuron in the
peri-infarct cortex.
In addition, new constructs are now developed for molecularly profiling projecting neurons and
thus bridging the gap between anatomical modification and underlying molecular mechanisms.
Using e.g. bacterial artifical chromosome (BAC) transgenic mice which express EGFP-tagged
ribosomal protein L10a in defined cell populations allowed purification of polysomal mRNAs
from genetically defined cell populations in the brain (Heiman et al., 2008; Doyle et al., 2008).
In another study by Ekstrand et al., 2014 ribosomes were tagged with a camelid nanobody
raised against GFP enabling the selective capture of translating mRNAs in projecting neurons.
Conclusion
Here we have reviewed current and new promising state-of the art techniques for studying
reorganization after stroke, for the identification and manipulation of distinct neuronal popu-
lations involved in restoration of function and approaches which allow to examine molecular
profiles of neurons which are part of the cortical reorganization process. These techniques
open up tremendous possibilities to analyze plastic processes and to target key players for the
development of new therapies in stroke.
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Aim of the present work
Only 5% of all stroke patients arrive early enough at hospital to be eligible for thrombolysis
therapy increasing their chances for a good recovery. For the other >90% of patients their
outcome heavily depends on the size and location of the lesion. Although forms of spontaneous
recovery exist, strokes with large lesions, where extensive parts of the sensorimotor cortex are
destroyed, reveal only little spontaneous capacities for functional restoration accompanied by
poor anatomical plasticity. Rehabilitative therapy, electrical stimulation and growth promoting
treatments such as Anti-Nogo A immunotherapy are well known to enhance functional recovery.
Experimentally all three treatment options show signs of increased fiber growth and neuronal
rewiring in forms of e.g. enhanced numbers of corticospinal fibers sprouting across the midline
of the spinal cord from the intact side to the de-nervated one as well as augmented axonal
growth of pre-existing ipsilateral projections (Schwab, 2004; Schwab, 2010a; Schwab, 2010b;
Dimyan and Cohen, 2011). However, our understand of increased plastic processes in the brain
after stroke is still very limited raising also questions about the neurobiology of rehabilitation:
How do external interventions such as rehabilitative training or growth-promoting therapies in-
terfer with intrinsic reorganization and rewiring processes? Are there critical, vulnerable time
periods for brain repair? Do distinct plastic phases during the reorganization process after
stroke correlate with functional outcome? Will we be able to go beyond correlative assump-
tions and distinguish meaningful newly formed circuits for regain of lost function from spared
connections? If we will have closed the loop from anatomical rewiring to behavior outcome will
we be able to design better, more optimized rehabilitative schedules?
The present work addresses these questions as follows:
In our first approach (chapter 3) we investigated reorganization in the peri-infarct area after a
small stroke destroying the forelimb motor cortex over time in dependence of the restoration
of skilled forelimb function. Our aim was here not only to study functional map shifts induced
by the stroke but also to analyze neuronal capacities in the peri-infarct cortex to ’take over’
function previously represented by now destroyed areas while preserving original functions.
In chapter 4 we studied the combination of Anti-Nogo immunotherapy and rehabilitative train-
ing of forelimb function after a large photothrombotic stroke destroying the sensorimotor cortex
of the preferred paw. In this experiment we questioned if timing is crucial for functional out-
come if two different treatment strategies are either applied concurrently or after each other,
whereby each of the approaches alone already enhanced plastic processes. We aimed at not only
identifying the optimal rehabilitation schedule but also at exposing the underlying anatomical
rewiring mechanisms responsible for the measured outcomes.
In Chapter 5 we investigate if different rehabilitative schedules (such as the rehabilitative
paradigms applied in chapter 4) induce distinct spatio-temporal expression patterns of growth-
promoting and neurotrophic factors after stroke. These data allow first insights into underlying
molecular mechanisms for anatomical rewiring and restoration of function in dependence of
external rehabilitative interventions.
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Abstract
Once a stroke occurs victims suffer from lifelong disabilities including the impair-
ment of speech, vision and motor control. No pharmacological therapy is currently
available to stimulate the restoration of function after a large stroke. However,
in cases of smaller strokes even without therapeutical interventions a certain de-
gree of spontaneous recovery exists while the underlying principles of increased
plasticity promoting map-shifts and rewiring of neuronal circuitry are not well un-
derstood. The brain region adjacent to the stroke damage - the penumbra zone -
has been shown to be critical for stroke rehabilitation. Thus, understanding the re-
organization of the peri-infarct tissue around small cortical strokes over time and
its contribution to functional recovery may inaugurate the development of new
treatments and improve rehabilitative strategies. Here we used Thy1-ChR2-YFP
transgenic mice to initiate a small photothrombotic stroke through a chronically
implanted cranial window targeting the forelimb motor cortex. Optical mapping
was performed to study the reorganization of the peri-infarct sensori-motor cortex
and correlated to the level of regained forelimb function using detailed kinematic
analysis. Animals showed constant improvement and complete recovery during 4
weeks after stroke in two grasping tasks, while optical mapping revealed a shift for
the center of forelimb function towards the cortical area originally representing the
hindlimb. Temporarily and reversibly shutting-off neurons in the peri-infarct area
using a virus-based pharmacogenetic approach resulted in a decline of regained
motor performance and the re-emergence of motor errors observed initially after
stroke onset, indicating the functional relevance of the penumbra for recovery and
for the re-establishment of motor engrams involved in skilled forelimb function.
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3.1 Introduction
A high degree of spontaneous recovery of function is very often found in small cortical strokes,
both in experimental and clinical studies. The mechanisms underlying the recovery are not
well understood, but have been attributed to events similar to those involved with plasticity
in the intact brain (Kleim and Jones, 2008): Stroke recovery implies both, the structural and
functional modifications of brain circuitry which are closely related to the stroke affected area
either spatially or functionally or both (Murphy and Corbett, 2009). Two major factors con-
tribute to the increased plastic capacity of the adult brain after stroke: First, a great amount of
dispersed and redundant connections between cortical and subcortical regions exists, meaning
that if one circuit is destroyed, the next related one is recruited to take over function. Second,
new circuits can form through rewiring and remapping of related regions (Murphy and Corbett,
2009).
The brain region adjacent to the stroke damage which typically experiences reduced blood
flow - the so-called penumbra - has been often the center of attention, both experimentally
and clinically (Rosso and Samson, 2014). Surviving neurons in the penumbra depict enhanced
neuroplasticity and undergo active functional remodeling after ischemic insult to form the ba-
sis for neurorehabilitation (Feydy et al., 2002; Werhahn et al., 2003; Clarkson et al., 2010;
Dancause and Nudo, 2011). In vivo two-photon imaging revealed that dendrites in the penum-
bra are damaged by stroke but can regain their structure during the restoration of blood flow
(Zhang et al., 2005; Li and Murphy 2008). On the molecular level a distinct axonal sprouting
transcriptome has been described in the penumbra(Li et al., 2010) which includes the distinct
induction of neuronal growth-promoting genes (e.g. neurotrophic factors such as BDNF and
Gap-43) in sequential waves (Carmichael et al., 2005). In contrast, growth inhibiting molecules
such as chondroitin sulfate proteoglycans are in particularly repressed by the peri-infarct cortex
(Carmichael, 2006), while within the glial scar representing the wall which separates the stroke
core from the surviving per-infarct tissue growth-inhibiting factors are induced.
Functionally, the ipsilesional cortex has shown increased activity such that representations of
impaired body parts shift towards undamaged surrounding areas. This cortical remapping
is organized activity dependently, and based on similarity of circuit function as well as com-
petition (Murphy and Corbett, 2009). In particular after a small cortical stroke, recovering
per-infarct areas with compromised circuitry compete for map territory with healthy adjacent
tissues (Winship and Murphy, 2008; Brown et al., 2009), thus making recovery levels highly de-
pendent on reorganization of peri-infarct tissue with similar function (Cramer et al., 2006). In
stroke patients, an enlargement of the cortical hand representation was found to be correlated
with improved arm/hand kinematics and clinical scores (Cicinelli et al., 1997, Ward et al., 2006,
2007). In a mouse model, the destruction of the forelimb sensory cortex by a stroke induced new
sensory representation in the territory previously only occupied by the forelimb motor cortex
(Winship and Murphy, 2008; Brown et al., 2009). In an endothelin-1 rat model which initiates
focal strokes, Starkey et al., 2012 found that, when destroying the forelimb motor cortex cells in
the hindlimb-sensory-motor area reorganize and become functionally connected to the cervical
spinal cord using intracortical microstimulation. However, it is unclear if the primary hindlimb
senorimotor cortex maintains its primary role in addition to newly covering for the forelimb
motor cortex. Furthermore, it remains elusive, when a map shift occurs, how the lost motor
engram due to stroke is re-established within the newly organized sensorimotor representation.
Here we used transgenic channelrhodopsin-2 mice which express a light-sensitive cation channel
in layer 5 cortical output neurons (Arenkiel et al., 2007) to perform optical mapping of the
sensorimotor cortex. In contrast to the limitations of intracortical electrical stimulation this
method allowed us a longitudinal study to examine the cortical reorganization process after a
small forelimb stroke. We not only demonstrate the critical role of the peri-infarct cortex for
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the functional recovery but also show how the motor engram for fine skilled forelimb function
re-emerges in the per-infarct cortex 4 weeks after stroke.
3.2 Material and Methods
Animals
Transgenic Th1-ChR2-YFP mice expressing channelrhodopsin 2 in layer 5 of the sensorimotor
cortex (Arenkiel et al., 2007), aged 2 – 4 months, weighed 19-23g, of both sexes were used in
this study. Mice were housed in groups of two to six per cage, on a 12h light:dark cycle. Food
and water was given ad libitum, except during the training phase and the baseline recordings,
when water was removed 4-6 h before the behavioral task in order to use it as a reward during
the behavioral conditioning (see ’The conditioned running wheel task’ below). All experiments
were performed in accordance to ethical guidelines and approved by the veterinary office of the
canton of Zurich, Switzerland.
Chronic window implantation over the sensorimotor cortex
For chronic window implantation we adjusted the protocol by Holtmaat et al., 2009 to our
conditions: Mice were anesthetized with 3% isoflurane (via a table top mounted anesthesia
machine, Tec3 vaporizer, Medical Supplies and Services Int’l Ltd, UK) and head-fixed in a
stereotaxic frame. Eyes were covered Vitamin A cream (Braun) for light protection during
surgery. The fur above the skull was removed using depilatory cream (Klorane). After a
midline incision the skin was retracted and the skull exposed and cleaned. All soft tissue was
carefully removed using a sharp blade. We also partly dissolved the fascia of the temporal
muscle from the underlying skull to enable a sealing of the dry skull with iBond (iBond self
etch; Heraeus Kulzer, Hanau, Germany). We then marked the center of a circular cranial
glass window (4mm in diameter) 2 mm lateral to bregma (Tennant et al., 2011, Fig. 1). A
ring of Charisma®(Heraeus Kulzer, Hanau, Germany) was applied at the skull indicating the
dimensions of dental cement fixation and including the labeling for the glass window. The
ring was filled with UV light-cured dental cement (Tetric EvoFlow; Ivoclar Vivadent, Schaan,
Liechtenstein. A blue light source (100mW/cm2; Bluephase style, Ivoclar vivadent, Schaan) was
used for polymerization of iBond, Charisma®and Tetric EvoFlow. After a craniotomy removing
the skull at the labeling for the glass window, the unblemished dura was covered with a circular
cover glass and set flush with the skull. The cover glass was sealed with Tetric EvoFlow; Ivoclar
Vivadent, Schaan, Liechtenstein. A blue light source (100mW/cm2; Bluephase style, Ivoclar
vivadent, Schaan). The skin was attached to the ring of Charisma®with acrylic glue (Histoacryl;
Braun, Tuttlingen, Germany) (Fig. 2). For postoperative care all animals received analgetics
(Rimadyl, 2.5mg/kg body weight, Pfeizer) at least for 3 days and antibiotics (Baytril, 5mg/kg
body weight, Bayer) for a week. The animals were checked and weighted on a daily basis over
the whole experimental period.
Headpost fixation
Following fixation to a stereotactic frame under isoflurane anesthesia the body temperature
of the animal was maintained at 37◦C. After a midline incision the skin was retracted and
the skull was exposed, cleaned and soft tissue and blood remnants were removed. iBond
(iBond self etch; Heraeus Kulzer, Hanau, Germany) was applied to the cleaned, nearly dry
skull, followed by polymerization with a handheld blue light source (100mW/cm2; Bluephase
style, Ivoclar vivadent, Schaan). A custom made aluminium head post (<1g weight, Fig. 2)
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Fig. 1: Organization of the mouse primary motor cortex (M1). A schematic representation of the
dorsal surface of the mouse cortex showing movement representation regions simplified by color coding all
forelimb-responsive sites as green and head movement representations as yellow. Blue represents movements
in the shoulder, while cortical representation of hindlimb movements is color coded in bright blue and grey
stands for movements of the trunk. The x-axis representing the horizontal line extending above the map is
+2.5 mm anterior and -2.0 mm posterior to bregma (A/P 0.0). The y-axis at the left side of the motor map
represents +3.0 mm lateral to bregma (M/L + 3.0). Image adapted from Tennant et al., 2011.
was first glued on the top of the bonding layer of the right hemisphere and then secured by
layers of transparent UV light-cured dental cement (Tetric EvoFlow; Ivoclar Vivadent, Schaan,
Liechtenstein). The open skin was sutured and attached to the implant with acrylic glue
(Histoacryl; Braun, Tuttlingen, Germany).
Photothrombotic stroke
A photothrombotic stroke was induced in six mice to unilaterally lesion the sensorimotor cortex
of the left forelimb area (Watson et al., 1985). Briefly, the animal was stereotaxically fixed as
described above. The skin was retracted after a midline incision following by labeling of the
right motor cortex coordinates (anterior to posterior (AP): -1 to 0.25 mm, medial to lateral
(ML): 0 to 3 mm; (Tennant et al., 2011) in relation to Bregma on the skull). The skull was
covered with an opaque template (15x15mm, with an opening of 3x1.5mm) and aluminium foil
to protect other regions of the brain and the eyes except for the region to be lesioned (left
motor cortex, forelimb area). Eight minutes after intraperitoneal (i.p.) injection of 0.1 ml Rose
Bengal (10 mg/ml Rose Bengal in 0.9% NaCl solution, Sigma Aldrich, Switzerland), the skull
was illuminated by a cold laser light source (Olympus KL1500LCD, 150 W, 300 K). Different
illumination times (8-9 min) were applied to find the stroke-size optimum. The wound was
then closed and sutured.
For the photothrombotic stroke through the chronic glass window, the rostral half of the window
area was covered with aluminium foil sparing the anterior forelimb region. Eight minutes after
intraperitoneal injection of the Rose Bengal solution the brain was illuminated for 8 min with
the same cold laser light source(Olympus KL1500LCD, 150 W, 300 K).
Asssessment of forelimb function
We used two tasks - the horizontal ladder walk test and the conditioned running wheel task -
to train and assess the animals for fine skilled forelimb motor function. Mice received ’baseline’
training in both tasks for at least 5 days before stroke surgery, after acclimatization to the
testing apparatus in two daily sessions (10 min per mouse). As both tasks contained the precise
57
A B
Fig. 2: Chronically implanted glass window for light-based motor mapping and other in-
vivo longitudinal imaging studies. (A) Image depicting a mouse with a chronically implanted cranial
glass window exposing the sensorimotor cortex. The mouse is headfixed using a screw which anchors the
headpost to a metal frame. (B) Cranial glass window displaying the vascular pattern covering the surface
of the sensorimotor cortex.
grasping of rungs, the rung sequences were irregularly set to prevent the habituation to the
rung pattern and the activation of solely central pattern generators in the spinal cord without
requirement of motor-cortical control. For ’baseline’ recordings three independent trials were
video-taped using high speed camera (high speed camera, Nikon, AF NIKKOR) at a frame rate
of 100 Hz. They were then evaluated using frame-by frame video analysis (virtualDub 1.9.11,
Avery lee) before stroke onset. Stroke-animals were tested one, three and seven days and then
on a weekly basis until four weeks after stroke induction in both tasks, the horizontal ladder
and the wheel set-up.
The horizontal ladder walk test
The Horizontal Ladder walk test was used as a method to assess movement coordination and
paw placement as an grasping event on the rung. The apparatus consisted of the horizontal
ladder construct itself with metal rungs in irregular sequence (distance between rungs 1-3cm)
placed between two sidewalls made of plexiglas. Below we placed a mirror in a 45◦ angle to the
camera which enabled us to simultaneous record from two perspectives - from below and from
the side view - while the animal was running on the ladder. Each animal crossed the ladder in
the same direction three times. For the evaluation of correct paw placement/ grasping events,
forelimb footsteps were analyzed using a 4 point rating system as described by Maier et al.
2008. Briefly, a step was counted to be correct when all four digits were placed in front of
the rung while enclosing it (4 points). For deficient grasping the following score was applied:
(1 point) animals misplaced the digits on the backside of the rung; (2 points) animals placed
the wrist instead of the paw on the rung and even slipped off the rung occasionally; (3 points)
animals completely missed the rung. Success rates were expressed as a percentage of perfect
grasps (perfect grasps/total grasps x 100) and were scored as average of three passes.
The conditioned running wheel task
As a second task for the evaluation of skilled forelimb motor function with an emphasis of
skilled grasping abilities we developed the conditioned running wheel task (Fig. 2). Mice were
placed on a ultra-light wheel with sidewalls from plexiglas and fiber-reinforced plastic rungs
in irregular sequence while being head-fixed by the implanted headpost to a metal rod with a
screw. (Fig. 2A). The wheel emulates a horizontal ladder, while keeping the mouse stationary.
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Fig. 3: The conditioned running wheel task. (A) Image depicting a mouse on the running wheel.
(B) Scheme I showing the time sequence of the conditioned running wheel task, when the first tone (12000
Hz) decreases in intensity (starting from 80 dB) while the mouse is running on the wheel. (C) Scheme II
showing the time sequence of the conditioned running wheel task, when a first high frequency tone (12 000
Hz, 80 dB) marks the switch-off of the brackets allowing the mouse to run till a second tone (4000 Hz, 60
dB) indicates the ’reward phase’ of the task, when the water reward is presented.
To augment the motivation of the animals to run on the wheel we established a custom-made
conditional reward system with two slightly diverse task set-ups:
(1) Fig. 3B: Animals are exposed to a high pitch start tone (12000 Hz, 80 dB), which would
initiate the release of the brakes of the wheel. While the animal is running on the wheel,
sound intensity of the high pitch start tone is decreasing until the animal would have circulated
a distinct distance (at least half a wheel diameter), as measured by a sensor. Once this set
distance is completed a lower pitch reward tone (4000 Hz, 60 dB) is displayed, while the brakes
stop the wheel. The mice are rewarded with a drop of water from a water port mounted to a
piezo film sensor (MSP1006-ND; Measurement Specialties) which triggers the delivery of water
(5− 6 µl) through a miniature rocker solenoid valve (0127; Buerkert).
(2) Fig. 3C: Animals are exposed to a high pitch start tone (12000 Hz, 80 dB) for 2 sec, which
would initiate the release of the wheel brakes and serve as a start signal for running a distinct
distance (at least half a wheel diameter). After completion of this distance measured by a sen-
sor, a second low pitch stop and reward tone (4000 Hz, 60 dB)is presented for 2 sec., thereupon
the brakes stop the wheel and the animals are rewarded with a drop of water as described above.
One testing session consisted of at least 6-8 conditioned trials (either (1) or (2)) dependent
on the distance set to receive at least 50-60 stepping movements which were summarized and
counted as one trial for final analysis of success scores.
59
Detailed grasping analysis
For the detailed analysis of stepping/grasping movement, we developed a scoring method which
quantifies every grasp in a 12 point scoring scheme to identify the most frequent foot step error
patterns: ’Total miss: grasp too long’ represents a grasping event where the rung is missed
because the grasping distance was too long. ’Total miss: grasp too short’ respectively is a
grasping event, where the rung is missed because the grasping distance was too short. ’Partial
slip with -wirst or -digit’ equalizes that the animal initially correctly placed the paw but then
slipped and found again foothold using either the wirst or one of its digits. ’Partial placement
with wrist’ described the initial placement of the wrist on the rung instead of using the palm
of the forepaw. A ’slip after correct placement with forward movement’ represents the initial
correct placement of the forepaw on the rung, but then the animal slips and loses contact to
the rung. ’Weight shift to MCP, to lateral forepaw or to elbow’ are terms that describe the
aberrant shifting of the weight from the palm of the forepaw in a perfect grasping position to
either the metacarpophalangeal (MCP) joints, the lateral forepaw or the elbow.
MRI for stroke volumetry
At the end of the behavioral assessment 4-6 weeks post stroke surgery, animals were first
anesthetized with 3% of isoflorane followed by a lethal overdose of pentobarbital (eskonarcon,
300-600 mg/kg bodyweight, i.p., Abbott Laboratories). Shortly, after cessation of respiration,
animals were transcardially perfused with ringer’s solution (containing 1000,000 IU/ heparin
(Roche) and 0.25% NaNO2) followed by 100 ml of a 4% phosphate-buffered paraformalde-
hyde solution (PFA), pH 7.4, to fix the brain. Brains were then removed and placed in PFA
(Sigma) solution for postfixation at 4◦C.Prior to ex vivo imaging for determination of lesion
size the brain tissue samples were placed in 15 ml falcon tubes filled with perfluoropolyether
(Fomblin®Y-LC 80, Solvay Solexis, Bollate, Italy). By applying a 7T small animal MR system
(Bruker BioSpin GmbH, Ettlingen, Germany), the brain MR measurements were accomplished
using a volume resonator for excitation and a four-element phased array surface coil for signal
detection. 17 coronary slices of 0.3 mm thickness with an interslice distance of 0.3 mm (no gap
between slices) resulted in T2-weighted images which were acquired using a TurboRARE se-
quence with the following parameter: matrix dimension= 200 x 200, spatial resolution= 50um
x 50um voxels, mean diffusivity= 200 x 140,repetition time= 350 s, echo time=10um, number
of averages= 120.
After ex vivo MRI, brains were removed from Fromblin and again placed in PFA. The quan-
tification of the lesion volume was performed with Image J, counting the pixels in the encircled
area of interest. We first measured volume of both hemispheres separately and then extrap-
olated the pixel count for the stroke volume to the corresponding volume of the unaffected
contralesional hemisphere taking the shrinkage of stroke scar tissue into account.
Histological analysis of stroke lesion
After perfusion and removal, brains were left in 4% PFA overnight and put in 30% sucrose for
3 days. The brains were embedded in Tissu-Tek®O.C.T.TM and frozen in isopentane (Sigma)
at −40◦C. Brains were cryosectioned (40µm slice thickness) and kept at −20◦C. The frozen
sections acclimatized to room temperature for 20min before the staining. Brain slices were
then washed in H20 followed by a short incubation time in 0.5% Cressyl violet (2-3 min) for
the Nissl staining. After dehydrating in graded alcohol solutions starting with 70% alcohol up
to 100%, the sections were cleared in xylene and cover-slipped with Eukit mounting medium.
The lesion volume of each brain was evaluated by reconstruction of every 9th brain section,
using Neurolucida 8.0 (MicroBrightField).
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Light-based motor mapping and map analysis
In order to study reorganization in the left peri-infarct sensorimotor cortex over the course of
4 weeks after stroke we performed light-based motor mapping in the Th1-ChR2-YFP mice,
a technology which has been described in detail by Ayling et al., 2009. We used a 473 nm
laser beam (Micron laser technology, focused to 100 µm diameter, 10 ms pulses, 2-4 mW total)
which was optically deflected by a motorized mirror system controlled by custom made software
(Labview, National Instruments) to an array of cortical sites (10 x 10, with 300 µm spacing
between sites) covering the whole aperture of the chronically implanted glass window over the
sensorimotor cortex (Fig. 4).
Before the motor mapping we applied a mild depilatory cream (Klorane) to remove the fur at
the limbs and tattooed small dots at different landmarks to label the joints using black tattooing
solution. We marked the following limb structures: the scapula, shoulder, wrist, metacarpopha-
langeal joint (MCP), digit-tip, hip, knee, angle, metatarsophalangeal joint (CTP) and toe-tip.
Before motor mapping mice were anesthetized by a single i.p. injection of ketamine (100mg/kg
body weight) followed by another ketamine supplement (30mg/kg body weight) if necessary
to complete the mapping. Mice were placed in a hammock (Fig. 4) that enable unrestricted
limb movement due to optical stimulation. While the sensorimotor cortex was stimulated fore-
limb and hindlimb movements were recorded by a video camera synchronized to the mapping
controller software. Stimulation was delivered in a semi-random order with identical stimulus
intensity for all cortical stimulation sites within a map, with the requisition that sites within 750
µm apart from each other could not be stimulated consecutively. An overlay function within
our software allowed us to superpose images of the mapping position from previous mapping
sessions to the current one enabling us to use landmarks within the cranial window such as the
blood vessel pattern or the cement sealing as reference points to track map positions over time
and relate motor maps.
For motor mapping analysis we used a semi-automated motion tracking software (Clickjoint,
Aleaso) which tracked the joint markers of the mice frame by frame from the videos, recording
the movements of the animal during motor mapping. This approach allowed us to generate
two dimensional coordinates (x,y) for every marker and time point. For the kinematic analy-
sis all movements were reconstructed from changes in the marker location between successive
frames. The software directly calculated angles and distances and data were then imported into
Microsoft Office Excel 2010. We then used a matlab script to create heatmaps depicting the
joint angle changes in summary or individualized for each joint in dependence of the cortical
stimulation site.
Pharmacogenetic inhibition of neurons in the stroke penumbra
Aiming at testing the functional relevance of the re-organized peri-infarct cortex for the regained
forelimb function 4 weeks after stroke the following experimental set-up was applied: Animals
(n=6) were pre-trained in the conditioned running wheel task (as described above)and received
a photothrombotic stroke impairing the left forelimb motor cortex. We assessed recovery of
forelimb motor function over the course of 4 weeks after stroke proceeded by virus injection
for short-term reversible pharmacogenetic inhibition of neurons and their connections in the
peri-infarct sensorimotor area using the virus mediated expression of an engineered Gi- protein-
coupled receptor (Gi/o-coupled human muscarinic M4 designer receptor exclusively activated
by a designer drug, hM4Di).
The surgical procedure was as follows: A craniotomy in the anesthetized (3% isofluran), and
stereotaxically fixed mice was performed exposing the left contralesional motor cortex. All
animals were injected in the penumbra area 4 weeks after stroke with a mixture of AAV2.1/2.2-
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Fig. 4: Light-based mapping of the motor cortex to study reorganization after stroke. (A)
Image showing the array of cortical stimulation sites (10 x 10, with 300 µm spacing between sites) covering
the whole aperture of the chronically implanted glass window over the sensorimotor cortex. The image is a
maximum projection of the sequence of images taken by a CCD camera mounted on top of the microscope
during the recording of the sequential arrangement of laser stimuli (473 nm laser beam, 100 µm diameter,
10 ms pulses) at random stimulation sites within the 10 x 10 stimulation grid in a mapping session. (B)
Photograph depicting a mouse with tattoos marking the joints of the fore- and hindlimb laying in a hammock
which enables free passive movements of the limbs during the light-based mapping session of the sensorimotor
cortex.
hSyn-dio-hM4D(Gi)mCherry vector (1:2, UNC Vectore Core, the University of North Carolina
at Chapel Hill). The injection sites for the penumbra area were 2 AP 2 ML; 1 AP 2 ML; 0
AP 2 ML; -1AP 1 ML; -2 AP 1 ML with variations among the individual mice. Coordinates
were slightly adjusted to the penumbra areas according to the extent of the individual strokes.
Injections were made in a coronal manner in at least 0.5 mm distance to the borders of the
stroke scar formation in. All stereotaxic injections (2x 20 nl each) were made through the intact
Dura using a 35 gauge, 10 µl syringe (World Precision instrument with a flow rate of 6nl/s),
controlled by an electrical pump. At each position two injections were performed: the first one
at -1mm depth keeping the syringe in place for 1 min followed by a second injection at -0.8mm
depth. After the second injection the syringe was left in place for 3 min to allow diffusion of
the virus, before the suringe was retracted.
Animals were allowed to recover from the virus injection surgery at least 2 weeks before re-
assessment of skilled forelimb function on the conditioned running wheel for at least 3 times and
subsequent initialization of the DREADD experiment: Animals were recorded while running on
the wheel at ’baseline’ (6-7 weeks after stroke surgery) followed by i.p. injection of clozapine-
n-oxide (CNO, 5-10mg/kg body weight; Enzo Life Sciences). Animals were put back on the
running wheel and stepping performance was recorded 30 min and 2h after CNO injection for
further analysis comparing pre-stroke ’baseline’ with the post-stroke performance as well as
each post stroke grasp with the performance at 30 min after CNO application. The experiment
was repeated at least 3 times at independent days. In a control experiment, repeated twice,
NaCl was applied instead of CNO to preclude an effect of the injection and treatment that
might have influenced the behavior.
At the end of the experiment animals were anaesthetized and transcardially perfused as de-
scribed above (section ’MRI images for stroke volumetry’). Coronar cortex sections (40µm slice
thickness) were examined for the distribution of mCherry-positive neurons with anti-mCherry
immunohistochemistry: Immediately after cryo-sectioning slices were blocked in Tris-NaCl-
blocking buffer and 0.1% Triton (TNB, TBST) for 1h at room temperature and incubated over
night at 4◦C in TNB, TBST and the primary antibody mCherry (Abcam, Lucernachem). After
washing with 0.1 PB, the biotinylated Goat Anti-Rabbit immunoglobulin-G (Ig G) (1:300; Jack-
son IR) secondary antibody in PBS was applied for 2 h at room temperature. The sections were
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washed in PBS and incubated in Alexa 488 Streptavidin (1:1,000; Jackson IR) and fluorescent
Nissl 640/660 (1:500; Neurotrace Invitrogen) in TNB for 30-60 min. Slices were washed for the
final step. Dried slices were covered with moviol. Images of mCherry positive cells were taken
by a confocal microscope (Leica TCS SP2) with red (TRITC) and infrared (Cy5) excitation or
emission filters at 20x magnification. mCherry positive cells were counted in relation to Nissl
stain positive cells in layer 5 of the sensorimotor forelimb cortex. The count was repeated on 3
sections of each brain. Neurolucida 8.0 was used, taking every 9th section(40µm), to perform
3D reconstruction of brains containing the DREADD virus and to evaluate the localization and
expansion of mCherry positive cells in the brain in distance from the stroke lesion.
Statistical analysis
The statistical analysis was performed using GraphPad Prism 6 (version 6.01-Windows; Graph-
Pad Software), Matlab and SPSS. All data are expressed as mean ± standard error of the means
(s.e.m.). Whenever two groups were compared e.g. for the detailed paw scoring method before
and after a lesion, the student’ s t-test (two tailed, unpaired) was used. For the correlation
study between the stroke volumetry and the behavioral deficit spearman correlation was ap-
plied. For the behavioral data obtained from mice for the spontaneous recovery after unilateral
stroke one-way repeated ANOVA measures followed by post hoc Bonferroni tests were used to
assess locomotion deficits (baseline vs. 1, 3 days or 1 day after injury vs.14, 21, 28 days). The
same test was used for the animals receiving the DREADD virus to evaluate their performance
on the wheel before and after CNO application. Two-way ANOVA with post hoc Bonferroni
was applied if different error grasping patterns on different time points where compared, as
tested for the naïve, the impaired, the recovered and the mice injected with the DREADD
virus.
3.3 Results
3.3.1 Establishment of a small forelimb stroke through a chronically
implanted glass window
Our approach was to study reorganization in the perilesional sensorimotor cortex after a small
stroke affecting the forelimb area in the same animal over the course of weeks with the aim
to correlate cortical rearrangement processes with functional recovery. We used transgenic
channelrhodopsin-2 mice (Arenkiel et al., 2007) which express a light-sensitive cation channel
in layer 5 cortical output neurons to perform longitudinal light-based mapping of the motor
cortex as described by Ayling et al., 2009 and Harrison et al., 2013. We first implanted glass
windows covering the sensorimotor cortex of the left hemisphere(4mm diameter, expanding
4mm lateral, 2mm anterior and 2mm posterior to bregma) in five mice. After training them in
two grasping tasks (horizontal ladder walk test and conditioned wheel running test, Fig. 5B, C)
2-3 weeks post surgery (Fig. 5A) for three independent baseline recordings, animals received a
small photothrombotic stroke impairing the forelimb area (Fig. 6).
Our aim was to establish a stroke lesion through a glass window which would be specific and
severe enough to target skilled forelimb function but would also be small enough to induce peri-
lesional sprouting and reorganization which we would then study through the cranial window.
For that, we applied an opaque template (with central opening of 3x1.5 mm) to the skull of the
animals and exposed it to light for 8 min. We found that small strokes of 1.2±0.1mm3 (Fig.
5F) of lesion size resulted in a substantial decrease of forelimb function in both grasping tasks
up to 7 days after stroke (horizontal ladder task, 39.4 ± 6.0% of baseline function on day 1
after stroke, Fig. 5D; conditioned wheel running task 54.7 ± 5.8% of baseline function on day
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Fig. 5: Mice show full spontaneous recovery of skilled forelimb function 28 days following a
photothrombotic stroke destroying the forelimb motor cortex. (A) Experimental time schedule.
We used two tests for the assessment of fine skilled motor function of the forelimbs: (B) The horizontal
ladder walk test and (C) the conditioned running wheel task. (D, E) 1-3 days post stoke surgery animals
(n=5) revealed a significant decline in grasping performance in both tasks compared to baseline sucess scores
before stroke. At 28 days after stroke animals gained almost the same levels of success rates than at the
healthy baseline condition indicating a full spontaneous recovery of forelimb function. Data are presented
as means ± s.e.m.; statistical evaluation was carried out with one-way ANOVA repeated measure followed
by Bonferroni post hoc, asterisks indicate significance: ∗P < 0.05,∗∗P < 0.01, ∗∗∗P < 0.001. (D) Ex vivo
magnetic resonance imaging (MRI, 7T small animal MR system) was used for anaysis of stroke volumes in
the different animals of this study cohort (M=mouse).(G) There was a correlation between lesion volume
and motor impairment at day 1 after stroke (p=0.0227, r=-0.9284, Pearson correlation, M=mouse 1-5).
64
HL
FL
Stroke
M L
R
C
A B C
Fig. 6: Establishment of a small photothrombotic stroke destroying the forelimb motor cortex.
(A) Scheme showing a cranial window exposing the sensorimotor cortex. Light-based optical mapping was
used to identify the forelimb (FL) and hindlimb (HL) motor cortex before a photothrombotic stroke was
introduced targeting 2/3 of the forelimb motor cortex from rostral (R= rostral, C= caudal, M=vmedial,
L=vlateral relative to bregma). (B) Ex vivo magnetic resonance imaging was used to evaluate lesion size
and localization. (C) Representative Nissl-stained section for histological analysis of stroke lesion size in the
left forelimb sensorimotor cortex 4-5 weeks post stroke after the completion of the behavioural assessment.
1 after stroke, Fig. 5E, one-way ANOVA, repeated measures). Animals showed spontaneous
restoration of forelimb function to a degree of almost full recovery in both grasping tasks (hori-
zontal ladder task, 97.7 ± 6.8% of baseline function on day 28 after stroke, Fig. 5D; conditioned
wheel running task, 92.3 ± 3.3% of baseline function on day 28 after stroke, one-way ANOVA,
repeated measures). There was also a correlation between lesion volume and motor impairment
on day 1 post-stroke (p=0.0227, r=-0.9284, Pearson correlation, Fig. 5G).
3.3.2 Stroke induces a stereotypic error pattern of forelimb move-
ments for grasping
To reveal distinct post injury behavioral failure and compensation patterns of forelimb usage,
which are crucial for spontaneous motor recovery analysis we developped a 12 point evaluation
score for detecting stereotypical error movement patterns which emerge after stroke onset (Fig.
7) based on the Whishaw Reaching Test assessment scale (Whishaw et al., 2008). We evaluated
the grasping distance (if the grasp was too long or too short relative to the rung target), the
targeting of the rung (correct targeting, partial slip or miss with either digit, paw or wrist),
placement of the forelimb on the rung as well as the balance and weight distribution on the
rung and during the grasping/stepping moment(e.g. lateral weight shift, aberrant weight shift
to MCP, lateral forepaw and wrist). We then compared the evaluation scores at ’baseline’
recordings to those obtained after stroke (1-3d post stoke surgery).
We identified two typical deficit movements which were repetitively detected one to three days
post-stroke: The first movement pattern was over-extensive grasping (totally missing the rung)
(18.6 ± 3.31% of total grasps analyzed for the time point ’1-3d post stroke’, p <0.001, Student’s
t-test, n=5, Fig. 7B) and partial slipping with the wrist (21.68 ± 2.99% of total analyzed
grasps 1-3d post stroke, p < 0.01, Student’s t- test, Fig. 7B). These two types of grasping
errors occurred 3-7 times more after stroke than in the healthy animals on baseline recordings:
Too long grasps were detectable in 19.5 ± 3.3% of all grasps 1-3d after stroke compared to
5.8 ± 1.8% at baseline while partial slipping after shoring up with the wrist on the rung was
measured in 22.7 ± 3.5% of all grasps 1-3d after stroke versus 3.4 ± 1.2% at baseline. Both
grasping error sub-patterns also emerged more often than the other error types measured with
our classification system (Fig. 7B).
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Fig. 7: Stroke induces a stereotypic error pattern of forelimb movements for grasping. (A)
Illustration of four stereotypical sequences of movements leading to grasping events which we evaluated
before and after stroke to identify and analyze pathological grasping kinematics (adapted from C. v. A.’s
master thesis) (B) A detailed dissection of movements leading to grasping features revealed two stereotypical
error patterns repeatedly emerging in all mice analysed (n=5) 1-3 days after stroke: The percentage of grasps
which failed either because the reaching action was too long, or because the rung was targeted by the wrist
joint leading into secondary slipping of the paw, was significant higher 1-3 days post stroke than at the
baseline recordings before stroke. Data are presented as means ± s.e.m.; statistical evaluation was carried
out with two-tailed Student’s t-test, paired, asterisks indicate significance: ∗∗P < 0.01, ∗∗∗P < 0.001.
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3.3.3 Center of the forelimb area shifts towards the hindlimb motor
cortex during 4 weeks post stroke.
We performed light-based mapping of the sensorimotor cortex (10 x 10 stimulation points cov-
ering the full expansion of the cranial glass window, Fig. 8A) while stimulus-evoked movements
were video-recorded and angle modifications measured by tracking of limb trajectories (see Ma-
terial and Methods, Fig. 8B, C) were used as a read-out to generate maps. To obtain a mean
value for each pixel of the map three independent baseline motor mapping sessions were exe-
cuted. 1-3 days after the third baseline session a photothrombotic stroke was targeted to the
forelimb motor cortex (Fig. 6) based on the map created as an average of the three baseline ses-
sions revealing the center of the fore- and hindlimb motor cortex (Fig. 8D, E). 2d, 16d and 23d
post stroke we stimulated the same cortical sites to study map shifts during the phase of cortical
reorganization. While we found no stimulus- evoked movements and thus joint angle changes for
the forelimb 2d after stroke (Fig. 8D), a diffuse pattern of stimulus-evoked forelimb movements
was detectable among stimulation of a broad range of sensorimotor cortex sites. A map shift
for the center of the newly reorganizing forelimb towards the hindlimb area became evident
which was further consolidated 23d post stroke (Fig. 8D).In contrast, hindlimb responses were
recorded within the same area at baseline and 2d post stroke indicating an exclusive injury of
the forelimb cortex by the stroke (Fig. 8E). In the phase of the reorganizing forelimb cortex
16d-23d after ischemic insult stimulus-evoked movement responses notably increased and the
cortical hindlimb representation extensively expanded (Fig. 8E). Analysis of cortical motor
maps in detail for extension or flexion movements in distinct forelimb joints (shoulder, elbow,
wrist and metacarpophalangeal (MCP)) revealed a nearly complete restoration of the center of
response for the MCP joint (Fig. 9A versus Fig. 9D for MCP) while we still measured diffuse
and disorganized responsive movements in the wrist among several stimulation sites which had
been attributed to both fore- and hindlimb cortex at baseline mapping sessions, even 21d after
stroke onset (Fig. 9A versus Fig. 9C, D for wrist).
3.3.4 The peri-infarct area is crucial for the restoration of skilled
forelimb function after stroke
As we detected a reorganization of the forelimb area with a map shift towards the hindlimb
cortex accompanied with an almost full restoration of the cortical representation for the MCP
joint, we aimed at closing the loop between cortical reorganization and restoration of skilled
forelimb movements: Thus, we used a pharmacogenetic approach to reversibly and temporarily
silence peri-infarct neurons in layer 5 of the sensorimotor cortex (Fig. 10B). After pre-training of
animals on the horizontal ladder walk test and the conditioned running wheel task, we initiated
a photothrombotic stroke destroying the left forelimb cortex (Fig. 10A). 4 weeks post stroke
animals revealed nearly full functional recovery in these fine skilled motor tasks (conditioned
running wheel task, 96.9 ± 1.3% 4 weeks after stroke compared to pre-stroke performance) as
seen before (Section ’Establishment of a small forelimb stroke through a chronically implanted
glass window’). We then injected an engineered Gi-coupled DREADD (hM4D(Gi)) receptor
(’designer receptors exclusively activated by designer drugs’) at 5 injection sites in the peri-
infarct area with at least 0.5 mm distance to the borders of the stroke scar formation. Such
receptors are only activated by the pharmacologically inert synthetic ligand clozapine n-oxide
(CNO), leading to increased intracellular mediated G-mediated signaling, resulting in hyper-
polarization of infected cells and their silencing (Armbruster et al., 2007; Conklin et al., 2008).
To test the inhibiting effect of such a pharmacogenetic tool we recorded and analyzed the right-
sided forelimb motor performance of the animals before CNO injection for baseline recording
(7 weeks after stroke surgery), 30 min, 1 hour and 2 hours following intraperitoneal CNO ap-
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plication (Fig. 10A, C). We found that the activation of the hM4Di DREADD receptors in
peri-infarct neurons by CNO resulted in a significant decline of forelimb motor performance 30
min after CNO injection in both tasks for skilled forelimb function(for the conditioned running
wheel task: 29.8 ± 5.6% of the success rate at baseline recordings before CNO application, Fig.
10C; for the horizontal ladder walk test: 38.4 ± 2.0%, Fig. 10D, two-way ANOVA repeated
measures, followed by Bonferroni post hoc test, Fig. 10C). In comparison, in the same animals
the induction of the photothrombotic stroke itself disturbed skilled forelimb function with a
decrease in the success rate of 39.6 ± 9.9% (Fig. 10C) relative to pre-stroke baseline record-
ings. The functional defects due to CNO application were fully reversible, with performance
returning to pre-injection levels about 1-2h after drug injection in both grasping tasks. In order
to exclude an unspecific effect of the drug application or other procedural co-founders, CNO
was substituted by i.p. NaCl injection in the same animals and the DREADD experiment was
repeated twice. We did not measure any decline of forelimb motor performance after NaCl
application in neither of the tests (Fig. 10C, D), indicating a specific inhibition of peri-infarct
neurons containing the hM4Di DREADD receptor due to CNO injection.
The DREADD receptor hM4Di was tagged with mCherry, which allowed neuroanatomical
localization of the neurons carring the hM4Di vector. Two-dimensional representations of 3D
reconstructions revealed the distribution of mCherry positive cells in layer 5 of the peri-infarct
area around the stroke area. 42.8 ± 1.6% of Nissle positive cells in layer five of the penumbra
region (around 0.5 mm distance to the border of the stroke scar) were also mCherry positive
(Fig. 10E, G). Notably, only a very limited number of cells were outside of this area, however the
distribution and the amount varied among different animals (Fig. 11), due to slight differences
in the stroke expansion and location. We found no significant correlation between the amount
of positive cells, expressing the hM4Di vector and the motor performance decline 30 min after
CNO injection. This result is most probably due to the inter-individual variability and the
small number of animals assessed. However, we could observe a tendency of an augmented
decline in motor performance in line with a higher amount of mCherry positive cells in the
penumbra (data not shown).
We also used our 12 point evaluation score, which we had developed for detection of stereotypical
error movement patterns (as described in section ’Stroke induces a stereotypic error pattern
of forelimb movements for grasping’), for the analysis of modified grasping movements in the
DREADD experiment. 30 min after CNO application animals did not only show a significant
decline in correct placement of the paw (32.3 ± 2.5% of all analyzed grasps 30 min after i.p.
CNO injection versus 54.9 ± 1.6% at baseline recordings 7 weeks post stroke, two-way ANOVA
repeated measures, followed by Bonferroni post hoc test, Fig. 12A), grasping movements were
also significant for the same stereotypic error patterns - too long grasps, partial slips with
precent weight reinforcement of the forelimb on the wrist as well as incomplete encompassing
the rung with all 4 digits (Fig. 12C-E) - which had been already detected the day after stroke
and which had been classified as part of a typical graspincal failure pattern due to the injured
forelimb cortex (Fig.7). Notably, the relative increase of these three grasping errors was in the
same range comparing 1d post stroke to baseline with 30min after CNO application to pre-CNO
baseline recordings (relative increase of ’too long grasps’ 1d after stroke 9.9 ± 5.8% compared to
baseline versus 9.0 ± 3.2% increase 30min after CNO compared to pre-CNO baseline; relative
increase of partial slips 9.7 ± 1.2% 1d after stroke versus 9.8 ± 2.2% increase 30 min after
CNO; relative increase of an aberrant closure of the paw around the rung 3.8 ± 1.2% for 1d
after stroke versus 5.0 ± 1.8% increase 30 min after CNO). These results do not only indicate
that the per-infarct area plays a crucial role for the recovery of skilled function after a small
cortical stroke, they also emphasize that the destroyed forelimb area is completely restored
by the reorganization of a new center for forelimb function in the penumbra, respectively in
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Fig. 10: The peri-infarct cortex is crucial for the restoration of skilled forelimb function
after a small stroke targeting the forelimb motor cortex. (A) Scheme for the experimental time
schedule. (B) Illustration showing the injection of the AAV2.1/2.2-hSyn-dio-hM4D(Gi)mCherry vector for
the expression of the Gi-protein-coupled DREADD receptor hM4Di at 5 injection sites in the peri-infarct
area (at 0.5 mm distance to the borders of the stroke scar) 4 weeks after stroke. (C, D) Motor performance of
animals significantly declined twice within the experimental period, first after stroke induction and second,
after the temporal restricted inhibition of neurons in the peri-infarct cortex 30 min after CNO application.
This decrease in success rates was measured in both tests for the assessment of skilled forelimb function
(the conditioned running wheel task (C) and the horizontal ladder walk test (D)). Data are presented as
means ± s.e.m.; statistical evaluation was carried out with two-way ANOVA repeated measures, followed
by Bonferroni post hoc test, asterisks indicate significance: ∗∗P < 0.01, ∗∗∗P < 0.001. (E) 28.55 ± 8.13%
of Nissl-positive neurons in layer five of the peri-infarct cortex were also positive for mCherry. (F, G)
Representative pictures verifying the hM4Di expression (iii) in Nissl-positive layer five neurons (i) in the
peri-infarct area, between 2.58 anterior (F) and -0.82 (G) posterior to bregma (ii represents the merged
image of i and iii). Scale bar= 20µm.
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Fig. 11: Verification of neurons expressing the hM4Di DREADD receptor in the peri-infarct
cortex relative to stroke lesion size using 3D neurolucida reconstruction. Two-dimensional rep-
resentations of 3D Neurolucida reconstructions revealed the distribution of mCherry positive cells (yellow)
in layer five of the peri-infarct area. Illustrations show the reconstructed brains of animals enrolled in the
DREADD experiment (Fig. 10). In all animals the stroke was localized within the forelimb motor cortex
and the mcherry positive cells were centered in the peri-infarct area. Stroke size varied from 2.68 - 1.10
anterior to -0.58-(-2.92) posterior relative to bregma. Neurolucida reconstructions were adapted from C. v.
A.’s master thesis.
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previous parts of the hindlimb area. Silencing this new center for forelimb function is followed by
the same typical features of grasping failure as evaluated after destroying the original forelimb
motor cortex area by the stroke.
3.4 Discussion
Mechanisms behind spontaneous recovery after a small stroke in the
forelimb motor cortex
Our aim was to establish a small stroke through a cranial window which selectively destroys the
forelimb area of the motor cortex and enables us to study reorganization of the peri-infarct tis-
sue in ensemble with the restoration of skilled forelimb function over time. Our results indicate
that the photothrombotic stroke we introduced is sufficient in size and location to specifically
destroy fine motor forelimb function: Light-based mapping of the sensorimotor cortex revealed
no movement responses upon stimulation of the area previously identified as the forelimb motor
cortex at the ’baseline’ mapping, 2 days after stroke onset (Fig. 8D) while the hindlimb motor
map was preserved (Fig. 8E). Forelimb grasping function declined between 40-50% in both
grasping tasks within the first week after stroke (horizontal ladder walking test, conditioned
running wheel task, Fig. 5D, E) compared to the pre-stroke healthy situation. Animals then
fully recovered considering their level of performance 28 days after stroke without any further
intervention such as rehabilitative training, enriched rehabilitative housing or neuro-protective
or growth-promoting pharmacological intervention.
Such functional recovery rates have been observed by others (Bouet et al., 2007; Alaverdashvili
et al., 2008; Liu et al., 2009). This high degree of spontaneous recovery may be explained by (1)
growth promoting molecular events leading to neuronal rewiring in the perinfarct cortex, (2)
recruitment of subcortical motor systems and (3) by the fact that the success scores obtained
in the behavioral tasks may in part not reflect true recovery but compensational events.
(1) Several studies have described that stroke triggers a specific regenerative molecular program
in peri-infarct neurons (Li et al., 2010) which leads to increased brain plasticity maximally en-
hanced 1 week after insult which plateaus at 3 weeks (Krakauer et al., 2012). Already existent
connections are recruited on an activity- and competition based-manner, new connections are
formed within the peri-infarct cortex, including projections to the contralesional cortex through
reduced callosal inhibition (Weiller et al., 1993, Seitz et al., 1998; Cramer, 2008; Li et al., 2011).
At the cellular level, dendritic spine morphogenesis occurs in parallel with expansions in the
cortical maps during the first 4 weeks after stroke (Brown et al., 2009; Mostany et al., 2010).
As dendritic spines are the receiving structures for neuronal input onto pyramidal neurons
(Krakauer et al., 2012), this modification of hardware structure likely plays a crucial role for
providing the textural basis for the restoration of activity in the peri-infarct cortex. In addition,
activity- dependent rewiring requires the alteration of electrical excitability of neurons partici-
pating in the reorganization process. Recent studies have demonstrated changes of excitatory
and inhibitory receptors in the peri-infarct cortex: Low levels of AMPA receptor blockade in
the first 2 weeks after stroke, which would not affect motor function in healthy mice, lead to a
transient decrease in recovery (Clarkson et al., 2011). In contrast, stimulating AMPA receptor
activity in the first weeks after stroke enhanced motor function. The underlying mechanism
responsible for this improvement in motor recovery was revelead to occur via induction of the
brain-derived neurotrophic factor (BDNF) through AMPA receptor dependent signaling.
(2)Although animals showed a significant loss of grasping ability during the first week after
stroke after the center of the forelimb motor cortex had been destroyed, still stepping on the
running wheel and even perfect grasps on the horizontal ladder were observable. Thus, these
results indicate that other subcortical centers for motor action took over immediately or they
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Fig. 12: Inhibition of neurons in the peri-infarct cortex resulted in the re-emergence of the
same two error patterns for grasping failure as observed in the acute phase following stroke
induction. (A) A score for detailed analysis of grasping kinematics revealed two significantly emerging error
features (too long grasps and partial slips after targeting the rung with the wrist joint) at 1-3 days after
stroke and after the pharmacogenetic inhibition of neurons in the peri-infarct area 30 min after i.p. CNO
application. Both failure patterns were significantly less frequent in healthy animals at baseline recordings,
in the recovered situation (4 weeks after stroke) and 2h after CNO application when the CNO concentration
was scoured in the CNS). Data are presented as means ± s.e.m.; statistical evaluation was carried out with
two-way ANOVA repeated measures, followed by Bonferroni post hoc test, asterisks indicate significance:
∗∗P < 0.01, ∗∗∗P < 0.001. (B-D) Four specific grasping patterns are depicted for each animal at the five
time conditions within the experimental schedule (baseline, 1-3d after stroke, baseline for the DREADD
experiment (49 d after stroke), 30 min and 2h after CNO application). Percentages are given relative to the
total amount of grasps analyzed for each condition. Illustrations of the grasping patterns are adapted from
C. v. A.’ s master thesis. 74
are permanently there just masked by the fine-tuned planning and controlling of movements by
the motor cortex. Some researchers have claimed that the corticospinal tract might not be the
major contributor to motor control in mice (Watson and Harrison, 2012) and cortical damage
may be more devastating in humans than in rodent, due to the higher capability to recruit the
rubrospinal and the medial system (resticulospinal and vestibulo spinal), which are larger in size
and function in rodents (Bachmann et al., 2014). The corticospinal and the rubrospinal tract
show many similarities, such as the somatotopical organization, with a greater representation
in distal than proximal limbs, as well as similar error patterns in grasping tasks once either
one or the other of the tract is impaired (Schwab and Rainteau 2001). Hence, the rubrospinal
tract, originating from the red nucleus, might also contribute to distal limb control in our mice
after stroke onset. Moreover, central pattern generators or propriospinal pathways as local
intraspinal pathways react and adapt to optimize impaired motor control after stroke (Barrière
et. al. 2008).
(3) Success scores of the grasping performance in both tasks indicated an almost full recovery of
motor impairment 28 days post stroke surgery. However, the scores we used (adapted for mice
from Maier et al., 2008, please refer to section ’Material and Methods’ above) took only into
account the targeting of the rung as a preferred-end-point model (Graziano, 2006) and did not
specifically analyze grasping tajectories reflecting the sequence of action during a grasp. For
these reasons the determination of the extent to which improved motor performance indicates
true recovery is challenging and functional recovery may rather reflect a combination of both,
true restoration of function and the activation of different subsets of behavioral compensations
(Moon et al., 2009; Murphy and Corbett, 2009).
A forelimb stroke induces hyperexcitability and expansion of the
hindlimb motor cortex
We used light-based mapping to study cortical reorganization in the peri-infarct cortex after a
small stroke in the forelimb motor cortex over weeks. While we not only detected a map ship
towards and organization of a new center for forelimb function in former parts of the hindlimb
area, we also saw an expansion of the hindlimb area accompanied by increased hindlimb move-
ment responses upon stimulation (Fig. 8D, E). Somatic map shifts are a common phenomenon
after stroke described in clinical as well as experimental studies (Brion et al., 1989; Chollet et
al. 1991; Ward, 2004). A study by Neumann-Haeflin et al., 1998 gave a first hind that cortical
excitability might be a result of the down-regulation of the α1 γ-amino butyric acid receptor
subunit and a decrease in γ-amino butyric acidergic inhibition. However, it remained unclear,
whether map shifts introduce replacement of the former functional representation of the area
the map is shifted to or whether an area maintains its primary role in addition to assuming
control for functions which have been represented by the destroyed areas before. Starkey et al.,
2012 found in a retrograde double tracing study that the majority of reorganized hindlimb cells
which ’take over’ forelimb function after a forelimb motor cortex stroke mainly connected to
the cervical spinal cord. Hence, these hindlimb cells lost their original connections and instead
became solely connected to forelimb output neurons in the cervical spinal cord. In contrast,
Harrison et al., 2013 used longitudinal light-based motor mapping to study reorganization after
a small sensory stroke, which caused a new sensory map shift to form in the motor cortex, that
maintained its center position despite becoming more dispersed. Our data are in accordance to
this: A new forelimb motor center was organized in a cortex area which originally represented
hindlimb function. Hindlimb function of this area was preserved but was even re-organized in
such a manner, that the area expanded and the threshold for stimulus evoked- motor responses
of hindlimb neurons became much lower. This change of excitability may be due to modifica-
tions of inhibitory receptor density or of interneuron populations and their activity as described
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(Zeiler et al., 2013).
A new center of forelimb function is organized in the peri-infarct
cortex in accordance with the re-establishment of motor engrams for
skilled forelimb function 4 weeks after stroke.
For many years the primary motor cortex has been viewed as a static map which can be further
divided into different sub-areas for the movement control of distinct body parts, joints or even
muscles while the body map is influenced by many pre-motor areas which authorize a range
of higher-order functions. Based on recent findings Graziano, 2006 and others hypothesized
a more complex model of the motor cortex better reflecting the highly plastic and adaptive
requirements of circuit connectivity and function within the motor cortex. Graziano, 2006
claimed three major interacting levels aiming at optimal motor control to perform a motor
task:
(1) The motor cortex may be divisible into zones that emphasize different behaviorally rele-
vant categories of movement instead of a somatotopic map which separates movements into
constituent muscles and joints.
(2) A motor neuron in the cortex may not connect to a single muscle in the periphery but
rather excites interneuron pools in the spinal cord resulting in the activation of muscle synergy
groups. A motor neuron cannot be simply classified for a specific direction tuning component,
speed, force angle and muscle activity - although in specific contexts correlations have been
described (Evarts, 1968; Cheney et al., 1985; Georgopoulos et al., 1992; Holdefer and Miller,
2002; Kakei et al., 1999) - instead, single neurons in the motor cortex may be tuned in an
idiosyncratic fashion to complex, behaviorally useful patterns of motor output which reflect
common actions. Thus, motor neurons are direction tuned within a specific meaningful task
which can rapidly change as the task changes - neurons are locally tuned, but globally not.
’Within this optimal control theory, there is no single preferred parameter for direction, end
posture or joint speed. Instead, the parameters being controlled depend on the task being
performed.’ (Graziano, 2006).
(3)The spinal cord controls movements at a level of complexity which cannot be summarized
on the level of muscle maps or joints proposed for fine-tuning by the primary motor cortex.
Thus, the connectivity between the motor cortex and muscles is not fixed but fluid, changing
constantly on the basis of feedback from the periphery.
This modern view of motor cortex - spinal cord interaction and computation may allow us to
explain the high capacity of the motor system to learn new tasks and to be adaptive after
damage to a part of the circuitry.
In this study we used the horizontal ladder walking test and a modified variant that even re-
quired more precise targeting and coordination of muscle strength, the conditioned running
wheel task, to assess skilled forelimb function. All animals were pre-trained in those tasks to
achieve at least 60% success rates before a photothrombotic stroke was introduced. Motor
learning of a task usually consists of two components, a slow and a fast process to enhance mo-
tor performance. The slow one occurs during the first few trials of the training session whereas
the fast process develops over time across sessions (Tucci et al., 2007). While mice were training
on the wheel, their grasping increased in accuracy accompanied by correct dedication of their
body weight, leading to improved balance control and coordination of limb strength over the
course of time. Such improvements suggest that grasping and stepping performance employs
complex brain connectivity (Tuccis et al., 2007). In addition, training of a motor task induces
not only changes in motor map organization but also establishes specific motor engrams which
reflect the acquired skills (Monfils et al., 2005). Thus, training on the wheel or horizontal ladder
may emphasize connections which lead to meaningful action patterns, such as adjustments of
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the paw placement according to the rung sequences.
When evaluating post stroke performance of mice we found two stereotypical grasps, which
were repetitively detected, in particular within the first week after stroke: over-extensive grasps
(missing the rung) and partial slips with the wrist. Hence, the stroke destroyed the motor map
organization resulting in a loss of the cortical network structure responsible of correct paw
placement in the preferred-end-posture model: Due to a defective optimal control strategy ac-
curate paw placement was lost and grasps became to long.
In addition, the lesion in the motor cortex of the forelimb area damaged layer 5 output-neurons,
which targeted axons in the subcortical area, involved in precise motor movements. As the cor-
ticospinal pathway originating from layer 5 neurons, regulates sequential and synergetic move-
ments of each muscle to control fine motor movement, especially the target reaching posture
(Ueno and Yamashita, 2011), the stepping on the irregular rung pattern required sequences of
skilled movements: First the targeting trajectory of the paw for the appropriate rung followed
by the accurate placing and finally, the closure of the paw around the rung with consecutive
contraction of flexion muscles within the elbow joints for the movement of the rest of the body
(Metz and Whishaw, 2002). In our study mice were able to place the paw on the rung but
were unable to close the paw and to stabilize body posture before moving towards the next
rung. Instead we detected extensive usage of wrist/heel retaining movements with coarse mo-
tor actions leading to subsequent slips. These observations indicate a failure of the target end
posture, but may also be explained as a result of impaired sensory perception, of inter-limb
coordination and the inability to perform balanced weight supported stepping movements after
damage in the sensorimotor area.
28 days after stroke animals depicted full recovery of success rates in both grasping tasks and the
two stereotypical error - too long grasping and slipping after targeting the rung with the wrist -
had disappeared (Fig. 5). However, when we used a pharmacogenetic approach to temporarily
and selectively inhibit neurons in the per-infarct regions (Fig. 10), both types of grasping
errors re-emerged. This result not only confirms the re-organization of the center for forelimb
motor control in the peri-infart area, something, which we have already seen during light-based
mapping over the course of 4 weeks after stroke surgery (Fig. 8), but also suggests the re-
establishment of specific motor engrams for skilled grasping function, meaning the rewiring
of sets of neurons tunable to form networks for precise sub-types for forelimb function within
the newly re-organized forelimb area. Neurons in the peri-infarct hindlimb cortex were able
to take-over meaningful forelimb function maintaining their hindlimb function. Thus, our
study provides new evidence for a sensorimotor cortex whose computational processing is very
adaptive and tunable, and which, instead of categorizing neurons in fixed specializations for
distinct movements, emphasizes behaviorally relevant neuronal circuit formation.
Conclusion and Outlook
In summary, this study indicates the crucial importance of the peri-infarct area for the restora-
tion of skilled forelimb function after a small stroke destroying the forelimb motor cortex.
Within 4 weeks after stroke the center of forelimb function is re-organized within a part of the
former hindlimb motor cortex accompanied by a full recovery of forelimb function. Temporar-
ily inhibiting neurons in the peri-infarct region lead to a decline of regained fine motor skills
and a re-emergence of stereotypical error patterns for grasping as detected immediately after
stroke. These results suggest a full establishment of motor engrams for grasping function in
the former hindlimb cortex. However, there are limitations to this study: Light-based mapping
of the sensorimotor cortex, although an improvement compared to the invasive intracranial
microstimulation, may always provide only rough map shifts while an approach which studies
neuronal networks on the level of single cell resolution opens up a broad range of possibilities to
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directly study formation, loss and re-emergence of specific motor engrams - even in dependence
of external rehabilitative interventions - before and after stroke.
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One sentence summary
Based on a distinct rehabilitation paradigm after stroke in adult rats we stimulate the formation
of new neuronal circuits that restore motor function and prove their functional relevance with
two diverse pharmacogenetic approaches for reversible blockade of the fibers from the forebrain
cortex to the spinal cord.
Abstract
The brain exhibits limited capacity for spontaneous restoration of lost motor func-
tions after stroke. Rehabilitation is the prevailing clinical approach to augment
functional recovery, but the scientific basis is poorly understood. Here we show
almost full recovery of skilled forelimb functions in rats with large strokes when a
growth promoting immunotherapy against a neurite growth inhibitory protein was
applied to boost the sprouting of new fibers, before stabilizing the newly formed
circuits by intensive training. In contrast, early high intensity training during the
growth phase destroyed the effect and led to aberrant fiber patterns. Pharma-
cogenetic experiments identified a subset of corticospinal fibers originating in the
intact half of the forebrain, side-switching in the spinal cord to newly innervate
the impaired limb and restore skilled motor function.
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Stroke is a major cause of severe disability in the elderly population, and recovery after large
strokes is limited (Murphy and Corbett, 2009; Dimyan et al., 2011). Current strategies to im-
prove long-term outcome in humans include mostly rehabilitative training and in experimental
models also electrical stimulation and pharmacological interventions (Langhorne et al., 2011).
However, all of these treatment options have had only limited success so far (Carmichael, 2006;
Zeiler and Krakauer, 2013). Here we show that rehabilitative training, if preceded by a nerve
growth-promoting antibody therapy almost completely restored skilled forelimb functions after
cortical strokes in adult rats. Sequential application of the treatments was essential: when
growth promotion by blockade of the neurite growth inhibitory protein Nogo-A was simulta-
neously applied with intensive forced-use training of the forelimb during the first 2 weeks after
the stroke, functional outcome was poorer compared to training, immunotherapy alone or no
treatment at all (Lindau et al., 2014). Anatomically, Nogo-A neutralization promoted growth
of corticospinal fibers from the intact forebrain motor cortex across the midline of the cervical
spinal cord. In rats with simultaneous antibody treatment and training, fiber branching was
exuberant with anatomically aberrant terminations. In contrast, in animals trained for forelimb
function subsequent to antibody treatment, axonal fibers originally terminating in the intact
spinal hemicord crossed the mid-line and innervated the ventral motor regions of the spinal
hemicord that had lost its input from the motor cortex. To prove the functional relevance of
these newly grown, ’side-switched’ descending corticospinal tract fibers, we selectively and tem-
porarily blocked these fibers by two different pharmacogenetic techniques: both suppressed the
restored forelimb function. Our results demonstrate that a sequential strategy of first promot-
ing fiber growth to enhance the low endogenous plastic potential of the brain and spinal cord
followed by rehabilitative training-induced selection and stabilization of functionally meaning-
ful connections can lead to much higher levels of functional restoration after large brain lesions
than currently obtained in conventional rehabilitation medicine.
4.1 Success of rehabilitation depends on timing
We compared four different therapy and rehabilitation schedules for promoting functional re-
covery of fine motor skills of forelimbs in a thrombotic stroke model in rats. Using the well-
established technique of photothrombosis (Lindau et al., 2014), we induced blood vessel blocks
by multiple microthrombi which destroyed > 90% of the sensory-motor cortex of adult rats.
Rats were then treated by intrathecal anti-Nogo A or control antibody for 2 weeks (Lindau et
al., 2014; Oertle et al., 2003). In addition, we trained rats intensely in skilled forelimb reaching
(100 reaches per day) either simultaneously with antibody application (’parallel’ groups) or dur-
ing the two weeks after antibody treatment (’sequential’ groups) (Fig. 1A). To avoid a training
effect of testing itself we did not re-assess the sequential groups (′anti−Nogo−A/sequential′
and ′controlsequential′) during the first two weeks post lesion. When the growth enhancing
anti-Nogo-A treatment was followed by the rehabilitative training (′anti−Nogo−A/sequential′
group), animals improved their performance from day 16 post-stroke onwards, and their skilled
reaching abilities almost completely recovered(Fig.1A, B; reaching 86.3 ± 2.0% of pre-stroke
level; significantly better than all other groups; p < 0.001, two-way repeated measures ANOVA
with posthoc Bonferroni). This group also performed best in two novel tasks of skilled forelimb
use tested at the end of the experiment (Montoya staircase grasping: success rate 34.1± 5.1%;
Fig. 1C; horizontal ladder crossing: success rate 65.±3.7%; Fig. 1D). As animals had not been
exposed to these tasks before, these results indicate a generalization of the recovery of forelimb
function in the sequential training group that is transferable to non-trained motor skills.
In contrast to these results, rats receiving intensive forelimb training concurrently to the anti-
Nogo-A antibody treatment (′anti−Nogo−A/parallel′ group) performed worse than all other
groups in the single pellet grasping task (success rate 10.0 ± 5.2%, Fig. 1A, B). In the novel
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tasks tested at the end these animals showed either no significant improvement (Fig. 1C) or
a tendency of decline over the course of trails (p = 0.1, two-way repeated measures ANOVA
with posthoc Bonferroni, Fig. 1D). The control antibody treated groups reached low levels of
recovery (35− 40% success rate in pellet grasping, Fig. 1 A−D), with an early training effect
visible in the group trained during the first two post-stroke weeks (′control/parallel′, Fig. 1A).
Final success scores did not correlate with stroke volume as determined ex vivo either from
whole-brain MR-images (r = 0.04, Spearmann correlation; Fig. 1F) or histological Nissl stains
(Fig. 2), suggesting no specific neuroprotective effect by any of the four therapeutic schedules.
We conclude that applying a nerve fiber growth-promoting cellular therapy and rehabilitative
physical training in sequence delivers greater functional recovery than when the same protocols
are applied concurrently.
4.2 Rehabilitative schedules induce distinct neuronal fiber
patterns
We investigated the neuroanatomical correlates of functional recovery by labeling the intact,
contralesional corticospinal tract, which normally innervates the spinal cord half opposite to
the one which has lost its cortical input, with only few fibers crossing the spinal cord mid-
line. Each of the four experimental groups presented a unique rehabilitation-induced pattern
of fiber sprouting in the cervical spinal cord (Fig. 3C). We counted labeled fibers originating
in the cortex of the intact side opposite to the stroke and crossing the midline of the spinal
cord (Fig. 3A). We also quantified their elongation and branching within the grey matter
of cervical spinal cord, i.e. the cord region containing the motor control circuits of the fore-
limb and paw (Fig. 3A,B). The greatest number of midline-crossing fibers was seen in the
′anti − Nogo − A/sequential′ treatment group, which also had the best functional outcome.
In contrast, the ′anti − Nogo − A/parallel′ group, showed extensive branching of the mid-
line crossing corticospinal fibers (Fig 3B, p < 0.05, two-way repeated measures ANOVA with
posthoc Bonferroni).
A quantitative analysis of the distribution and density of ipsilaterally projecting corticospinal
fibers using pattern recognition algorithms to analyze both single corticospinal fibers and related
fiber growth parameters (see Methods) confirmed overshooting fiber growth and aberrant ter-
mination patterns in the ′anti−Nogo−A/parallel′ group. In the ′anti−Nogo−A/sequential′
group midline-crossing sprouting corticospinal fibers displayed a radial organization with few
branches and a preference for the premotor and motor spinal cord (laminae 6−9, Fig. 3D−G).In
contrast, fibers in the ′anti−Nogo−A/parallel′ group appeared less organized with more than
double the number of branches and a different laminar distribution including the dorsal, pre-
dominantly sensory laminae 1−5. We also assessed the connectivity of the ipsilaterally project-
ing corticospinal fibers by quantifying the density of axonal boutons recognized morphologically
in the premotor interneuron lamina 7: A significantly higher bouton density was detected in
the ′anti − Nogo − A/parallel′ group compared to the ′anti − Nogo − A/sequential′ group
(Fig. 3H; p < 0.05, Student‘s t-test, two-tailed, unpaired). The ′anti − Nogo − A/parallel′
group showed a greater tendency of axons to grow beyond the grey/white matter boundary,
and a highly aberrant growth pattern (Fig. 3H, I). In the medio-ventral funiculus, such fibers
are probably intermixed with sprouts of the small, uncrossed ipsilateral corticospinal tract.
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Fig. 1: Timing matters when a growth promoting anti-Nogo A immunotherapy is combined
with training. (A) Success rates in the single pellet grasping task at baseline (intact, trained), 2 days after a
large, unilateral photothrombotic stroke to the sensorimotor cortex of the preferred paw, and during training
and re-testing sessions until 4 weeks post-insult. The ′anti−Nogo−A/sequential′ group showed significant
improvement compared to all other groups whereas the performance of the anti-Nogo-A/parallel group was
significantly worse (′anti−Nogo−A/parallel′, n=16; ′control/parallel′, n=8; ′anti−Nogo−A/sequential′,
n=16; ′control/sequential′, n=9). (B) Recovery rates expressed as success rates of last testing session
normalized to baseline performance (100%). (C, D) Animals in the ′anti−Nogo−A/sequential′ group also
performed significantly better in novel grasping tasks such as the Montoya staircase test (C) or the horizontal
ladder crossing task (D) introduced after the completion of the rehabilitation schedules for 3 consecutive
trails. Data are presented as means ± s.e.m.; statistical evaluation was carried out with two-way ANOVA
repeated measure followed by Bonferroni post hoc, asterisks indicate significances: ∗P < 0.05,∗∗P < 0.01,
∗∗∗P < 0.001. (E) Representative picture of an ex vivo MRI image stack for 3D stroke reconstruction. (F)
There was no correlation between stroke volume and end point success rate in the single pellet grasping task
among all rehabilitation groups (r = 0.04, Spearman correlation).
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Fig. 2. Histological analysis and MRI imaging of stroke volume reveals no difference in lesion
size among rehabilitation groups. (A, B) Representative coronal sections of a brain after the completion
of rehabilitative treatment 8 weeks post a photothrombotic stroke for analysis of stroke volume using histo-
logical Nissl staining (A) and MRI imaging (B) (scale bar= 1000 µm). (C) Stroke lesion size did not differ
among the four different rehabilitation groups using both MRI imaging and 3D Neurolucida reconstructions
of coronal sections after Nissl staining (animals per rehabilitation group, n=3, r=0.95 Pearson correlation).
(D) Stroke volumetry on MRI images determined by a compositional registration and warping algorithm
developed to extract the shape of the lesion and to measure its size correlated with histological analysis of
Nissl stained sections. Data are presented as means ± s.e.m.; statistical evaluation was carried out with
two-way ANOVA repeated measure followed by Bonferroni post hoc (C).
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Fig. 3: Corticospinal tract sprouting depends on timing of rehabilitative training correlat-
ing with functional recovery. The four rehabilitation schedules (′anti − Nogo − A/parallel′, n=10;
′control/parallel′, n=8; ′anti − Nogo − A/sequential′, n=10; ′control/sequential′, n=8) differently influ-
enced the sprouting of corticospinal fibers from the intact side of the spinal cord across the spinal cord
midline (M). (A) Low and high magnification micrographs of BDA-labelled corticospinal fibers in intact
spinal hemicord (left) growing into the stroke-denervated hemicord (right; inset) at spinal cord level C4.
D1-D4: Lines for intersection counts with corticospinal fibers (scale bar=200 µm). (B) Fibers crossing the
midline (M) and branching in the grey matter at distances D1-D4 were counted and normalized to the num-
ber of BDA-positive labelled fibers in the main tract. (C) Micrographs showing different sprouting patterns
of corticospinal fibers from the ipsilateral cortex in the denervated cervical spinal cord (C4) in lamina 7
in the different treatment groups (scale bar=200 µm). (D) Combining anti-Nogo-A immunotherapy with
simultaneous training (′anti−Nogo−A/parallel′) results in a significantly higher density of ipsilateral CST
fibers in the stroke-denervated cervical spinal cord than anti-Nogo-A/sequential treatment. (E) The most
significant difference in fiber density between ′anti−Nogo−A/parallel′ and ′anti−Nogo−A/sequential′
animals was detected in lamina 6/7 and lamina 9 of the denervated cervical hemicord. Lamina 7 was also
significant for increased fiber branching (F) (branching index=branches per fiber/BDA positive fibers in
the intact CST) and bouton numbers (G) in the ′anti − Nogo − A/parallel′ group. (H, I) Significantly
more fibers cross the grey-white matter boundaries in the dorsolateral (A), the ventrolateral (B) and the
ventro-medial funiculus (C, scheme shown in H) in the anti-Nogo-A/parallel group. Data are presented as
means ± s.e.m.; statistical evaluation was carried out with two-way ANOVA repeated measure followed by
Bonferroni post hoc (b) and Student´s t-test (two-tailed, unpaired) for e-j, asterisks indicate significances:
∗P < 0.05,∗∗P < 0.01, ∗∗∗P < 0.001. 87
4.3 Nerve cells from the intact forebrain cortex are
responsible for recovery
Our results suggest that the recovery of rat forelimb function after stroke in the ′anti −
Nogo−A/sequential′ group originates from extensive and precise re-innervation of the stroke-
denervated spinal hemicord by midline-crossing fibers from the intact motor cortex and corti-
cospinal tract. We tested this hypothesis in the animals of the ′anti − Nogo − A/sequential′
group, all of which showed excellent functional recovery, by using two different experimental
approaches for inducible, selective and reversible inactivation of the ipsilaterally projecting cor-
ticospinal fibers on the long and short term, respectively. For long-term blockade we used virus
to deliver a doxycyclin-inducible tetanus toxin to temporarily inactivate the synaptic release
mechanism (Kinoshita et al., 2012). We injected the highly efficient retrograde gene transfer
lentivector HiRet carrying enhanced tetanus neurotoxin light chain (eTeNT) with an enhanced
green fluorescent protein (EGFP) downstream of a tetracycline-responsive element (TRE) into
the stroke-denervated side of the cervical spinal cord at level C5-C6, and the adeno-associated
serotype 2.2 (AAV2) vector carrying the reverse tetracycline transactivator (rtTAV16, Tet-on)
into the contralesional, intact pre-motor and motor cortex (n = 6, Fig. 4A, B). Only cortical
neurons with axons projecting to the stroke-denervated spinal cord would contain both trans-
genes and activate tetanus toxin in response to doxycycline. We applied the same procedure in
4 control animals except that these animals received injections of the HiRet lentivector coding
for EGFP only.
After recovery from the surgery and the reassessment of re-gained grasping skills, doxycycline
was orally administered for two weeks (Fig. 4A, C). In the experimental group grasping per-
formance declined within a few days reaching a very low level from day 7 after doxycycline
initiation (p < 0.05, statistical comparison TeNT versus control group, two-way repeated mea-
sures ANOVA with posthoc Bonferroni; Fig. 4C).When the drug administration was ceased,
the lost function was regained within 2 weeks. All animals again showed a loss of skilled food
pellet grasping movements when oral doxycycline intake was re-started for a second time over
the course of another 3 weeks (Fig. 4C). No deterioration of the post-stroke recovered skilled
grasping was observed in control animals (EGFP instead of eTeNT) under the same dosage
of doxycycline and within the same time frame (98.1 ± 0.9% of pre-doxycycline grasping per-
formance). As the retrogradely transported virus was EGFP tagged, corticospinal neurons
projecting to the ipsilateral cervical spinal cord segments C5-6 could be quantified. These neu-
rons were concentrated in layer 5 of a specific region of the rostral, premotor and the primary
(M1) forelimb motor cortex (3.7mm ± 0.2 anterior to bregma). In the center of the labeled
region, 41.4 ± 5.6% of Nissl-positive cells of layer 5 contained the transgene (Fig. 4D, E).
These results demonstrate that midline-crossing corticospinal fibers from the intact hemisphere
opposite to the stroke lesion anatomically and functionally switch sides, which is crucial for
the recovery of skilled forelimb movements. They maintain their new function, even if they are
functionally blocked for weeks. Evidently, their role cannot be compensated by other cortical
or subcortical motoneuronal pathways in the injured system.
4.4 Temporally blocking rewired corticospinal fibers re-
sults in decline of regained function.
For short-term reversible inactivation of the midline-crossing corticospinal fibers we used a
pharmaco-genetic approach involving virus-mediated gene transfer to express engineered Gi/o-
coupled DREADD receptors (‘designer receptor exclusively activated by designer drug‘). These
receptors are only activated by the otherwise pharmacologically inert synthetic ligand clozapine-
88
Rehabilitation schedules/Re-testing 
Photothrombotic stroke 2 weeks 5 weeks4 weeks
HiRet injection (spinal cord)
AAV injection (contralesional cortex)
Anti-Nogo sequential
A
7 weeks 10 weeks 12 weeks 15 weeks
Recovery 
from Tracing
Re-Testing
Anti-Nogo A Training
Pre-Training Doxycycline  
(3 weeks)
Doxycycline  
(3 weeks)
Perfusion and 
tissue
preparation
Behavioural analysis
B C
TeNT
EGFP (Control)
0
20
40
60
%
 o
f G
FP
+ 
ce
lls
 in
 N
is
sl
+ 
ce
lls
 in
 la
ye
r 5
, 3
.7
m
m
 
± 
0.
2 
an
te
rio
r t
o 
br
eg
m
a
ED
I
II
III
IV
V
i) ii) iii) iv)
Virus injection
Su
cc
es
s r
at
e 
%
Ba
sel
ine
 I-I
II
2d
 po
st 
str
ok
e
TeNT EGFP (Control)
0
50
100
Training 2 weeks
2 3 4 7 9 11 17 2 4 7 8 17
Dox
(d of administration)
Dox
***
***
** *
**
*
** **
Anti-Nogo
2 weeks
Break 2 weeks
C5
-C
6
Stroke CST
HiRet-TRE-EGFP.eTeNT/
HiRet-TRE-EGFP
AAV2.2-CMV-rtTAV 16
Fig. 4: Long-term reversible blockade of midline crossing corticospinal fibers abolishes the
functional recovery after stroke. (A) Experimental schedule; all animals had anti-Nogo-A immunother-
apy followed by intensive reaching training, leading to almost full functional restoration of skilled forelimb
functions. (B) Schematic diagram of vector injections into the contralesional motor cortex (AAV2.2-CMV-
rtTAV -16) and stroke-denervated cervical spinal cord (HiRet-TRE-EGFP-TeNT or HiRet-TRE-EGFP as
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N-oxide (CNO) resulting in increased intracellular Gi/o –mediated signaling which leads to
membrane hyperpolarization and silencing of the infected neurons (Conklin et al., 2008; Alexan-
der et al., 2009; Ferguson et al., 2011). We used only rats that had undergone the treatment
schedule of growth promotion by Anti-Nogo-A antibodies followed by another 2 weeks of reha-
bilitative training. The virus injections started at the end of the training period (Fig. 5). To
selectively manipulate the corticospinal fibers projecting from the intact, contralesional motor
cortex to the denervated cervical spinal cord, we first injected an adeno-associated serotype 2.9
(AAV2.9) vector carrying the Cre sequence into segments C5 and C6 of the stroke-denervated
cervical spinal cord, followed by injections of the Cre-dependent AAV2.1 vector carrying the
Gi/o-coupled DREADD (hM4Di) receptor into the contralesional pre- and sensorimotor cortex
(n = 6, Fig. 5B). The DREADD receptor hM4Di was tagged with mCherry, which allowed neu-
roanatomical confirmation that only double-infected cells expressed the hM4Di receptor (Fig.
5C): We found mCherry- positive cells concentrated in layer 5 of the same region of the con-
tralesional premotor and motor cortex (3.7mm±0.2 anterior to bregma) as in the tetanus toxin
experiment. 31.6±2.4% of Nissl-positive layer 5 cells in this region were mCherry-positive (Fig.
6A, B), with very limited numbers of mCherry-positive cells outside of this area. In control an-
imals that received injection of the Cre-dependent AAV2.1-hM4Di vector in the contralesional
cortex without AAV-Cre-virus injection in the spinal cord, only 4.3 ± 0.5% of Nissl-positive
cells in layer 5 were positive for mCherry indicating low background noise (n = 4, Fig. 6A).
Three weeks after virus injection both hM4Di/+Cre and control hM4Di/-Cre animals per-
formed at > 80% of success rate in single pellet grasping (Fig.6C). Animals were then injected
intraperitoneally with the channel activating drug CNO. Control animals showed no change
in reaching and grasping abilities over the 50 minutes of observation time. However, animals
of the hM4Di/+Cre group lost their grasping abilities over 10-30 minutes, with performance
declining to 38.9 ± 6.0% success rate, significantly lower compared to the control group (Fig.
6C; p < 0.001, two-way repeated measures ANOVA with posthoc Bonferroni). The defective
movements were characterized by a specific failure to target the paw to the pellet and to close
the paw around the pellet (Fig. 6D), but with little modifications in overall grasping trajectories
(Fig. 7). The abatement of distal motor functions was confirmed by performing discriminative
classification based on a non-parametric representation (Ommer et al., 2009) of paw posture
and its change over time (p = 0.02, grasps at ’baseline’ versus ’after 30 min CNO’, K-S-Test).
This mainly distal impairment may also be due to the fact that only the cervical segments C5
and C6 were injected with the Cre-virus. These functional defects were fully reversible, with
performance returning to pre-injection levels about 40− 50 min after the CNO injection (Fig.
6C, D).
4.5 Pharmacogenetic inhibition of regained
EMG activity
We confirmed the CNO-specific blockade of neuronal firing of ipsilaterally projecting, in part
midline-crossing corticospinal fibers of the intact, contralesional motor cortex by electrophys-
iology using intracortical microstimulation (ICMS) at the end of the behavioural testing: We
used a 5x12 point stimulation grid (positioned at +3 to -3 mm anterio-posterior and 1 to 3.5
mm medio-lateral relative to bregma, Fig. 8A) and electromyogram (EMG) recordings of wrist,
elbow and shoulder muscles of the impaired paw as readouts (Fig. 8B). In all animals each
cortical position within the exploration grid was stimulated twice, first as baseline stimulation,
then again 30 min after CNO injection. In all hM4Di/-Cre control animals the EMG responses
at baseline and 30 min post CNO injection were not significantly different for the 60 stimulation
points (for wrist 95% confidence interval between ’baseline’ and ’30 min CNO’ was for animal 1
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Fig. 5: Short term-reversible blockade of ipsilateral corticospinal fibers using DREADD.
(A) The experimental schedule. (B) Schematic diagram of vector injections in the contralesional motor
cortex (Cre-dependent AAV1-hsyn-dio-hM4Di-mCherry) and cervical spinal cord (AAV9-CaMKII-Cre). (C)
mCherry positive pyramidal cell in layer 5 of contralesional motor cortex. Scale bar= 50 mum. (D) CNO
application specifically reduced EMG responses in wrist recordings in the hM4Di group when premotor and
rostral forelimb area of the contralesional motor cortex were stimulated. The heatmap shows the difference
of EMG response due to CNO application for each stimulation point between the control, hM4Di/-Cre group
and hM4Di/+Cre group.
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Fig. 6: Short term-reversible blockade of ipsilateral corticospinal fibers abolishes recovered
grasping function and forelimb EMGs. (A, B) Quantification of mCherry positive cells in percentage of
Nissl positive cells in layer 5 of contralesional pre- and motor cortex (M1), 3.7 mm anterior to bregma in the
hM4Di/+Cre group (n=6) and the hM4Di/-Cre control group (n=4) (A) and the illustration of its location
using Neurolucida reconstruction (B). (C) Activation of the DREADD receptor in the hM4Di/+Cre group
induced a rapid, massive, but fully reversible impairment of grasping performance 10 – 40 min after CNO
application; reaching success rates were unchanged in the control, hM4Di/-Cre CNO treated group over the
same time frame. (D) CNO application disturbed fine motor function of closing the paw around the pellet
in the hM4Di/+Cre group (p=0.02, K-S-Test): The figure shows the spatial probability densities for the
location of hand closure relative to the sugar pellet during grasping at ’baseline’ and after CNO application.
x represents the position of the sugar pellet relative to the forelimb position during grasping. Scale bar =
10 mm. (E) CNO application leads to a decrease of EMG responses in the hM4Di/+Cre group (n=5) after
ICMS of the contralesional motor cortex compared to ICMS stimulation at baseline and 30min after CNO
application in control animals (n=3). Given are heatmaps of the cortical stimulation grid (60 stimulation
points, 80 µA, +3 to -3 mm AP and 1 to 3.5 mm ML relative to bregma) whereby each stimulation point is
color coded with the mean value of EMG response for a muscle group (wrist or elbow or shoulder) at this
stimulation point (in mV) normalized to the mean of all stimulation points at baseline. Data are presented
as means ± s.e.m.; statistical evaluation was carried out with two-way ANOVA repeated measure followed
by Bonferroni post hoc, asterisks indicate significances: ∗∗∗P < 0.001.
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Fig. 7: Analysis of grasping kinematics before and during pharmacogenetic inhibition of
the newly outsprouting CST fibers.(A) schematic illustration of backward tracking of the paw during
the grasping process over 15 consecutive frames. (B) Overall grasping trajectories of animals in the Anti-
Nogo/sequential-training rehabilitation group did not significantly change between ’baseline’ (4 weeks post
stroke at the end of the rehabilitation schedule) and after pharmacogenetic inactivation of CST fibers
(p=0.65, K-S-test). The black cross indicates the sugar pellet position. (C) The mean trajectory of individual
Anti-Nogo/sequential-training animals before and after pharmacogenetic inactivation of CST fibers. The
red box indicates a significant difference of the motion trajectory of animal 3 (p=0.05, K-S-Test). However,
over all animals this was not significant as shown in (b); asterisks indicate significances: ∗P < 0.05
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0(0 to 0.001); animal 2 0(0 to 0); animal 3 0(0 to 0.001); One-sample Wilcoxon signed rank test,
Fig. 8C, Fig. 6E). In contrast, in 4 out of 5 hM4Di/+Cre animals the ICMS evoked EMG re-
sponses significantly decreased 30 min post CNO injection compared to baseline (for wrist 95%
confidence interval was for animal 1 -0.002(-0.002 to -0.001); animal 2 -0.004(-0.005 to -0.003);
animal 3 -0.002(-0.002 to -0.002), animal 4 0(0 to 0.001), animal 5 -0.012(-0.016 to -0.009), One-
sample Wilcoxon signed rank test, Fig. 8D, Fig. 6E). Calculating the mean EMG response
for every stimulation point in hM4Di/+Cre animals versus hM4Di/-Cre controls revealed a
significant decline of EMG responses in wrist and elbow muscles in the hM4Di/+Cre group 30
min post CNO application compared to controls (p < 0.05, Mann-Whitney Test, Fig.6E). No
significant abatement of EMG responses occurred in shoulder muscles of hM4Di/+Cre animals
(p = 0.4, Mann-Whitney Test, Fig. 6E). CNO application resulted in the largest difference in
EMG responses of wrist recordings when premotor and rostral forelimb areas of the contrale-
sional motor cortex were stimulated in hM4Di/+Cre group compared to controls (Fig. 5D).
These areas also expressed the highest concentration of mCherry expressing cells (Fig. 6A).
4.6 Discussion
Our study shows that in a rat model of large forebrain cortex strokes, timing of rehabilitative
training relative to timing of a nerve fiber growth promoting therapy affects the recovery of lost
motor function and the pattern of fiber sprouting. When rats received first Anti-Nogo-A im-
munotherapy followed by two weeks of specific, intense rehabilitative training forelimb function
was almost fully restored (Fig. 1A, B) indicating a far more extensive recovery rate relative to
stroke size than previously obtained by training (Adkins and Jones, 2005;Alaverdashvili et al.,
2008; Starkey et al., 2011) or growth-promoting therapy alone (Lindau et al., 2014; Tsai et al.,
2007). These animals not only outperformed the other rehabilitation groups in the single-pellet
grasping task, they were also able to better transfer their regained skills to novel forelimb tasks
(Starkey et al., 2011). The behavioral recovery was associated with crossing of CST fibers
from the lesion-spared, intact motor cortex to the stroke-denervated side of the spinal cord.
This observation is supported by various stroke and spinal cord injury models (Wiessner et
al., 2003; Tsai et al., 2007; Maier et al., 2008; Garcia-Alias et al., 2009; Starkey et al., 2011)
that relate midline-crossing corticospinal fibers to functional outcome. Our analysis shows that
not only the quantity of newly out-sprouting corticospinal fibers is relevant but also their ter-
mination pattern: Intensive training, when applied too early, induced hyperinnervation and
aberrant growth even beyond the grey/white matter boundary and into dorsal sensory lami-
nae. Such widespread sprouting may results in wrong circuit connectivity involving cervical
interneurons, V2a propriospinal neurons and motoneurons, thus impairing grasping function
e.g. by co-activation of agonistic and antagonistic muscles (Asante and Martin, 2013; Azim et
al., 2014).
Our data suggest the presence of critical time windows, during which the brain is most re-
sponsive to the application of growth promoting agents and to training-dependent plasticity. A
correct, timed sequence of interventions is required to maximize the effectiveness of rehabilita-
tive therapies after stroke. Suppression of the action of the endogenous growth inhibitory factor
Nogo-A by immunotherapy in a first step may diminish constraints on lesion-induced structural
plasticity through mechanisms such as neurotrophic factors, modified electrical properties of
motoneurons, alteration in neuronal energy balance (Petruska et al., 2007) and recruitment
of new circuits leading to hyperexcitability and prolonged responses to external stimuli (Mur-
phy and Corbett, 2009). In analogy to development, many of these newly formed connections
may be weak and imprecise. Training in a second step may then help to shape the spared
and new circuits by selection and stabilization of functional connections and pruning of the
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Fig. 8: Electrophysiological evaluation of reversible pharmacogenetic inhibition of CST fibers
using intracranial microstimulation with forelimb EMG as a readout. (A) schematic illustration
of the grid for ICMS (5 x 12 stimulation points, +3 to -3 mm AP and 1 to 3.5 mm ML relative to bregma)
in the contralesional sensorimotor cortex. (B) Example of EMG recordings at wrist, elbow and shoulder
muscles after intracortical microstimulation (ICMS) of the contralesional motor cortex. (C, D) Heatmaps at
baseline and 30 min after CNO application for each animal in the two groups (control hM4Di/-Cre versus
hM4Di/+Cre group) representing the maximal amplitudes of the EMG responses measured in wrist muscles
at a distinct location of cortical stimulation relative to bregma. The value at each stimulation point (mV)
was normalized to the baseline mean of maximal amplitudes at all stimulation points.
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non-functional ones. This second step might involve Hebbian learning rules, in the sense that
Hebbian plasticity redistributes synaptic strength to favor functionally relevant pathways that
are coincidently active (Murphy and Corbett, 2009). The high degree of recovery of important,
cortically controlled motor functions in rats with large ischemic strokes as demonstrated here
points to a possible avenue to explore growth-inhibitor blockade in combination with rehabilita-
tive training as a treatment strategy for humans with motor cortex stroke. Antibodies against
Nogo-A are currently used in clinical trials in humans for amyotrophic lateral sclerosis, multiple
sclerosis and spinal cord injury (www.clinicaltrials.gov). Careful consideration of rehabilitation
onset times, in particular with regard to windows of sprouting and circuit plasticity but also
vulnerability of the injured brain, and tailored training adapted to the type and extent of stroke
and the patient‘s history will be essential for future approaches in the clinic (Dimyan et al.,
2011; Krakauer et al., 2012).
4.7 Material and Methods
Experimental set-up
A total of n = 70 adult female Long-Evans rats (200-250g, 3-4 months of age, Janvier, France)
were used in this study. Animals were housed in groups of three to four under a constant 12h
dark/light cycle with food and water ad libitum. All experimental procedures were approved
by the veterinary office of the canton of Zurich, Switzerland. They are in accordance with the
Stroke Therapy Academic Industry Roundtable (STAIR) criteria (1999) for preclinical stroke
investigations. The objective of this study was the examination of combined rehabilitative
training with growth/plasticity enhancement by Anti-Nogo A antibody or control antibody
treatment – sequentially and in parallel – in order to compare distinct rehabilitation schedules
after a stroke for the restoration of skilled forelimb function. All animals received training in
single pellet grasping followed by a photothrombotic stroke and the intrathecal applicaton of
Anti-Nogo A antibodies or Ig G control antibodies delivered by osmotic mini pumps as described
below. Only animals that revealed a severe lesion deficit two days post stroke surgery (less than
12% success rate in the single pellet grasping task compared to pre-stroke baseline levels) were
included in this study. Animals were then randomized in four different rehabilitation groups.
This experimental set-up was repeated in N=3 independent studies with n = 12− 16 rats per
cohort for behavioural and morphological analysis. As there was no statistically significant
difference in the outcome of lesions, behavior and anatomy, the data shown here were pooled
from all three studies. Animals were number-coded and investigators were always blinded to
the treatment groups until the end of the data analysis.
Photothrombotic stroke and antibody treatment
Animals were anaesthetized with 3% isoflurane followed by a subcutaneous injection of a mix-
ture of Hypnorm (600µl/kg body weight, Janssen Pharmaceutics) and Dormicum (3.75mg/kg
body weight, Roche Pharmaceuticals). A photothrombotic stroke to unilaterally lesion the
sensorimotor cortex corresponding to the preferred paw (see ’rehabilitative training’ section)
was introduced as previously described (Lindau et al., 2014). Briefly the animal was fixed in
a stereotactic frame, the skull exposed through a midline incision, cleared of connective tissue
and dried. A cold light source (Olympus KL 1500LCS, 150W, 3000K) was positioned over
an opaque template with an opening for the light source (10 x 5mm) 5mm to -5mm anterior
and 0.5mm to 5.5mm lateral to Bregma. Rose Bengal (13mg/kg body weight, 10mg/ml Rose
Bengal in 0.9% NaCl solution) was injected in the femoral vein and after 2 min, the brain was
illuminated through the intact skull for 10 min.
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For constant delivery of the function blocking Ig G1 mouse monoclonal anti-Nogo-A antibody
11C7 (3 or 4.2mg/ml, gift from Novartis, Oertle et al., 2003) against an 18–amino acid Nogo-A
peptide corresponding to the rat sequence amino acids 623 to 640 or the monoclonal control
antibody anti-bromodeoxyuridine (BrdU; 3 or 4.2mg/ml, AbD Serotech), a fine intrathecal
catheter (32 gauge) was placed in the subarachnoid space at lumbar level L2 after laminectomy
and connected to an osmotic minipump (Alzet 2ML2; 5µl/h, 3.1µg/µl). For postoperative
care all animals received analgetics (Rimadyl, 2.5mg/kg body weight, Pfeizer) and antibiotics
(Baytril, 5mg/kg body weight, Bayer) for 3 days as well as a single subcutaneous injection of
mannitol (20%, 17mg/ml, B. Braun) to reduce swelling of the cortex. After 2 weeks pumps
and catheters were removed.
Rehabilitative training and testing
All animals were trained in the single pellet grasping task (Starkey et al., 2012) to assess fine
motor control of the forelimb. Animals were placed in a Plexiglas box (34 x 14 cm) with two
openings on opposite ends and had to grasp pellets (45-mg dustless precision pellets, TSE Sys-
tems Intl. Group). During testing sessions animals were given 20 pellets within a maximum
time of 10 min. Grasping performance was scored as follows (Starkey et al., 2012): a trial,
defied as the animal putting its paw through the grasping window to grasp a new pellet pre-
sented to the preferred side was scored as 1 (successful grasp) if the animal retrieved the pellet
and brought it directly to its mouth. A score of 1 was also given if the animal required several
attempts to grasp the pellet, without retracting the paw through the window and into the box,
which was defined as the end of the attempt. A score of 0.5 was given if the animal successfully
grasped the pellet but dropped the pellet inside the box. If the animal knocked the pellet off the
shelf, the trial was scored as 0. The success rate was calculated as the percentage of retrieved
pellets of the number of all trials. Animals were trained 3-4 weeks for baseline recordings be-
fore stroke. Only animals with a 60% or higher success rate at baseline were selected for the
study. Two days post stroke surgery animals were re-tested in grasping to determine the lesion
deficit and then randomized into the four rehabilitation groups (′anti − Nogo − A/parallel′,
′control/parallel′, ′anti−Nogo−A/sequential′, ′control/sequential′): Here ’parallel’ indicates
the parallel training of forelimb function in single pellet grasping simultaneously to antibody
application for 2 weeks while training was initiated for the animals in the ‘sequential’ groups
after the completion of the antibody therapy and was maintained for another 2 weeks therefore
ending 4 weeks post insult. Training consisted of 100 trials per session in 7 sessions/ week with
the last 20 trials being scored for the success rate. Testing sessions were filmed (Panasonic
HDC-SD800 High Definition Camcorder, 50 frames/s) for further analysis of grasping kinemat-
ics.
After completing the rehabilitative training schedules in the four rehabilitation groups all ani-
mals were exposed to novel tasks of grasping function such as the horizontal ladder test and the
Montoya staircase (Montoya et al., 1991) in order to determine their non-task specific recovery
levels of forelimb function. The irregular horizontal ladder crossing was conducted as reported
previously (Maier et al., 2008): On three consecutive days three runs per animal were recorded
(Panasonic HDC-SD800 High Definition Camcorder) and analyzed frame by frame (VideoReDo
TV Suite, H 264, Drd Systems Inc.). The performance was scored as reported (Maier et al.,
2008). The success rate was calculated by dividing the amount of correct steps by the number
of total steps taken with the respective paw x 100 in the 3 test runs. The Montoya staircase
was performed as described previously (Montoya et al., 1991): Pellets were presented on five
different steps with 3 pellets per step to the animals placed into the staircase box for 10 min.
As the level of difficulty for reaching the pellets from the different steps changed, the amount of
eaten pellets from each step was multiplied by the number of the step. Then all products were
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added to the ’sum of eaten pellets’ (=’eaten pellets step 1’ x 1 + . . . .+’eaten pellets step 5’ x
5). The success rate in the test (’sum of eaten pellets’ x 100) was normalized to the maximum
possible score (45) in this test.
Anterograde tracing of the intact corticospinal tract (CST)
After the completion of the behavioural training and testing, the intact contralesional motor cor-
tex of animals in all 4 rehabilitation groups (′anti−Nogo−A/parallel′ n=10, control/parallel
n=8, ′anti−Nogo−A/sequential′ n=10, ′control/sequential′ n=8) was traced anterogradely
with Biotinylated Dextran Amine (BDA, 10,000 molecular weight, 10% solution in 0.01 M PBS,
Invitrogen). 10 stereotactic injections (200 nl each) were made through the intact dura using
a 35-gauge, 10µl syringe (World Precision instruments) with a flow rate of 6nl/s controlled
by an electrical pump (World Precision instruments). The injection coordinates for the motor
cortex were: 2 mm anterior to bregma (AP), 3 mm lateral to bregma (ML); 2.5 AP, 3.5 ML;
1.5 AP, 3.5ML; 1.5 AP, 2.5 ML; 2.5 AP, 2.5ML; -2.0 AP, 2.0 ML; -1.5 AP, 2.5 ML; -2.5 AP, 2.5
ML; -2.5 AP, 1.5 ML; -1.5 AP, 1.5 ML. All injections were at 1.5 mm depth and the syringe
remained in place for 2 min after completion of each injection.
Three weeks after BDA injections animals were anaesthetized (pentobarbital, 450mg/kg body
weight i.p., Abbott Laboratories) and perfused transcardially with 100 ml Ringer solution (con-
taining 100000IU/l heparin (Roche) and 0.25% NaNO2) followed by 300ml of a 4% phosphate-
buffered paraformaldehyde solution, pH 7.4. Brains and spinal cords were dissolved and cry-
oprotected in a phosphate-buffered 30% sucrose solution for cryostat sectioning in 40µm thick
sections before being stained by on-slide processing using the nickel-enhanced DAB (3,3’-
diaminobenzidine) protocol (Vectastain ABC Elite Kit, Vector Laboratories; 1:100 in Tris-
buffered saline plus TritonTM X-100).
CST fiber growth in response to stroke was evaluated at spinal cord levels C2-Th1. Fibers
crossing the spinal cord midline were counted at 20x magnification and branching of these
fibers was evaluated at 4 defined distances from the midline in the grey matter using a virtual
grid (D1-D4, Fig. 2a), with each line 125µm apart. To correct for variations in BDA labelling,
we normalized the data to the number of BDA-labelled axons in the intact CST for each animal
(CST axons: counted in five rectangular areas (4000µm2) and extrapolated to the total area of
the CST (0.1144mm2 ± 0.01) per slice in two sections at spinal cord level C2 and C5. Results
are expressed as newly out-sprouting fibers divided by the number of labelled fibers in the
intact CST for each animal.
Analysis of sprouting patterns in the cervical spinal cord
Mosaic images of 3 sections at spinal cord level C4 of each animal which received BDA tracing
were obtained (Zeiss Axioskop 2MOT with motorized stage, 20x magnification) for analysis of
distinct sprouting patterns according to the four different rehabilitation groups. Each image
was labelled with 3 landmarks (midline of the spinal cord, lateral tip of the ventral horn, dorsal
white-grey matter border of the dorsal horn) using a standard template of the cervical level C4.
Images were then warped to bring the landmark points into correspondence and compensate
for the overall deformation. Fibers were detected by computing the probability of boundary
(Maire et al., 2008) and using morphological operators to compensate for noise. Thereafter,
we trained detectors to localize fiber crossings. 100 exemplary crossings were cropped from
images, clustered into ten groups (agglomerative clustering with Ward’s method), and used as
training samples for linear Support Vector Machines. The discriminative classifiers for each
of the ten groups provided a linear filter. Images were then convolved with this filter bank
and non-maximum suppression was performed to detect fiber crossings. The combination of
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unsupervised clustering and discriminative classification was necessary to render the approach
computationally feasible for large-scale experimentation. A similar approach was followed for
bouton detection. Again 100 training samples were gathered and clustered into ten groups
before training linear filters using Support Vector Machines.
MRI images for stroke volumetry
Prior to ex vivo imaging for determination of lesion size the brain tissue samples were placed
in 15 ml falcon tubes filled with perfluoropolyether (Fomblin®Y-LC 80, Solvay Solexis, Bollate,
Italy). The MR measurements were performed using a 4.7T (200 MHz) small animal MR system
(Bruker BioSpin GmbH, Ettlingen, Germany), equipped with a volume resonator operating in
quadrature mode for excitation and a four-element phased array surface coil for signal reception.
T2-weighted images, in total 15 coronal slices of 0.9mm thickness with an interslice distance
of 1.10mm covering most of the brain, were acquired using a TurboRARE sequence with the
following parameters: field of view = 20 x 20mm2, matrix dimension = 200 x 200, yielding
an in-plane voxel dimension of 100 x 100µm, repetition time = 3930ms, echo time = 28ms,
effective echo time = 84ms, RARE factor = 8, number of averages = 15.
After ex vivo MRI, the brains were removed from Fomblin and placed again in PFA. To quantify
the degree of the lesion, automatic shape analysis was employed. A compositional registration
and warping algorithm was developed to extract the shape of the lesion and measure its size.
Following the approach of Yarlagadda and Ommer (Yarlagadda and Ommer, 2012), proba-
bility of boundary was computed for MRI image stacks and edge pixels were grouped into
candidate compositions. Thereafter, similar compositions were re-detected to find correspon-
dences between both brain hemispheres and to identify a symmetry plane. This registration
of compositions against a large degree of background clutter was based on the max-margin
discriminative chamfer matching with explicit modeling of background accidentalness (Eigen-
stetter et al., 2012). As described (Eigenstetter et al., 2012), the compositional shape matching
and the max-margin chamfer regularization are significantly more robust with respect to noise,
occlusion, or accidental distortions than a direct registration of edge pixels. As a result of the
compositional shape matching, both brain hemispheres were identified and the lesion, which is
an abnormality that is present in only one hemisphere, was detected and quantified in size.
Histological analysis of stroke volume
After ex vivo MRI imaging, rat brains fixed in 4% PFA were placed in a phosphate-buffered
30% sucrose solution at 4◦C before being cryoprotected. The brains were embedded in Tissu-
Tek®O.C.T.TM and frozen in isopentane (Sigma) at −40◦C. Brains were cut coronally on a
cryostat in 40µm sections and collected on slides (SuperFrost®). The frozen sections were dried
at room temperature, rehydrated and immersed in 0.5% cresyl violet (2 min) for Nissl staining.
After washing in water, the sections were dehydrated in graded alcohols, cleared in xylene
and cover-slipped with Eukit®mounting medium. The lesion volume of all four rehabilitation
groups was evaluated by 3D reconstruction of every 10th brain section, using Neurolucida 8.0
(MicroBrightField).
TeNT experiment
For long-term reversible blockade of midline crossing fibers originating from the intact CST
we combined two viral vectors being part of a Tet-on system as described (Kato et al., 2011;
Kinoshita et al., 2012): Animals were anaesthetized as mentioned previously for the stroke
lesion and a craniotomy was performed exposing the contralesional pre and sensorimotor cortex:
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12 injections (200nl each) of the Tet-on transactivator AAV2.2-CMV-rtTAV16 (1.6 x 10e13
copies/ml) were made as described above for the anterograde BDA tracing using the same
coordinates plus two coordinates in the premotor cortex (Fig. 4B): 2.2 AP, 2.5 ML; 2.2 AP,
3.5 ML. 2 days later, a minimal invasive laminectomy at spinal level C5-C6 was performed.
11 x 120nl of the highly efficient retrograde gene transfer (HiRet) vector HiRet-TRE-EHGFP-
eTeNT (7.2 x 10e11 copies/ml)(n=7) or the control vector HiRet-TRE-EGFP (9.0 x 10e11
copies/ml) (n=4) were injected in the denervated cervical hemi spinal cord (Fig. 4B) 0.7mm
lateral to the midline and 1.2mm below the spinal cord surface using a 35-gauge, 10ml syringe
(Hamilton, BGB Analytik) driven by an electric pump (World Precision Instruments) with a
flow rate of 6nl/s. Each injection was made in 2 steps of 60 nl keeping the syringe in place
for 3min between steps. After 1 week of recovery animals were re-trained and re-tested in the
single pellet grasping task for 2 weeks (Fig 4A) before doxycycline administration. For initiation
doxycycline (Doxycycline hyclate, Sigma-Aldrich) was applied via i.p. injection (10mg/kg body
weight in 0.9% NaCl) followed by oral administration (2mg/ml in 5% sucrose) during the course
of the experiment. Oral intake of the doxycycline/sucrose solution in combination with body
weight was checked on a daily basis. Doxycycline was applied twice for 3 weeks with a break of
2 weeks in between and animals were continuously re-assessed in the function of their impaired
paw. At the end of the experiment animals were anaesthetized and transcardially perfused as
described above (section ’Anterograde labeling of the CST’). Coronar cortex sections (40µm
slice thickness) were examined for the distribution of EGFP-positive neurons with anti-GFP
immunohistochemistry: Immediately after cryo-sectioning slices were blocked in Tris-NaCl-
blocking buffer and 0.1% Triton (TNB, TBST) for 1h at room temperature and incubated over
night at 4◦C in TNB, TBST and the primary antibody green fluorescent protein (GFP) (rat
monoclonal antibody, 1:1000; Nacalai). The biotinylated Goat Anti-Rat immunoglobulin-G (Ig
G) (1:300; Jackson IR) secondary antibody in PBS was applied for 2 h at room temperature.
The sections were washed in PBS and incubated in Alexa 488 Streptavidin (1:1000; Jackson
IR) and fluorescent Nissl 640/660 (1:500; Neurotrace Invitrogen) in TNB. Images were acquired
with a confocal microscope (Leica TCS SP2) with respective green (FITC) and infrared (Cy5)
excitation or emission filters at 20x magnification. The percentage of GFP-positive cells of Nissl
positive cells in layer 5 of the sensorimotor cortex was counted in 5 adjacent sections 3.7mm
(± 200 µm) anterior to bregma (Fig. 4D,E).
DREADD experiment
For short-term reversible blockade of midline crossing fibers originating from the intact CST
we used viral mediated- expression of an engineered G protein-coupled receptor (Gi/o-coupled
human muscarinic M4 designer receptor exclusively activated by a designer drug, hM4Di) that
is activated by an otherwise pharmacologically inert ligand, clozapine-N-oxide (CNO) (Conklin
et al., 2008; Alexander et al., 2009; Ferguson et al., 2011). In order to selectively express hM4Di
in midline crossing fibers coming from the intact CST we applied a Cre-dependent approach:
After completion of the rehabilitative training n=6 animals were injected with AAV2.1-hSyn-
dio-hM4D(Gi)-mCherry vector (UNC Vector Core, the University of North Carolina at Chapel
Hill) in the contralesional pre- and sensorimotor cortex followed by injection of an AAV2.9-
CamKIIα.-Cre vector (Penn Vector Core, Philadelphia) in the denervated cervical hemi spinal
cord at spinal cord level C5-C6 (Fig. 5B) as described above (’TeNT experiment’). Control
animals (n=4) just received injections of the AAV2.1-hSyn-dio-hM4D(Gi)-mCherry vector in
the cortex without application of the Cre-Vector in the spinal cord. 3 weeks post surgery
animals were video-taped (100 frames/s, GenieTM Teledyne Dalsa) in single pellet grasping
as ’baseline’ recording followed by i.p. injection of CNO (1.2mg/kg body weight; Enzo Life
Sciences). Animals were immediately put back into the grasping box and grasping performance
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was recorded for the next 50 min for further analysis (’Analysis of grasping performance’ be-
low). Each animal was tested for 3 independent trials in single pellet grasping at baseline and
under CNO application. Results are expressed as mean of these 3 trials per animal. The same
animals were then used for intracortical microstimulation (ICMS) described below. After com-
pletion of all experiments coronar cortical sections (40µm) were stained with fluorescent Nissl
640/660 (1:500; Neurotrace Invitrogen) in PBS and examined for the distribution of mCherry
positive neurons in the pre-and sensorimotor cortex by taking images with a confocal micro-
scope (Leica TCS SP2) with respective red (TRITC) and infrared (Cy5) excitation or emission
filters. Analysis of mCherry positive cells in relation to Nissl positive cells was undertaken as
above (see section ’TeNT experiment’).
Analysis of grasping performance
Based on an automated unsupervised tracking, and a discriminative machine learning approach
we studied the overall grasping kinematics as well as the process of closing the paw.
To analyze the grasping kinematics we first recognized the grasping event and localized it in
space and time. Therefore, the sugar pellets were detected using a holistic recognition algorithm
(Monroy and Ommer, 2012). The forelimb was tracked in both temporal directions (forward
and backward) from the moment it came close to the pellet. As there was significant back-
ground clutter and no manual initialization was provided for the tracking, we utilized a generic
compositional recognition and tracking approach (Ommer et al., 2009). This method provided
spatiotemporal grasping trajectories which were brought into the same reference frame by first
registering the scene of each camera shot to compensate for overall variations in magnification,
alignment, etc. For each experiment and time point (Baseline, 30min CNO application, and
50min CNO application) we thus obtained average trajectories per animal and performed a
pairwise agglomerative clustering with Ward’s method which provided a grouping of trajec-
tories into two clusters corresponding to hM4Di/+Cre and hM4Di/-Cre animals. We then
performed a discriminative analysis to measure the probability of misclassification.
The process of closing the paw upon grasping was analyzed by a discriminative classifica-
tion approach. Therefore the paw posture and its change were jointly represented using a
non-parametric model (Ommer et al., 2009), which comprises appearance, shape, and mo-
tion. Then a classifier was trained on these representations to separate functional from non-
functional grasps at baseline and 30min. Classification yielded a separating manifold and a
projection into a low-dimensional subspace, which best discriminated samples from baseline
and 30min. Projecting the 50min data into this subspace, yielded a contrasting measure be-
tween baseline/30min and baseline/50min. We then compare these measures for hM4Di/+Cre
and hM4Di/-Cre control animals based on a KS-test.
Intracortical microstimulation
For intracortical microstimulation hM4Di/+Cre and hM4Di/-Cre control animals were anaes-
thetized with a subcutaneous mixture of ketamine (50mg/ml, 7mg/ kg body weight, Streuli
Pharma) and xylazine (20mg/ml, 5mg/kg body weight, Streuli Pharma) plus a single injection
of mannitol (20%, 17ml/kg, B. Braun). The forelimbs were shaved for better visibility of mus-
cles and the rat was mounted in a stereotactic frame (Emmerick et al., 2003). A craniotomy was
performed on the contralesional side exposing the entire motor cortex (4mm to -4mm AP, 4mm
lateral relative to bregma). Using bregma as a landmark electrode penetrations were made
perpendicular to the pial surface (depth 1.3mm) tracing an rectangular exploration grid of 5 x
12 stimulation points localized from 3mm to -3mm AP and 1 to 3.5mm ML relative to bregma
with a distance of 500µm for each stimulation point (Fig. 8). Forty-five-millisecond trains of
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0.2ms biphasic pulses at 333 Hz (Lindau et al., 2014) were delivered through a glass isolated
platinum/tungsten stimulation electrode with an impedance of 0.5 – 1MΩ (Thomas Recording).
EMG recordings from the ipsilateral forelimb (M. extensor digitorum for wrist, M. biceps and
triceps for elbow, M. trapezius for shoulder) were used as readouts. The same points within
the exploration grid were stimulated twice with a current of 80µA insuring a stable response
(Brus-Ramer et al., 2007; Petruska et al., 2007; Soleman et al., 2012): First for ’baseline’ stimu-
lation, then again, 30 minutes after i.p. injection of CNO (1.2mg/kg body weight), to determine
electrophysiological modifications of corticospinal signal transmission under CNO. The EMG
signal was amplified, filtered, digitized and visualized via PowerLab (AD instruments). The
EMG data was subsequently transferred to Matlab and the maximum of the EMG-amplitude
was detected at each stimulation point and for all joints. Heatmaps represent the maximal am-
plitudes of the EMG responses in a joint at a distinct location of cortical stimulation relative to
bregma. Maximal amplitudes at all stimulation points at baseline or under CNO dosage were
normalized to the mean of maximal amplitudes at all stimulation points at baseline. For the
calculation of the difference of EMG responses due to CNO application between the control,
hM4Di/-Cre group and hM4Di/+Cre group the following formula was used for each stimula-
tion point: hM4Di/-Cre ((meanCNO - meanbaseline)/meantotal) - hM4Di/+Cre ((meanCNO
- meanbaseline)/meantotal), meantotal= mean of maximal amplitudes at all stimulation points
at baseline.
Statistical analysis
All data are expressed as mean ± standard error of the mean (s.e.m.). For comparing the
behavioural and anatomical reorganization of the four rehabilitation groups, a two-way ANOVA
followed by Bonferroni‘s post hoc test was used. In all these experiments differences between the
rehabilitation groups were significant for the chosen size of the cohort, thus justifying samples
size. Whenever two treatments were compared at one time point, Student‘s t-test (two-tailed,
unpaired) was used. For correlation analysis between behavioural recovery and out-sprouting
fibers or stroke volumetry Spearman correlation was applied. The Mann-Whitney Test as well
as the Wilcoxon Signed Ranks Test were used as non-parametric tests to test for statistical
significant difference of ICMS data between groups as well as between conditions within each
animal. The level of significance was set at ∗P < 0.05,∗∗P < 0.01, ∗∗∗P < 0.001.
102
4.8 References and Notes
Adkins D. L., Jones T. A. (2005). D-amphetamine enhances skilled reaching after ischemic cortical lesions in
rats. Neurosci Lett.380:214-8.
Alaverdashvili M., Foroud A., Lim D. H., Whishaw I. Q. (2008). "Learned abuse" limits recovery of skilled
reaching for food after forelimb motor cortex stroke in rats: a new analysis of the effect of gestures on success.
Behav Brain Res. 188:281-90.
Alexander G. M., Rogan S. C., Abbas A. I., Armbruster B. N. , Pei Y. , Allen J A., Nonneman R. J., Hartmann
J., Moy S. S. , Nicolelis M. A. , McNamara J. O. , Roth B. L. (2009). Remote control of neuronal activity in
transgenic mice expressing evolved G protein-coupled receptors. Neuron 63:27-39.
Asante C. O., Martin J.H. (2013). Differential joint-specific corticospinal tract projections within the cervical
enlargement. PLoS One. 8:e74454.
Azim E., Jiang J., Alstermark B., Jessell T. M. (2014). Skilled reaching relies on a V2a propriospinal internal
copy circuit. Nature. 508:357-63.
Brus-Ramer M., Carmel J. B. , Chakrabarty S. , Martin J. H. (2007). Electrical stimulation of spared corti-
cospinal axons augments connections with ipsilateral spinal motor circuits after injury. J Neurosci. 27:13793-801.
Carmichael S. T. (2006). Cellular and molecular mechanisms of neural repair after stroke: making waves. Ann
Neurol. 59:735-42.
Conklin B. R. , Hsiao E. C., Claeysen S., Dumuis A., Srinivasan S., Forsayeth J. R., Guettier J M., Chang W.
C., Pei Y., McCarthy K. D., Nissenson R. A. , Wess J. , Bockaert J., Roth B. L. (2008). Engineering GPCR
signaling pathways with RASSLs. Nat. Methods. 5:673-8.
Dimyan M. A., Cohen L. G. (2011). Neuroplasticity in the context of motor rehabilitation after stroke. Nat
Rev Neurol. 7:76-85.
Eigenstetter A., Yarlagadda P., Ommer B. (2012). Max-Margin Regularization for Reducing Accidentalness
in Chamfer Matching. In Proceedings of the Asian Conference of Computer Vision (ACCV), Springer, pages
152-163.
Emerick A.J., Neafsey E. J., Schwab M. E. , Kartje G.L. (2003). Functional reorganization of the motor cortex
in adult rats after cortical lesion and treatment with monoclonal antibody IN-1. J Neurosci. 23:4826-30.
Ferguson S. M., Eskenazi D., Ishikawa M. , Wanat M.J. , Phillips P. E. , Dong Y. , Roth B. L., Neumaier J.
F. (2011). Transient neuronal inhibition reveals opposing roles of indirect and direct pathways in sensitization.
Nat. Neurosci. 14:22-4.
García-Alías G., Barkhuysen S., Buckle M., Fawcett J. W. (2009). Chondroitinase ABC treatment opens a
window of opportunity for task-specific rehabilitation. Nat Neurosci. 12:1145-51.
Kato S., Kuramochi M., Kobayashi K., Fukabori R., Okada K., Uchigashima M., Watanabe M., Tsutsui Y.,
Kobayashi K. (2011). Selective neural pathway targeting reveals key roles of thalamostriatal projection in the
control of visual discrimination. J Neurosci. 31:17169-79.
Kinoshita M., Matsui R., Kato S., Hasegawa T., Kasahara H., Isa K., Watakabe A., Yamamori T., Nishimura Y.,
Alstermark B., Watanabe D., Kobayashi K., Isa T. (2012) Genetic dissection of the circuit for hand dexternity
in primates. Nature. 487:235-8.
Krakauer J. W., Carmichael S. T., Corbett D., Wittenberg G. F. (2012). Getting neurorehabilitation right:
what can be learned from animal models? Neurorehabil NeuralRepair. 26:923-31.
Langhorne P., Bernhardt J., Kwakkel G. (2011). Stroke rehabilitation. Lancet 377:1693-702.
Lindau N. T., Bänninger B. J., Gullo M., Good N. A., Bachmann L. C., Starkey M. L., Schwab M. E.(2014).
Rewiring of the corticospinal tract in the adult rat after unilateral stroke and anti-Nogo-A therapy. Brain
137:739-56.
103
Maier I. C., Baumann K., Thallmair M., Weinmann O., Scholl J., Schwab M. E. (2008). Constraint-induced
movement therapy in the adult rat after unilateral corticospinal tract injury. J Neurosci. 28:9386-403.
Maire M., Arbelaez P., Fowlkes C., Malik J. (2008). Using contours to detect and localize junctions in natural
images. In Proceedings of the International Conference on Computer Vision and Pattern Recognition.
Monroy A. and Ommer B.(2012). Beyond Bounding-Boxes: Learning Object Shape by Model-driven Grouping.
In Proceedings of the European Conference on Computer Vision (ECCV), LNCS 7574, Springer, pages 582-595.
Montoya C. P., Campbell-Hope L. J., Pemberton K. D., Dunnett S. B. (1991). The "staircase test": a measure
of independent forelimb reaching and grasping abilities in rats. J Neurosci Methods. 36:219-28.
Murphy T. H., Corbett D. (2009). Plasticity during stroke recovery: from synapse to behaviour. Nat Rev
Neurosci. 10:861-72.
Oertle T., van der Haar M. E., Bandtlow C. E., Robeva A., Burfeind P., Buss A., Huber A. B., Simonen M.,
Schnell L., Brösamle C., Kaupmann K., Vallon R., Schwab M. E. (2003). Nogo-A inhibits neurite outgrowth
and cell spreading with three discrete regions. J Neurosci. 23:5393-406.
Ommer B., Mader T., Buhmann J. M.(2009). Seeing the objects behind the dots: Recognition in videos from
a moving camera. Int. J. Computer Vision, 83:57–71.
Petruska J. C., Ichiyama R. M., Jindrich D. L., Crown E. D., Tansey K. E., Roy R. R., Edgerton V. R., Mendell
L. M. (2007) Changes in motoneuron properties and synaptic inputs related to step training after spinal cord
transection in rats. J Neurosci. 27:4460-71.
Soleman S., Yip P. K., Duricki D. A. , Moon L. D. (2012). Delayed treatment with chondroitinase ABC
promotes sensorimotor recovery and plasticity after stroke in aged rats. Brain.135:1210-23.
Starkey M. L., Bleul C., Maier I. C., Schwab M.E. (2011). Rehabilitative training following unilateral pyrami-
dotomy in adult rats improves forelimb function in a non-task-specific way. Exp Neurol. 232:81-9.
Starkey M. L., Bleul C., Zörner B., Lindau N. T., Mueggler T., Rudin M., Schwab M. E. (2012). Back seat
driving: hindlimb corticospinal neurons assume forelimb control following ischaemic stroke. Brain. 135:3265-81.
Stroke Therapy Academic Industry Roundtable (STAIR) (1999). Recommendations for standards regarding
preclinical neuroprotective and restorative drug development.Stroke. 30:2752-8.
Tsai S. Y., Markus T. M. , Andrews E. M., Cheatwood J. L. , Emerick A. J. , Mir A. K., Schwab M. E., Kartje
G. L. (2007). Intrathecal treatment with anti-Nogo-A antibody improves functional recovery in adult rats after
stroke. Exp Brain Res. 182:261-6.
Wiessner C., Bareyre F. M. , Allegrini P. R. , Mir A. K. , Frentzel S., Zurini M. , Schnell L., Oertle T., Schwab
M. E. (2003). Anti-Nogo-A antibody infusion 24 hours after experimental stroke improved behavioral outcome
and corticospinal plasticity in normotensive and spontaneously hypertensive rats. J Cereb Blood Flow Metab.
23:154-65.
Yarlagadda P., Ommer B. (2012). From Meaningful Contours to Discriminative Object Shape. In Proceedings
of the European Conference on Computer Vision (ECCV), LNCS 7572, Springer, pages 766-779.
Zeiler S. R., Krakauer J. W. (2013). The interaction between training and plasticity in the poststroke brain.
Curr Opin Neurol. 26:609-16.
104
Chapter 5
Different rehabilitation schedules
induce distinct spatio-temporal
expression patterns of
growth-promoting genes after stroke
Anna-Sophia Wahl1
1Brain Research Institute, University of Zurich, and Dept. of Health Sciences and Technology, ETH Zurich,
Switzerland.
105
Abstract
Nervous system injury such as stroke induces the expression of growth promoting
genes and neurotrophic factors as part of the intrinsic molecular repair machinery
that orchestrates plastic processes determining the location and degree of neuronal
rewiring. However, how external stimuli such as Anti-Nogo immunotherapy and
rehabilitative training influence internal repair processes is not well understood.
Here we performed a candidate-based screening for the induction of growth pro-
moting genes and neurotrophic factors in tissue of rats with different rehabilitation
paradigms after a large photothrombotic stroke in the sensorimotor cortex. Rats ei-
ther received no rehabilitation (’spontaneous recovery’ group) or intensive rehabili-
tative training of the forelimb concurrently (′Anti−Nogo−A/parallel′ group) or after
the application of Anti-Nogo-A immunotherapy (′Anti−Nogo−A/sequential′ group)
or control Ig G antibody (′control/parallel′ or ′control/sequential′ group). Tissue for
analysis of induced mRNA levels of growth-promoting genes and neurotrophic fac-
tors was extracted at distinct areas adjacent and remote from the stroke core in the
brain and spinal cord at 7 and 28 days after stroke. We found distinct temporal and
spatial expression patterns of growth-promoting genes depending on the rehabilita-
tive paradigm: BDNF mRNA levels were highly up-regulated in the penumbra and
the ipsilesional cervical hemi spinal cord of the ′Anti − Nogo − A/sequential′ group.
The excellent functional recovery rate of this group correlated with BDNF levels in
the spinal cord. Only spinal cord tissue of the ′Anti−Nogo−A/sequential′ group was
significant for increased levels of STAT3 - a pathway associated with enhanced ax-
onal regeneration after CNS injury. In contrast, brain and spinal cord tissue of the
′Anti−Nogo−A/parallel′ group which had displayed the poorest functional outcome,
revealed increased mRNA levels of GFAP and Synapsin Ib in areas of the brain
and spinal cord indicating gliosis as well as aberrant and excessive synaptogenesis.
In summary, this study provides first insights into molecular mechanisms which
might underlie structural and functional recovery and indicate a critical threshold
when rehabilitative training could be successful. Furthermore, data suggest that
BDNF is a key player mediating efficiency of optimal rehabilitation paradigms.
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5.1 Introduction
Within the last 10-15 years the old paradigm of the adult CNS as a stable and static structure
has been replaced by new concepts showing a high capacity of the CNS for neuronal remodeling
and repair after stroke (Schwab et al., 2010). Recent studies in humans and animal models
revealed rewiring of neuronal circuits, neuro- and synaptogenesis, spine turnover (Brown et al.,
2007) and increased neuron - to glia interaction contributing to synapse remodeling and circuit
re-shaping (Wake et al., 2009) in areas adjacent to and remote from the stroke lesion (Murphy
and Corbett et al., 2009; Takatsuru et al., 2009). Although the exact details for the under-
lying molecular and cellular mechanisms are lacking, there is evidence that the basis of these
’hardware’ changes are intrinsic molecular repair algorithms with precisely timed and spatially
controlled gene induction and repression comparable to rules held during the development of
the nervous system and experience-dependent plasticity (Murphy and Corbett, 2009).
Although the synthesis of most mRNAs and their respective proteins decreases following cere-
bral ischemia (Kleihues and Hossmann, 1971; Kiessling et al., 1986) more than 90 different
genes have been shown to be acutely induced, generally with an early peak within minutes
or hours of onset of ischemia and a rapid return to normal or subnormal levels. Whether the
early transient increase in gene expression during the initial post ischemic hours is related to
outcome remains unknown (Johansson et al., 2000). Carmichael et al., 2005 were the first
showing the induction of sequential waves of growth- promoting and inhibiting genes in the
peri-infarct cortex for the initiation, maintenance and termination of axonal sprouting using
a model of stroke in the rat somatosensory barrel cortex. Growth-promoting genes mediate
growth cone membrane signaling events, transcriptional control in the regenerating neuron,
cytoskeletal reorganization and axonal extension. They include immediate early genes such as
c-fos, junB and c-jun as well as GAP43, CAP23, MARCKS, members of the stathmin family,
Tα1 tubulin, L1, p21/waf1, and SPRR1 (Carmichael et al., 2005).
Furthermore, several neurotrophic factors are induced in an early response to stroke (Mattson,
2008; Carmichael, 2012): The up-regulation of the brain-derived neurotrophic factor (BDNF),
nerve growth factor (NGF) and neurotrophin 3(NT-3 ) as well as fibroblast growth factor
(FGF2 ) and insulin-like growth factor (IGF-1 ), epidermal growth factor (EGF) and glial cell
line-derived neurotrophic factor (GDNF) have been described (Carmichael, 2012). In addition,
each neurotrophic factor species depicts a specific temporal and cellular expression pattern (Abe
et al., 2000): While GDNF is mainly distributed in neurons, astroglia induce CNTF expression
and the vascular endothelial growth factor (VEGF) gene expression is detected in both cell
types - neurons and glia- after stroke.
For optimal axonal sprouting and neuronal rewiring not only the induction of growth-promoting
but also the repression of growth-inhibiting molecules is crucial. Three general classes of axonal
growth inhibitors are found in the CNS: myelin associated proteins (NogoA, myelin-associated
glycoprotein, oligodendrocyte myelin glycoprotein), extracellular matrix proteins (e.g. chon-
droitin sulfate proteoglycans) and repulsive cues for growth cones usually described as key
players during development (e.g. ephrins, semaphorins). The expression of the chondroitin sul-
fate proteoglycans aggrecan, phosphacan and versican appears relatively delayed after stroke
compared to the early and middle phase of the growth-promoting gene expression (Carmichael
et al., 2005; Carmichael et al., 2012).
Besides the distinct waves of temporal expression patterns, the spatial distribution of growth-
promoting and inhibiting genes plays a central role to induce neuronal self-repair processes:
E.g. in the peri-infarct cortex, axonal sprouting takes only place close to but in distance to
the glial scar. Within the glial scar which represents the wall separating the stroke core from
the surviving per-infarct tissue, both, growth-promoting and growth inhibiting factors, are ex-
pressed while the peri-infact cortex represses the induction of growth inhibiting molecules. Vice
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versa, mRNA levels of neurotrophins are largely enhanced in the growth-permissive penumbra
and suppressed in the stroke core (Lanfranconi, 2011).
Together, the precise interplay of timed induction of growth promoting and the repression of
growth inhibiting genes at distinct locations within and apart from the stroke core orchestrate
plastic processes after stroke which are the fundament for spontaneous recovery. They define a
time window in which the central nervous system is vulnerable but can also be further shaped
through enhanced rewiring processes by external stimuli. Such external stimuli represent re-
habilitative training, pharmacological intervention and electrical devices to stimulate neuronal
repair. The challenge for neuro-rehabilitative strategies remains to capitalize the vulnerable
period and enhance the internal remodeling process by external intervention.
Aim of the study
In chapter 4 we combined Anti-Nogo immunotherapy with rehabilitative training after stroke,
whereby rehabilitative training was either applied concurrently or after completion of the im-
munotherapy. Control groups either received an inactive control body with early or delayed
training after stroke. The application of the four rehabilitation paradigms resulted in very
diverse levels of functional recovery for forelimb fine motor skills rising the question of different
underlying molecular mechanisms. The objective of this study is the examination of distinct
induction patterns for growth-promoting genes and neurotrophic factors in these four rehabil-
itative treatment groups in rats with stroke. This candidate-based screen may provide first
insights in the efficiency of rehabilitative schedules and may help to understand the molecular
basis of one rehabilitation strategy excelling the others.
5.2 Material and Methods
Animals
A total of n= 30 adult female Long-Evans rats (200-250g, 3-4 months of age, Janvier, France)
were used for tissue analysis either after photothrombotic stroke and spontaneous recovery
or rehabilitation or in naive animals as controls. Animals were housed in groups of three to
four under a constant 12h dark/light cycle with food and water ad libitum. All experimental
procedures were approved by the veterinary office of the canton of Zurich, Switzerland. They
are in accordance with the Stroke Therapy Academic Industry Roundtable (STAIR) criteria
(1999) for preclinical stroke investigations.
Experimental Set-up
In the first cohort of animals a photothrombotic stroke was introduced over the sensorimotor
cortex as described before (Chapter 4, Lindau et al., 2014) and tissue from the brain and spinal
cord was extracted for RNA extraction 7 or 28 days after the stroke surgery. For the second
cohort animals were trained in the single pellet grasping task (Metz and Whishaw, 2000) before
unilaterally lesioning the sensorimotor cortex corresponding to the preferred paw and before
implanting osmotic mini pumps for the intrathecal applicaton of Anti-Nogo A antibodies or Ig
G control antibodies as described (Chapter 4, Material and Methods). The function blocking Ig
G1 mouse monoclonal anti-Nogo-A antibody 11C7 (3 or 4.2 mg/ml, gift from Novartis, Oertle
et al., 2003) against an 18–amino acid Nogo-A peptide corresponding to the rat sequence amino
acids 623 to 640 or the monoclonal control antibody anti-bromodeoxyuridine (BrdU; 3 or 4.2
mg/ml, AbD Serotech) were delivered for 2 weeks post stroke. After re-testing in the single
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pellet grasping task to assess the lesion deficit animals were randomly distributed to the four
rehabilitation groups as described in Chapter 4: Animals either received rehabilitative training
in grasping of the impaired forelimb either concurrently to Anti-Nogo antibody immunotherapy
or Ig G control antiody application (anti−Nogo−A/parallel group; Control/parallel group) or
sequentially for 2 weeks after the completion of the immunotherapy (anti−Nogo−A/sequential
group; Control/sequential group). Brain and spinal cord tissue was extracted for further
analysis 4 weeks after stroke after the completion of all rehabilitation schedules.
RNA extraction and cDNA synthesis
For tissue extraction animals were anesthetized with 3% isoflurane before decapitation. The
brain and spinal cord were quickly removed while dissecting on ice and put into fluid nitrogen for
storage at −80◦C. Brains and spinal cord were then transferred to −20◦C using the RNAlater®-
ICE Frozen Tissue Transition Solution (Ambion®) to keep the RNA in the tissue stable. Brains
and spinal cord were dissected on ice under a microscope.
To determine the expression levels for growth-promoting genes in the different tissue subsets
we removed the stroke core (labelled as ’stroke i’), which was identified by a typical glial scar
and cystic formation, as well as tissue in the contralesional cortex (labelled with ’stroke c’)
at the same rostrocaudal position (5mm to -5mm anterior and 0.5mm to 5.5mm lateral to
Bregma). According to Keyvani et al., 2002 we removed a frame of tissue within a distance
of 2.5mm to the borders of the stroke core (labelled with ’penumbra i’) for the analysis of the
penumbra region as well as the corresponding tissue in the contralesional hemisphere (labeled
with ’penumbra c’). We also extracted tissue of the visual cortex (2mm broad band from the
very caudal part of the cortex) ispi- and contralaterally to the stroke (labelled with ’visual
cortex i’ and ’visual cortex c’).
For the analysis of the spinal cord tissue we first dissected the ispi- and contralesional hemi-
spinal cord along the midline from spinal cord level C4 to C6 (enlargement of the cervical spinal
cord) and then extracted in a second step the grey matter under the micrsocope. All tissue
extraction was performed on ice and all dissected tissue was directed transferred to QIAzol
Lysis Reagent (Qiagen, Hilden, Germany), homogenized using micropistles while chloroform
was added to perform a phenol-chloroform extraction for RNA purification. For the following
steps we used the RNeasy Lipid Tissue Mini Kit (Qiagen, Hilden, Germany) according to
the manufacturer’ s instructions with additional on-column DNase I digestion during RNA
purification. The final concentration of the isolated RNA was adjusted to 50 ng/µl. For reverse
transcription, equal amounts of total RNA were transformed by using oligo(dT) primers and
M-MLV reverse transcriptase (Promega) (Pernet et al., 2013).
Semi-quantitative real time RT-PCR (qRT-PCR)
We used qRT-PCR measurements in different tissue (stroke core, contralesional ’stroke area’,
penumbra, contralesional penumbra ’area’, ispi- and contralesional spinal cord as well as ispi-
and contralesional grey matter of the cervical spinal cord C4-C6) as described by Pernet et
al., 2012. Relative quantification was calculated using the comparative threshold cycle (DDCT )
method. cDNA levels were normalized to Gapdh (reference gene) and a control sample (cali-
brator set to 1) was used to calculate the relative values.
The PCR amplification efficiency was established for each gene from the slope of the calibration
curve according to the equation: E = 10(_1/slope) (Pfaﬄ, 2004). We performed triplicates for
each reaction and at least n = 3−4 mice per condition were analyzed. The cDNAs correspond-
ing to 10ng of total RNA were amplified with the following specific primers designed to span
intronic sequences or cover exon–intron boundaries: glyceraldehyde-3-phosphate dehydrogenase
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Fig. 1: Experimental set-up to analyze spatio-temporal expression patterns of growth pro-
moting genes in the brain and spinal cord. (A) Schematic illustration depicting the tissue dissection
for RNA extraction from the stroke core, the penumbra, the spinal cord and the visual cortex and from the
corresponding areas in the contralesional hemisphere. (B) Schema showing grey matter extraction from the
cervical hemi spinal cord to analyze modifications in gene induction in the ispsi- and contralesional spinal
cord.
(GAPDH ) (forward, 5’-CAGCAATGCATCCTGCACC-3’; reverse, 5’-TGGACTGTGGTCATG
AGCCC-3’), growth associated protein 43 (GAP43 )(forward, 5’-GGAAGATACCATGCTGT-
3’; reverse, 5’-TATGAGCCTTATCCTCCGGT-3’), Brain-derived neurotrophic factor (BDNF),
(forward, 5’-CAAAGCCACAATGTTCCACCAG-3’; reverse, 5’-AGTTGCCTTGTCCGTGGA
CGTT-3’), Cyclic AMP-dependent transcription factor (ATF-3 ), (forward, 5’- CCTCTGGAG
TGTCAGTCAC-3’; reverse, 5’-GCAGGCACTCTGTCTTCTCT-3’), fibroblast growth factor
(FGF2 ) (forward, 5’- GGCTGCTGGCTTCTAAGTGT-3’; reverse, 5’-TCCGTGACCGGTAA-
GTGTTG-3’), Synapsin Ib (SYN ) (forward, 5’- CAAGAAGCTTGGAACAGAGG-3’; reverse,
5’- CCTGGAAGTCATGTTGGTTG-3’), Glial fibrillary acidic protein (GFAP) (forward, 5’-
AGTGGTATCGGTCCAAGTTTGC-3’; reverse, 5’-TGGCGGCGATAGTCATTAGC-3’), Sig-
nal transducer and activator of transcription 3 (STAT3 ) (forward, 5’-GGCCCTTAGTCATCAA
GACTGGTG-3’; reverse, 5’- AGGAAATTTGACCAGCAACCTGAC-3’), GAIP-interacting
protein, C terminus (GIPC ) (forward, 5’- TCGAGGGCTTCACTAATGTCAAGG-3’; reverse,
5’- TGAGGGTACAGAACATCACCTCAG-3’).
Statistical analysis
The statistical analysis was performed with GraphPad Software, Prism 5. Bar graphs are
presented as mean ±SEM. Statistical analyses were performed by using a two-way ANOVA
followed by a post-hoc Bonferroni test. The correlation of qPCR data and behavioral per-
formance of animals, Pearson correlation was applied. The level of significance was set at
∗P < 0.05,∗∗P < 0.01, ∗∗∗P < 0.001.
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5.3 Results
5.3.1 Stroke induces a distinct spatial and temporal expression pro-
file for growth- associated genes and neurotrophic factors.
We performed a literature based screening for growth-associated genes and neurotrophic fac-
tors which were described to be up-regulated after stroke (> 5 x-fold changes) and have been
correlated with plasticity and/or functional recovery (Kinouchi et al., 1994; Akins et al., 1996;
Soriano et al., 2000; Kim et al., 2002; Lu et al., 2003; Mitsios et al., 2007; Büttner et al.,
2008; Li et al., 2010; Shono et al., 2010). We chose candidate genes which were associated
with distinct growth-promoting functions within a specific context. In an early response to
ischemia (Mattson, 2008; Carmichael, 2012), several neurotrophic factors such as brain-derived
neurotrophic factor (BDNF), nerve growth factor (NGF) and neurotrophin3 (NT-3 ) and fibrob-
last growth factor (FGF-2 ) are induced. While BDNF, NGF, NT-3 and FGF-2 are involved
in neuronal survival, neurogenesis, synaptogenesis and angiogenesis (Maisonpierre et al., 1990;
Acheson et al., 1995; Huang and Reichardt, 2001; Freeman et al., 2004), BDNF in particular is
known for its crucial role in learning and memory processes (Yamada and Nabeschima, 2003)
as well as its association to accelerated sensorimotor recovery after stroke (Schabitz et al., 2004;
2007). Another candidates for our screen were the Growth Associated Protein 43 (GAP43 ),
Synaptophysin I (SYN), Glial fibrillary acidic protein (GFAP) and the Cyclic AMP-dependent
transcription factor 3 (ATF-3 ).GAP43 is expressed in neuronal growth cones during devel-
opment and during axonal regeneration (Benowith and Routtenberg, 1987;). Synaptophysin
I (SYN) as a synaptic marker is up-regulated by exercise in the naive and impaired animal
(Vaynman et al., 2004; Ploughman et al., 2007). The Glial fibrillary acidic protein (GFAP)
gene is usually expressed in astrocyte cells (Jaques et al., 1978) and has been also shown to
play an important role in neuronal repair (Onose et al., 2009). The transcription factor ATF3
was chosen as its neuroprotective role has been depicted after ischemic brain damage (Zhang
et al., 2011; Ahlgren et al., 2011). We examined gene expression levels using qRT-PCR in
the stroke core, the penumbra and the ispilateral visual cortex at 7 and 28 days after a large
photothrombotic stroke in the sensorimotor cortex. We also were interested in modifications
of growth promoting and neuroprotective genes in the corresponsing areas of the unimpaired
contralateral hemisphere (Figure 1). We found that BDNF was significantly induced in the
penumbra region (a frame of 2.5mm around the stroke core) at both time points (two-way re-
peated measures ANOVA with posthoc Bonferroni, ∗∗P < 0.01, Fig. 2A). FGF2 mRNA levels
were increased >13 x-fold and for ATF3 mRNA >169 x-fold increase was found in the stroke
core 28 days after injury compared to naive control samples from the same region (Fig. 2C, D).
Expression of GFAP mRNA was significantly enhanced in the penumbra and the corresponding
contralesional sensorimotor cortex 7 days post insult (two-way repeated measures ANOVA with
posthoc Bonferroni, ∗∗P < 0.01, ∗∗∗P < 0.001, Fig. 2E).
5.3.2 Expression patterns of growth promoting genes in the brain
differ among different rehabilitation paradigms
In chapter 4 we have described that timing matters when rehabilitative training is applied
in combination with Anti-Nogo immunotherapy after stroke. We found that animals which
first received two weeks of Anti-Nogo antibody followed by two weeks of intensive training
(′Anti − Nogo − A/sequential′) in the single pellet grasping task showed an almost complete
recovery at the end of the rehabilitation schedule (Chapter 4, Fig. 1A, B). In contrast, concur-
rent training together with Anti-Nogo A immunotherapy (′Anti−Nogo−A/parallel′) resulted
in the worst outcome with a recovery rate <12%. Animals in the control group which received
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Fig.2: Gene expression analysis of growth associated proteins and neurotrophic factors. mRNA
levels were measured by qRT-PCR from tissue taken at the stroke core (’stroke i’), or the contralesional
corresponding sensorimotor cortex (’stroke c’), the penumbra (’penumbra i’) or the corresponding area in
the contralesional hemisphere (’penumbra c’) as well as the ispi- (’visual cortex i’) or contralesional visual
cortex (’visual cortex c’) 7 or 28 days after stroke surgery relative to control tissue from the same areas
in naïve rats. Stroke induced a significant up-regulation of BDNF and GFAP in the penumbra at 7 days
post stroke, while ATF3 and FGF2 mRNA levels were enhanced in the stroke core 28 days post insult
(sample size n=3-4 per group and condition). Data are presented as means ± s.e.m.; statistical evaluation
was carried out with two-way ANOVA repeated measure followed by Bonferroni post hoc, asterisks indicate
significances: ∗∗P < 0.01, ∗∗∗P < 0.001
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early training (′control/parallel′) had a tendency to excell control animals which were trained
after the application of control Ig G antibody (′control/sequential′). The distinct outcomes
due to the different rehabilitation paradigms were reflected by different anatomical sprouting
patterns of newly growing corticospinal fibers. We hypothesized that the different rehabilita-
tion paradigms induced diverse intrinsic molecular expression patterns leading to the hardware
changes we had found in our anatomical analysis (chapter 4, Fig. 2). We extracted RNA from
tissue of the stroke core, penumbra and visual cortex as well as the corresponding contralesional
areas (Fig. 1A) in all 4 rehabilitation groups 28 days post stroke as described above. The focus
again lay on the analysis of enhanced mRNA expression of the same growth associated genes
and neurotrophic factors.
Indeed, we found that distinct rehabilitation paradigms induce distinct patterns of neurotrophic
factors and growth promoting genes in the brain. In particular the Anti-Nogo-A/sequential
group, which depicted the highest level of functional recovery, also had the highest mRNA lev-
els of the neurotrophic factors BDNF and FGF2, as well as the growth promoting gene GAP43
at distinct locations relative to the stroke core (Fig. 3): BDNF induction was significantly
higher in the stroke core and both visual cortex areas in the Anti-Nogo-A/sequential group
than in all other rehabilitation groups, while FGF2 and GAP43 expression was significantly
enhanced in the penumbra region of this group (two-way repeated measures ANOVA with
posthoc Bonferroni, ∗P < 0.05,∗∗P < 0.01, ∗∗∗, Fig. 3A,B and D).
In the Anti-Nogo-A/parallel group we in particular detected high mRNA levels of GFAP as
signs of gliosis and scar formation while BDNF levels in the same area were even slightly below
controls (Fig. 3E). SignificantGFAP induction was also found in the stroke core area of the ’con-
trol/parallel’ group. Both groups, the ′Anti−Nogo−A/parallel′ and the ′control/sequential′
group, had demonstrated the poorest degree of forelimb restoration 4 weeks after stroke (Fig.
3E).
The anti-Nogo-A parallel group was also significant for enhanced expression of the synaptic
marker Synapsin Ib in the penumbra and ipsilesional visual cortex (>57 x-fold change com-
pared to naive control tissue in the same region, two-way repeated measures ANOVA with
posthoc Bonferroni, ∗P < 0.05,∗∗P < 0.01, Fig. 3F).
Stroke core tissue of animals in the ′control/parallel′ which had received early intensive training
after stroke induced the highest mRNA expression levels of the neuroprotective transcription
factor ATF3 compared to all other groups (two-way repeated measures ANOVA with posthoc
Bonferroni, ∗∗∗, Fig. 3C). This group performed second with a final recovery rate of 35− 40%
after the ′Anti − Nogo − A/sequential′ group (received a success rate of >85%) (Chapter 4,
Fig. 1 A,B).
Expression patterns of growth promoting genes in the spinal cord
differ among different rehabilitation paradigms
We also analyzed grey matter tissue of the lesioned and unlesioned cervical hemi spinal cord
(at level C4 to C6) to detect differences in expression patterns of growth promoting genes in
the four rehabilitation groups versus naive control tissue or animals without rehabilitation af-
ter stroke. We again found that the growth promoting genes BDNF, GAP43 and FGF2 were
significantly more enhanced in the spinal cord for animals in the ′Anti−Nogo−A/sequential′
group, the group with the best functional outcome, than in all other groups (two-way repeated
measures ANOVA with posthoc Bonferroni, ∗P < 0.05,∗∗P < 0.01, Fig. 4A, B, C).
Here we show in particular that the increased induction of mRNA levels of BDNF and the
Signal transducer and activator of transcription 3 (STAT3 ) in the impaired hemi spinal cord
were specific for the ′Anti−Nogo− A/sequential′ group in this experimental set-up. STAT3
is a protein which is activated through phosphorylation of tyrosine 705 (Yuan et al., 2004), in
113
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Fig. 3: Distinct rehabilitation schedules induce diverse spatio-temporal expression patterns
of growth promoting genes and neurotrophic factors in the brain 28 days after stroke. mRNA
levels were measured by qRT-PCR from tissue taken at the stroke core (’stroke i’), or the contralesional
corresponding sensorimotor cortex (’stroke c’), the penumbra (’penumbra i’) or the corresponding area in
the contralesional hemisphere (’penumbra c’) as well as the ispi- (’visual cortex i’) or contralesional visual
cortex (’visual cortex c’) from rats without rehabilitation (’spontaneous recovery’ group) or from rats of
the four rehabilitation paradigms (’Control/parallel’, ’Control/sequential’, ’Anti-Nogo-A/sequential’, ’Anti-
Nogo-A/parallel’) versus control tissue from the same areas in naïve rats (sample size n=3-4 per group
and condition). mRNA levels of the growth associated genes BDNF, Gap43 and FGF2 were highly up-
regulated in the Anti-Nogo-A sequential group (A, B, D), the group with the best functional recovery of
skilled motor function (Chapter 4, Fig. 1). In contrast, the Anti-Nogo-A parallel group was significant
for signs of increased astrocytosis (E) and enhanced expression of the synaptic marker synapsin Ib in the
penumbra (F). Data are presented as means ± s.e.m.; statistical evaluation was carried out with two-way
ANOVA repeated measure followed by Bonferroni post hoc, asterisks indicate significances: ∗∗P < 0.05,
∗∗P < 0.01, ∗∗∗P < 0.001. 114
response to various cytokines and growth factors including interferons and interleukins as well
as a downstream signaling factor for growth factors such as epidermal growth factor (EGF), the
leukemia inhibitory factor (LIF) and the ciliary neurotrophic factor (CNTF)(Atreya s et al.,
2006; Jablonka et al., 2014). CNTF signaling via the Jak/Stat-3 pathway has been described
to play a major role in axonal regeneration of retinal ganglion cells (Park et al., 2003; Muller
et al., 2007) and motoneurons (Jablinka et al., 2014). We found that changes for both genes,
STAT3 and BDNF, were significantly higher in ′Anti−Nogo−A/sequential′ animal compared
to the ′Anti−Nogo−A/parallel′ group, which had displayed the poorest functional recovery
rate (two-way repeated measures ANOVA with posthoc Bonferroni, ∗P < 0.05, Fig. 4 A, G).
In contrast, mRNA levels of synapsin Ib (SYN ) were exclusively elevated in the contrale-
sional hemi spinal cord in ′Anti−Nogo−A/parallel′ animals compared to naive controls and
all other rehabilitation groups (two-way repeated measures ANOVA with posthoc Bonferroni,
∗P < 0.05,∗∗P < 0.01, Fig. 4F), reflecting increased synaptic turn-over which we have also
detected on the anatomical level (Chapter 4, Fig. 2G). The ′Anti−Nogo−A/parallel′ group
was also significant for the highest x-fold changes for GFAP in the spinal cord (Fig. 4, E).
We also found significantly increased mRNA levels of the gene coding for GAIP-interacting
protein, C terminus (GIPC )exclusively expressed in the contralesional hemi spinal cord of the
′Anti−Nogo−A/parallel′ group. GIPC is a regulatory protein in the postsynaptic density for
extrasynaptic NMDA receptor trafficking (Yi et al., 2007) which is associated with NMDA re-
ceptor (NMDAR)-induced excitotoxicity contributing to cell death in certain neurodegenerative
diseases, stroke, epilepsy, and traumatic brain injury (Hadingham and Bading, 2010; Parsons
and Raymond, 2014).
5.3.3 Increased BDNF mRNA levels in the contralesional hemi spinal
cord correlate with good functional outcome
As described in Chaper 4 we have found that animals which first received Anti-Nogo-A im-
munotherapy followed by 2 weeks of training showed the best recovery to nearly full forelimb
function at the end of the rehabilitative training in the single pellet grasping task. We found
in this group the highest expression patterns of BDNF mRNA levels, both in the brain (con-
tralesional sensorimotor cortex (’stroke c’, Fig. 3a) and ipsilateral visual cortex, BDNF x-fold
induction >400-fold compared to naive control set to 1, Fig. 3A) and the spinal cord (impaired
spinal hemi cord, BDNF x-fold induction >10-fold compared to naive control set to 1, Fig. 4A)
while no significantly enhanced BDNF mRNA levels were detected in the other tested rehabil-
itation paradigms or the group with spontaneous recovery after stroke. In particular, BDNF
mRNA levels in the contralateral healthy spinal hemi cord positively correlated with the final
success scores of animals in the ′Anti−Nogo−A/sequential′ group 4 weeks after stroke onset
(r=0.93, Pearson’s correlation, Fig. 5B). There was no correlation of BDNF gene expression
levels with final success rates or recovery rates at the end of the rehabilitative training in any
of the other rehabilitation groups or for animals with spontaneous recovery.
5.4 Discussion
BDNF as a prognostic marker for functional outcome levels after
stroke?
Several studies have described how rehabilitative training and enriched environment rehabilita-
tion influence not only outcome levels for motor recovery but also modify temporal profiles of
growth factors after cerebral ischemia (Vaynman and Gomez-Pinilla, 2005; Ploughman et al.,
115
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Fig. 4. Timing of rehabilitative paradigms differently influences expression of growth as-
sociated genes in the cervical spinal cord 28 days after stroke. mRNA levels were measured
by qRT-PCR in tissue from the impaired (’spinal cord i’) or contralateral healthy cervical hemi spinal
cord (’spinal cord c’) at level C4-C6 from rats without rehabilitation (’spontaneous recovery’ group) or from
rats of the four rehabilitation paradigms (’Control/parallel’, ’Control/sequential’, ’Anti-Nogo-A/sequential’,
’Anti-Nogo-A/parallel’) versus control tissue from the same areas in naïve rats (sample size n=3-4 per group
and condition). (A) BDNF expression levels were significantly higher up-regulated in the ’Anti-Nogo-
A/sequential’ group than in all other rehabilitation groups in the de-nervated hemi spinal cord. (B, D) Both
rehabilitation groups treated with Anti-Nogo antibody (’Anti-Nogo-A/sequential’, ’Anti-Nogo-A/parallel’)
revealed increased levels of GAP43 and FGF2 in the de-nervated hemi spinal cord. (C) In non of the experi-
mental groups a significant modification of ATF3 gene expression was detected. The ’Anti-Nogo-A/parallel’
group depicted the highest mRNA levels for GFAP among all rehabilitation groups in the spinal cord (E), but
was the only group with significant up-regulation of the synaptic marker synapsin Ib (F). STAT3, as part of
the growth promoting Jak/STAT3 pathway was exclusively enhanced in the ’Anti-Nogo-A/sequential’ group
(G) while GIPC expression pattern in the ’Anti-Nogo-A/parallel’, a protein associated with extrasynpatic
NMDA receptor signaling for cell death promoting, excelled mRNA levels in all other rehabilitation groups
(H). Data are presented as means ± s.e.m.; statistical evaluation was carried out with two-way ANOVA
repeated measure followed by Bonferroni post hoc, asterisks indicate significance: ∗∗P < 0.05, ∗∗P < 0.01,
∗∗∗P < 0.001. 116
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Fig. 5. BDNF expression in the spinal cord correlates with regained fine motor skills in the
single pellet grasping task 28 days after stroke. Success rates 28 days post stroke, at the end of the
rehabilitative schedule from animals which first received 2 weeks of Anti-Nogo-A immunotherapy followed by
2 weeks of intense rehabilitative training in the single pellet grasping task (’Anti-Nogo-A/sequential’ group)
were compared with BDNF mRNA levels in the impaired (’SC i’) and contralateral healthy (’SC c’) cervical
hemi spinal cord. Only BDNF mRNA levels in the healthy, contralateral hemi spinal cord correlated to the
final success rates (B, r=0.93, Pearson’ s correlation) while there was no correlation between success rates
in the single pellet grasping task and BDNF expression in the de-nervated (’i’= impaired) hemi spinal cord
(A, r=-0.69, Pearson’ s correlation).
2007; Gelfo et al., 2011; MacLellan et al., 2011; Zeiler and Krakauer, 2013). Here we show that
applying rehabilitative training concurrently (′Anti − Nogo − A/parallel′ group) or following
Anti-Nogo-A immunotherapy (′Anti − Nogo − A/sequential′ group) resulted not only in two
distinct outcome levels (10% final success rate for the ′Anti−Nogo−A/parallel′ group versus
>86% success rate for the ′Anti−Nogo−A/sequential′ group at the end of the rehabilitative
scheduel, 4 weeks after stroke surgery, chapter 4), but also revealed two distinct expression
patterns of growth promoting genes and neurotrophic factors. In particular brain and spinal
cord tissue of animals in the ′Anti−Nogo−A/sequential′ group was significant for increased
mRNA levels of BDNF, Gap43 and FGF2 (Fig. 3, 4). However, these genes were enhanced at
specific areas in relation to the stroke core 4 weeks post stroke: While Gap43 and FGF2 mRNA
levels were up-regulated in the penumbra region of the stroke (Fig. 3B, D), expression of BDNF
was increased in remote areas to the stroke core- such as the contralesional sensorimotor cortex
(’stroke c’) and the ispi- and contralateral visual cortex (Fig. 3A).
BDNF along with the insulin-like growth factor (IGF-1 ) and the vascular endothelial-derived
growth factor (VEGF) is one of the principal growth factors known to mediate the effects of
exercise on the brain (Cotman etal., 2007). Up-regulation of BDNF in the brain and spinal
cord post CNS injury have been reported repeatedly (Mocchetti and Wrathall, 2005; Vaynman
et al., 2005). In particular, increased recovery rates after rehabilitative training or enriched
rehabilitation was associated with enhanced levels of BDNF expression (Vaynman et al., 2006;
Kazlaukas et al., 2011; Gelfo et al., 2011; MacLellan et al., 2011). Administrating BDNF im-
proved sensorimotor recovery in rats after ischemia (Schabitz et al., 2004; Muller et al., 2008),
whereas blocking endogeneous BDNF with antisense oligonucleotide (Ploughman et al., 2009)
or blockade of TrkB, the BDNF receptor, (Vaynman et al., 2004; Vaynman et al., 2006) with an-
tibodies attenuated the positive effects of rehabilitative exercise and learning. The current data
also support the role of BDNF as a marker for enhanced recovery levels due to a specific reha-
bilitation paradigm after stroke: BDNF mRNA levels in the contralesional cervical hemi spinal
cord correlated with final success rates in the ′Anti−Nogo−A/sequential′ group (Fig. 5), while
no induction and no correlation was detected for the ′Anti−Nogo−A/parallel′ rehabilitation
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group depicting the poorest outcome. A similar effect was described by Griesbach et al., 2004a:
In a traumatic brain injury model premature exercise had inhibited BDNF up-regulation and
resulted in impaired recovery of cognitive function and even precluded the normal induction of
plasticity molecules regulated by BDNF action, such as CREB and synapsin I (SYN ). However,
delayed exercise 14 days post injury enhanced BDNF levels and cognitive function (Griesbach
et al., 2004b).
Do enhanced BDNF levels indicate a prolonged plastic phase after
stroke?
The wave-like precisely timed induction of growth-promoting and inhibiting genes (Carmichael
et al., 2005) after stroke as well as recent behavioral studies in humans and animals indicate
a limited period of heightened neuroplasticity, comparable to that what occurs during visual
system development (Murphy and Corbett et al., 2009). In one first important experiment only
early exposure to enriched rehabilitation (5 or 14 days post stroke) resulted in significant recov-
ery in a rat stroke model, whereas rats given delayed training (30 days post stroke) exhibited
little improvement (Biernaskie et al., 2004). In the current study the sequential application of
first Anti-Nogo-A immunotherapy for two weeks followed by 2 weeks of intense rehabilitative
training of the impaired forelimb had not only resulted in the best functional outcome compared
to all other tested rehabilitation groups but also in the induction of increased BDNF levels in
the brain and spinal cord in these animals. The application of Anti-Nogo-A immunotherapy
may have expanded the time window for increased plasticity. The consecutive training may
not have only guided processes for specific circuit selection and stabilization as well as pruning
of unspecific neuronal rewiring, but may also have maintained areas plastic remote from the
stroke core through exercise and by the induction of BDNF.
In contrast, as we just analyzed gene expression patterns after the completion of all rehabilita-
tive schedules 4 weeks after stroke surgery, we cannot rule out increased BDNF mRNA levels
in the ′Anti − Nogo − A/parallel′ group earlier after stroke, presumably 14 days post insult,
when the training concurrently to the Anti-Nogo-A immunotherapy had been completed. En-
hanced BDNF levels at that time may have induced synapsin I mRNA which we detected to
be exclusively up-regulated (> 20 x-fold compared to naive controls in the spinal cord, Fig.
4F) for this groups 4 weeks after stroke. The ability of BDNF to regulate components of the
synaptic release machinery such as synpasin I under exercise conditions has been described
elsewhere (Molteni et al., 2002; Vaynman et al., 2003). Interestingly, synapsin I also regulates
neuronal developmental processes, e.g. the formation and maintenance of presyaptic struc-
tures, axonal elongation and new synaptic formation (Ferreira et al., 1998). An early extensive
up-regulation of BDNF by simultaneous training and Anti-Nogo-A antibody application in the
′Anti − Nogo − A/parallel′ group may have exaggerated BDNF-levels and consecutively ini-
tiated excessive expression of synapse formation and regulation proteins such as synapsin I.
Thus, this may have created the aberrant and limitless neuronal sprouting and synaptogenesis
detected in the anatomical analysis of spinal cord slices for this group (Chapter 4, Fig. 2).
The STAT3 -pathway is induced in the ′Anti − Nogo − A/sequential′
group
In recent years the activation of the Jak/Stat3 pathway has been identified as one of the central
players that regulate intrinsic growth programs (Aaronson and Horvath, 2002). STAT3 expres-
sion induces neuronal outgrowth in vitro (Smith et al., 2011) and enhanced STAT3 expression
associated to the conditioning response of DRG neurons (Pernet et al., 2013). In addition,
increased levels of STAT3 expression and phosphorylation are involved in axonal regeneration
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(Schwaiger et al., 2000; Sheu et al., 2000) and axonal remodeling (Bareyre et al., 2002). The
role of STAT3 in axonal regeneration has been in particular described as an initiator for pre-
cisely timed initiation of axonal regeneration in the peripheral nervous system but does not
participate in the subsequent elongation of PNS axons (Bareyre et al., 2011). STAT3 was
up-regulated in sprouting unlesioned fibers from the contralateral, right forelimb portion of the
corticospinal tract in response to the unilateral denervation by pyramidotomy in a rat spinal
injury model (Lang et al., 2013). These newly formed collaterals extended towards the dener-
vated side of the spinal cord resulting in a significant increase in the number of midline crossing
fibers (Lang et al., 2013).
In the current study STAT3 mRNA levels were in particular significantly up-regulated in the
′Anti−Nogo−A/sequential′ group in both, the ipsi- and the contralesional hemi spinal cord
(Fig. 4G) while there was no significant enhancement of STAT3 expression in any of the other
rehabilitation groups. The ′Anti − Nogo − A/sequential′ group was also the group with the
highest number of midline crossing corticospinal fibers growing from the intact hemi spinal cord
across the midline of the central canal to the denervated side (Chapter 4, Fig. 2). We hypothe-
size that the STAT3 pathway was involved in this recruitment of unlesioned corticospinal fibers
whereas the enhancement of ipsilateral projecting corticospinal fibers maintained and exceeded
the number of recruited unlesioned contralateral corticospinal fibers for circuit remodeling in
animals of the ′Anti−Nogo− A/parallel′ group. Nevertheless, whether the STAT3 pathway
was induced by molecules such as the neuropoietic cytokines IL-6, ciliary neurotrophic factor,
and leukemia inhibitory factor, as well as the intracellular regulator SOCS3, which have been
shown to influence axonal regeneration (Cafferty et al., 2001, 2004; Smith et al., 2009), has to
be elucidated.
Tissue of the ′Anti−Nogo−A/parallel′ group reveals signs of enhanced
astrocytosis
After stroke, reactive astrocytes proliferate, migrate and form a glial scar around the injured
brain tissue (Ostergaard and Jensen, 2013). However, the role played by astrocytosis for the
functional recovery remains ambiguous: Although positive features of reactive astrocytosis ex-
ist - such as the establishment of structural support for cellular elements, the release of growth
factors, the maintenance of the blood-brain-barrier and the reestablishment of extracellular
homeostasis (Pekny and Nilsson, 2005), most authors associate increased astrocyctic markers
with negative aspects: The inhibition of axonal growth through the formation of a physical
barrier (glia scar) as well as the secretion of factors inhibitory to axon growth cones may
negatively influence recovery levels after brain injury (Abeysinghe et al., 2014). We found en-
hanced GFAP expression in the stroke core of the′Anti − Nogo − A/parallel′ group and the
′Control/sequential′ group, (Fig. 3E). This indicates strong glial scar formation in the stroke
core which may have aggravated remodeling and reorganization processes thus contributing to
the poor functional outcome seen in those two rehabilitation groups.
The contralesional hemi spinal cord of animals in the ′Anti−Nogo−A/parallel′ group was also
significant for increased mRNA levels of GIPC (Fig. 4H). The PDZ protein GIPC is preferen-
tially associated with extrasynaptic NMDA receptors and may play a role in their organization
and trafficking (Yi et al., 2007). Increased extrasynaptic NMDA receptor signaling has been
described to promote cell death through excitotoxic events (Hardingham and Bading, 2010).
However, if excitotoxic events with consecutively exaggerated neuronal apoptosis contributed
to the poor recovery level of animals in the ′Anti − Nogo − A/parallel′ group remains to be
enlightened.
119
Conclusion and Outlook
This study described that distinct rehabilitative schedules induce specific spatio-temporal ex-
pression patterns of several growth promoting genes and neurotrophins. We identified fac-
tors such as BDNF and STAT3 exclusively enhanced in tissue of animals with a particu-
larly high functional recovery rate (′Anti − Nogo − A/sequential′ group) while signs of glio-
sis were found in the rehabilitation groups with less restoration of skilled forelimb function
(′Anti−Nogo−A/parallel′ and ′Control/sequential′ group). However the current study was
conducted on a candidate based screening while deep sequencing or chip analysis of laser mi-
crodissected tissue may elucidate new molecular components playing a role in the intrinsic
repair machinery of the central nervous system after stroke. Furthermore new state-of the
art technology such as molecular profiling of neurons, interneurons and glia based on activity
(Knight et al., 2012) and connectivity (Ekstrand et al., 2014) opens up possibilities to not only
understand how extrinsic rehabilitative strategies influence internal repair mechanisms but also
to develop new therapeutic concepts to maximize repair of lost functions for stroke patients.
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This thesis aims at understanding basic principles of stroke-induced cortical reorganization as
well as analyzing the role of neurorehabilitation on plastic mechanisms after ischemic insult.
From both, clinical and experimental studies, it is well known that the capacity of the brain
and spinal cord to induce functional recovery highly depends on the size of the stroke and its
location.
In a first step we studied the reorganization in the peri-infarct area after a small focal stroke
destroying the forelimb motor cortex in Thy1-ChR2 transgenic mice. After an initial decline
of skilled forelimb function due to the stroke, animals fully recovered without any further in-
tervention within 4 weeks after stroke surgery. This regain of function was accompanied by a
map shift of the forelimb area towards the hindlimb motor cortex as measured by longitudinal
light-based motor mapping within the same animal over the course of weeks post stroke. In
addition, the cortical representation of the hindlimb expanded diffusely and stimulus-evoked
responses were increased indicating a lowered threshold for corticospinal signal transduction.
Detailed analysis of grasping kinematics revealed two stereotypic error patterns which appeared
within the first week after stroke onset: Animals grasped too long and therefore failed to target
the rung or targeted the rung with the wrist and consecutively slipped due to missed grasping
force of the digit and MCP joint around the rung. We then used a pharmacogenetic approach
to temporarily and reversibly silence neurons in the peri-infarct area in order to test the func-
tional relevance of the penumbra area for the regain of skilled forelimb function. And indeed,
30 min after CNO application, animals showed a decline of the fully regained forelimb function,
comparable to the decrease of success rates in the two grasping tasks assessed within the first
week after stroke. As detailed analysis of grasping kinematics revealed that the same grasping
errors stereotypical for the grasping pattern 1-3 days after stroke reemerged 30 min after CNO
application, a first indirect proof was delivered that the motor engram formed during the pre-
stroke training was re-established within the newly formed center for forelimb function after 4
weeks of stroke induced cortical reorganization. However there are limitations to this study.
Analyzing single neuron activity in networks before, during and after stroke may elucidate not
only the existence of specific microcircuits coding for specific movement parameters, but will
furthermore allow to feature to which degree neurons are tunable to ’take over’ a multitude of
functions.
In our second study we combined two therapeutic treatment options to examine how different
rehabilitative schedules influence functional outcome of forelimb motor skills in a rat stroke
model. We choose 4 different rehabilitation paradigms: Intensive rehabilitative training of the
forelimb was either combined concurrently to Anti-Nogo A immunotherapy immediately af-
ter stroke, or Anti-Nogo A immunotherapy was applied for 2 weeks after stroke followed by
another two weeks of rehabilitative training. In accordance with this, control groups either
received training simultaneously to Ig G control antibodies are afterwards (early versus delayed
training). We found a very diverse picture of outcome levels depending on the rehabilitative
paradigm we applied: Rats which first received Anti-Nogo A immunotherapy for two weeks
followed by two weeks of rehabilitative training showed nearly full recovery of forelimb function
(>86% recovery rate compared to baseline levels). In contrast, simultaneous application of
Anti-Nogo A immunotherapy and rehabilitative training resulted in poor outcome levels (10%
of baseline function) which were even lower than comparable levels of animals in the control
groups or no rehabilitation at all.
Anatomical studies where we visualized the fibers coming from the motor forebrain cortex to
the spinal cord revealed large numbers of fibers growing from the intact side across the midline
in the cervical spinal cord in the animals treated with the anti-Nogo A antibody. In the well
recovered group of rats, these fibers formed a near normal branching and termination pattern.
In contrast, rats with early rehabilitation concurrently to the immunotherapy and poor func-
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tional recovery showed overshooting fiber growth, aberrant branching and too high numbers
of synapses, in part in wrong areas of the spinal cord. We then used two virus-based phar-
macogenetic approaches for reversible short-and long-term inactivation of corticospinal fibers
originating in the intact contralesional hemisphere which side-switched in the cervical spinal
cord forming midline crossing fibers from the healthy spinal hemi cord to the denervated one.
Silencing these newly outsprouting corticospinal fibers resulted in a decline of regained skilled
forelimb function in animals, which had received Anti-Nogo-A immunotherapy followed by
rehabilitative training before, indicating the functional relevance of these corticospinal fibers
for the restoration of forelimb function. As the constructs for silencing the fibers were tagged
with mCherry, we could identify the neurons sending these corticospinal midline crossing fibers.
They were localized in a distinct area of the contralesional pre-motor and rostral primary motor
cortex. We had shown for the first time, that the new formation of a distinct neuronal circuit
was crucial for the re-establishment of lost motor function due to stroke. No compensation by
other circuitry was apparent during the inhibition of these distinct subsets of midline crossing
corticospinal fibers.
In the last part of the present work we aimed at gaining first insights into underlying molec-
ular mechanisms for anatomical rewiring and functional recovery when distinct rehabilitative
schedules are applied. We used a candidate-based approach to analyze if different rehabilitative
paradigms induce distinct spatio-temporal expression patterns of growth-promoting genes and
neurotrophic factors after stroke. We found that induction levels of BDNF - in particular in
the unimpaired spinal hemicord were correlated with good functional outcome. Only spinal
cord tissue of the group with excellent functional outcome (which had first received Anti-Nogo
A immunotherapy followed by rehabilitative training) was significant for increased levels of
STAT3 - a pathway associated with enhanced axonal regeneration after CNS injury. In con-
trast, signs of gliosis (increased mRNA levels of GFAP) and excessive synaptogenesis (increased
mRNA levels of Synapsin Ib) were characteristic for the rehabilitation group with the poorest
level of performance at the end of the rehabilitative schedule - animals which had been trained
concurrently to Anti-Nogo-A immunotherapy.
Our study shows the importance of carefully designing rehabilitation schedules after stroke,
in particular if different therapeutic options such as training and growth enhancing agents are
combined: A rehabilitative approach that supports the intrinsic potential of the brain and
spinal cord to reinforce lost functions by boosting the growth of new fibers and by stabilizing
the meaningful newly formed circuits may result in robustly enhanced recovery of motor func-
tion. In contrast, rehabilitative schedules may lose their beneficial character if applied at the
wrong time and intensity. During an early phase after the injury, the brain seems to be in a
particularly vulnerable state, and forced rehab therapies should therefore be applied with great
caution during this period of circuit plasticity. These results have crucial implications also for
designing clinical rehabilitation trials: By adding different drugs or training programs whereby
each of them itself leads to a certain degree of functional improvement, you may not end up
in added percentages of functional outcome levels and thus overall enhancement of function,
but rather the opposite. Treatments may interfere with each other and with intrinsic plastic
processes. Maybe, in a certain phase, the brain has to be left alone to do first its job and
activate its own repair mechanisms. It needs first to be settled and prepare itself for external
intervention. We may help the brain getting settled and prepared, meaning we need to find
answers to a quantity of questions experimentally, till we face the challenge of a clinical setting.
Thus, the work presented here can just be a starting point. We have identified so far a re-
habilitative design which provides excellent recovery of motor function in a rat model. We
have analyzed the reorganization of a specific tract and by temporarily silencing it, found sup-
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ported evidence that the newly outsprouting fibers of this tract are crucial for the restoration
of skilled motor function. And we gained first hints that growth factor distribution is different
among animals from different rehabilitation paradigms. However, according to the philosopher
of science, Karl Popper, ’Science may be described as the art of systematic over-simplification.
And specialization may be a great temptation for the scientist. For the philosopher it is the
mortal sin.’ How much of what we saw is true recovery and how much of it was compensation?
Does in a simplified model rehabilitative training activate another pathway than Anti-Nogo A
immunotherapy and are these pathways able to inactivate each other? What about sensory-
feedback to shape the level of functional recovery? Thus, we have just opened the door to
understand how molecular key players lay the basis for neuronal rewiring leading to a mean-
ingful action and in the case of stroke to the restoration of lost function.
What kind of questions would we need to address next? When neurons within a network are
destroyed by a stroke, we would like to know, which kind of other neurons take over, which
kind of cell types? Do they just shoulder new function because they are spatially close to the
destroyed ones or because they had a related function before? Are they tunable to a multi-set
of functions? What is the molecular signaling behind the selection of one cell against another?
If cells are selected – how do they find other selected cells? Which kind of signals do they
send out, pure signs of electrical activity? How about chemo-attractant and chemo-repulsive
molecular signals? Do cells keep other cells they are connected with active and thus alive by
increased synaptic input? Are intact cellular networks - meaning cells which already wire and
fire together, recruited after stroke to reorganize and establish function or are completely new
cellular ensembles formed? And last but not least, how would the ideal experiment look like to
examine all the questions raised?
In the ideal situation we would see how the stroke occurs, how first the neurons in the stroke
core die. We could measure how other neurons are affected by the death-signal of the dying
neurons and by inflammatory signals. We could see how the input to neurons connected to
the dying cells is decreasing. We could monitor how they decide to degenerate or instead
strengthen connections from which they get input- or, they even form new connections as a
survival strategy.
How can we study all these events? A selective labeling of neurons directly affected by the
stroke would be required as well as a labeling of their connections. We also would need specific
labeling of newly outsprouting axons as well as markers for connections which get strength-
ened versus those that got lost. In addition, all labeling approaches can be combined with
genetic profiling allowing the identification of underlying genomics and proteomics. Longitu-
dinal studies in the same animal over time would be also essential to understand if connection
strengthenings are robust and constant over time. Then ultimately, we could challenge the
pathophysiological events by applying therapeutical interventions. In the ideal experiment, we
study both, the network level as well as the molecular level while we analyze the behavioral out-
put and determine if an intervention is beneficial or harmful. We zoom in from the behavior to
the cellular and to the molecular event. All these means huge data accumulation and analysis.
It also means a team effort including biologists, physicists, computer scientists, engineers and
clinical neurologists to finally bridge the gap from experimental modeling to patient care. As
Francis Crick in one of his Kuﬄer lectures at the University of California at San Diego in 1999
said, when he gave advice to neuroscientists to go to their molecular biologist colleagues to ask
for appropriate techniques and new tools, ’we should discuss and tell what to do next. Once
the word gets around that a certain type of problem exists it is surprising how often someone
has a bright idea of how to solve it. So, don’ t be shy - ask! After all, exactly how our brain
works, is of vital interest to us all, so why shilly-shally.’
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After stroke the central nervous system reveals a spectrum of intrinsic capacities to
react as a highly dynamic system which can change the properties of its circuits,
form new contacts, erase others, and remap related cortical and spinal cord regions.
This plasticity can lead to a surprising degree of spontaneous recovery. It includes the
activation of neuronal molecular mechanisms of growth and of extrinsic growth promoting
factors and guidance signals in the tissue. Rehabilitative training and pharmacological
interventions may modify and boost these neuronal processes, but almost nothing is
known on the optimal timing of the different processes and therapeutic interventions and
on their detailed interactions. Finding optimal rehabilitation paradigms requires an optimal
orchestration of the internal processes of re-organization and the therapeutic interventions
in accordance with defined plastic time windows. In this review we summarize the
mechanisms of spontaneous plasticity after stroke and experimental interventions to
enhance growth and plasticity, with an emphasis on anti-Nogo-A immunotherapy. We
highlight critical time windows of growth and of rehabilitative training and consider different
approaches of combinatorial rehabilitative schedules. Finally, we discuss potential future
strategies for designing repair and rehabilitation paradigms by introducing a “3 step
model”: determination of the metabolic and plastic status of the brain, pharmacological
enhancement of its plastic mechanisms, and stabilization of newly formed functional
connections by rehabilitative training.
Keywords: stroke, rehabilitation, Nogo-A, critical time window, plasticity, training
INTRODUCTION
The human brain works wonders to fulfill the requirements of
every-day life. These unique capacities are then fully esteemed
when all of a sudden even simple activities fail or become
a problem: cerebral strokes leave the victims with often large
psychical and physical impairments—from vision problems to
aphasia and motor deficits—leading to the number one cause of
adult disability worldwide with great impact on public health.
In the acute phase, “time is brain”—ruptured blood vessels
(hemorrhagic stroke) or aggregates of platelets and blood cells
that clog cerebral blood vessels (ischemic stroke) cause acute
shortage of glucose and oxygen resulting in metabolic distress
and long-term neuronal cell loss. The destruction process is
complex and can only be dampened in the case of the ischemic
stroke by very early intervention (within 4–6 h) with throm-
bolysis, (Hacke et al., 2008). Currently, only about 10% of all
stroke patients reach a hospital early enough or fulfill the cri-
teria for being able to receive thrombolysis in the therapeu-
tic time window. Prognosis and recovery then depend on the
location and extent of the stroke lesion. Clinically, the most
successful therapy to further enhance this recovery of function
is rehabilitative training. Rehabilitation as a term “to reach and
maintain optimal functioning in physical, intellectual, psycholog-
ical and/or social domains” (WHO. International classification
of functioning disability Health ICF. Geneva: WHO; 2001) is
evidence based medicine and does not exclude a specific subgroup
of patients.
Nevertheless, for many rehabilitative interventions, in partic-
ular those for long-term or chronic rehabilitation, robust data
or adequately controlled studies are lacking (Quinn et al., 2009):
e.g., comparisons between different training methods in current
use could not show that any particular physiotherapy or stroke
rehabilitation strategy is superior to another (Johansson, 2000).
Consequently optimal rehabilitation strategies can only be
defined if we understand the way in which training and the
rehabilitation protocol influences the neurobiology of the central
nervous system with priority on the aspects of timing, kind and
intensity of rehabilitative training. Measurable endpoint criteria
for rehabilitative outcome are required in order to achieve two
purposes: the adjustment of the ideal rehabilitative strategy to
the individual patient, and the choice of the optimal therapy
protocol.
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In this review we focus on mechanisms of spontaneous
recovery after stroke, on rehabilitative designs to enhance
plasticity, on growth promoting mechanisms with an emphasis
on anti-Nogo-A immunotherapy, and on the time windows of
rehabilitative training and pharmacological interventions and the
combination of both.
MECHANISMS OF SPONTANEOUS RECOVERY AFTER
STROKE—FROM HUMAN PATIENTS TO ANIMAL MODELS
For many years people have thought that the hardware of the
brain is that “hard”, that once an incident such as stroke happens,
brain areas and functions are lost forever. The old paradigm
of the adult CNS as a stable and static structure, consisting of
billions of nerve cells and circuits, has now been replaced by a
much more dynamic view of the CNS which includes processes
of growth, connectivity changes and areal remodeling that can
occur after CNS injury or stroke and plays an important role in
recovery and functional repair.
Spontaneous recovery is seen in stroke patients weeks to
months after the incident. However, due to variability across
subjects and across neurological domains efforts of summarizing
this process with precision have been frustrating. Among the
most obvious factors that contribute to the extent of spontaneous
recovery are infarct size, infarct location, age and pre-stroke dis-
ability (Cramer, 2008). Most spontaneous recovery tends to occur
within the first 3 months. While patients with milder deficits
achieve spontaneous recovery more quickly than patients with
more severe deficits, the pattern of spontaneous recovery can also
differ within the same patient for different functions (Cramer,
2008).
SPONTANEOUS RECOVERY OF SENSORIMOTOR FUNCTION IN HUMANS
Motor recovery has been among the most often examined because
motor impairments belong to the symptoms that are most fre-
quently and precisely diagnosed after stroke (Gresham et al., 1998;
Rathore et al., 2002; Langhorne et al., 2009). Motor impairment
can be regarded as a loss or limitation of function in muscle
control or movement or a limitation in mobility. It is a focus
of physiotherapy or occupational therapy in terms of stroke
rehabilitation (Langhorne et al., 2009). The natural history of
motor recovery is considerably heterogeneous: the first voluntary
movements can be seen anywhere from 6 to 33 days after a
hemiplegic stroke (Twitchell, 1951). The largest improvement
occurs in the first 30 days after stroke, though significant progress
is still found in patients with more severe deficits up to 90 days
after stroke (Wade, 1983; Duncan et al., 1992, 1994, 2005). Studies
on arm disability revealed that a maximum of function is reached
by 80% of the patients within 3 weeks and by 95% of patients
within 9 weeks (Nakayama et al., 1994). Still significant long-
term improvement is found if arm function starts to ameliorate
16 weeks after stroke onset (Broeks et al., 1999).
Insights into the underlying remodeling and re-organization
processes for functional recovery in the brain after stroke can
be obtained in human patients via functional neuroimaging
methods and brain mapping. These data suggest that recovery of
motor function after stroke leads to brain-wide modifications in
neuronal activity patterns and connectivity (Rehme and Grefkes,
2013). While initially tissue function and neurophysiological
responses are diminished within the injured primary neocortex,
cortical function increases over time (Marshall et al., 2000;
Calautti et al., 2001; Feydy et al., 2002; Grefkes and Fink, 2011).
In terms of good functional outcome one of the major correlates
is the degree of recovery of neurophysiological activity in the
affected primary cortical areas (Cramer, 2008). In other terms:
the best behavioral outcomes are associated with the greatest
restoration/remodeling of brain function towards the normal
state of organization (Ward et al., 2003; Zemke et al., 2003;
Ward, 2004; Murphy and Corbett, 2009). This is true even if
the post-stroke behavior is far from being identical to the pre-
stroke motor kinematics. In particular the extent of corticospinal
tract integrity is positively correlated to functional recovery as
revealed by transcranial stimulation of the motor cortex (M1)
and its efferents after stroke (Talelli et al., 2006). In general, if
an ischemic event occurs, those areas are recruited for structural
and functional modification which are either close or functionally
related and connected or both. Therefore, after a small stroke,
peri-infarct tissue is mainly involved that has similar function.
By contrast, after a large stroke, tissue that has similar functions
might be only found at more distant sites or in unaffected regions
of the contralateral hemisphere, where still enough capacity for
structural remodeling remains (Murphy and Corbett, 2009).
THE ROLE OF THE PREMOTOR AND CONTRALESIONAL MOTOR CORTEX
Which areas are activated and what they contribute in terms of
beneficial re-organization for functional recovery is still under
debate: a meta-analysis revealed that activation of premotor
areas and the contralesional primary M1 are consistent find-
ings (Rehme et al., 2012; Rehme and Grefkes, 2013). Interac-
tions between premotor areas and the lesioned primary M1 are
directly related to recovery and functional outcome. For example,
Johansen-Berg et al. (2002) showed that disruption of dorsal
premotor cortex activity by transcranial magnetic stimulation
(TMS) over both the ipsi- and contralateral hemisphere lead to
a deterioration of performance in stroke patients, but not in
healthy controls (Johansen-Berg et al., 2002). The exact role of
the activation of contralesional M1 is a subject to controversy:
longitudinal functional MRI studies revealed enhanced neuronal
activity in motor-related areas in both hemispheres after a large
stroke. But then during the first 12 months post-stroke this
activity returns to unilateral levels similar to those of healthy
controls for those patients with good motor recovery (Ward
et al., 2003). Remaining increased activity in the contralesional
M1 was often associated with poor outcome. Further studies
have demonstrated that inhibition of contralesional M1 activity
using repetitive TMS may lead to ameliorated motor perfor-
mance of the stroke-affected hand in the subacute and chronic
phase (Nowak et al., 2008; Takeuchi et al., 2012). In contrast,
Rehme et al. (2011) found that increases in contralesional M1
activity over the first 10 days after stroke correlate with the
amount of spontaneous motor improvement in initially more
impaired patients. These data suggest a supportive role for func-
tional recovery in the early phase after stroke for the contrale-
sional M1. In addition, disrupting contralesional M1 activity
with TMS resulted in a deterioration of motor-performance of
Frontiers in Human Neuroscience www.frontiersin.org June 2014 | Volume 8 | Article 381 | 2
Wahl and Schwab Finding an optimal rehabilitation paradigm
the stroke-affected hand of stroke patients with capsula interna
infarcts (Lotze et al., 2006). A clear time-, size or lesion-
location- dependent influence of the contralesional M1, be it
either beneficial or harmful for functional recovery, remains to
be demonstrated.
CHANGES IN CORTICAL EXCITABILITY, LATERALIZED ACTIVATION AND
SOMATOTOPIC RE-MAPPING
For the above described remodeling and recruitment of areas
three main forms of reorganization have been described: (1)
increased cortical excitability in cortical regions distant from,
but connected to the stroke core; (2) reduced lateralized acti-
vation; and (3) somatotopic modifications within intact cortical
regions.
Increased activity, as a first form of reaction to stroke in
areas which before stroke formed a distributed network, has been
described many times (Brion et al., 1989; Chollet et al., 1991).
This phenomenon occurs in several cortical areas which include
motor, language, attention and visual functions (Cramer, 2008).
Widespread areas of cortical hyperactivity appear days after stroke
and diminish within months post incident (Ward, 2004). This
form of modification in cortical excitability is thought to be a
result of the down-regulation of the α1 γ -amino butyric acid
receptor subunit and a decrease in γ -amino butyric acidergic
inhibition (Neumann-Haefelin et al., 1998).
The second form of reaction to stroke—reduced lateralized
activation—reflects the increased activity in the contralesional
hemisphere, which reduces the extent of interhemispheric balance
as demonstrated in many stroke studies (Weiller et al., 1993; Seitz
et al., 1998). Reduced lateralized activation is a common brain
response not only seen in stroke but also in other neurological
contexts such as epilepsy, traumatic brain injury and multiple
sclerosis (Cramer, 2008). The exact function of this reduced
laterality remains to be elucidated: it may be just a subtype of
the described increased activity as described in the first form or
a passive event reflecting a reduced interhemispheric inhibition
resulting from the stroke. Another interpretation is that the
contralesional hemisphere has to take over functions that were
previously based in the ipsilesional hemisphere.
Both phenomena, increased cortical excitability and reduced
laterality, are related to spontaneous functional recovery (Cramer,
2008). Both are time dependent, increasing in the early weeks
after stroke and decreasing over months thereafter. This decrease
is greater among stroke patients with stronger functional recovery
while the persistent increased activity over both hemispheres
is greatest in those patients with the poorest outcome (Ward
et al., 2003; Cramer and Crafton, 2006). A relation to increased
susceptibility for seizures and phantom pain is possible.
The third response to ischemic injury—somatotopic
reorganization—implies that intact cortical regions—in
particular within the perinfarct area—reassign their functions
which they subserved before stroke and take over function, which
have been affected or lost by the ischemic event. Some studies
suggest that the largest degree of somatotopic reorganization is
associated with very large stroke injuries (Cramer and Crafton,
2006). Such map shifts occur in primary and secondary cortical
areas (Byrnes et al., 2001).
ANIMAL MODELS TO STUDY STROKE INDUCED CORTICAL
RE-ORGANIZATION ON THE ANATOMICAL AND MOLECULAR LEVEL
As studies in stroke patients have limitations, animal models of
stroke have been used to describe remodeling and reorganization
processes on the macro and molecular level. Although spon-
taneous recovery in animals tends to occur earlier (depending
on stroke size), imaging and mapping data show a number of
analogues between recovery in animals and in humans: connec-
tivity changes between sensorimotor cortex and deep grey matter
structures after middle cerebral artery occlusion (MCAO) in rats
were comparable to results in human stroke patients (van der
Zijden et al., 2007). fMRI studies concentrating on the affected
upper limb in rats have described a shift in laterality of activation
after stroke such that early after stroke, brain activation during
affected paw stimulation is mainly in the contralesional cortex,
later after stroke activity shifts toward the normal pattern, that
is the ipsilesional cortex (Dijkhuizen et al., 2001, 2003). Hsu and
Jones (2006) found that the larger the ischemic insult the stronger
the activity in the contralesional M1. In accordance with human
studies van Meer et al. (2012) could show that functional recovery
after MCAO in rats was correlated with the extent of preservation
or restoration of the ipsilesional corticospinal tract in combina-
tion with reinstatement of interhemispheric neuronal signal syn-
chronization and normalization of focal network organization.
New mapping methods allow describing somatotopic map
shifts in animals in greater detail: a recent study using light based
motor mapping in transgenic mice expressing light-sensitive
channelrhodopsin-2 before and after focal ischemic lesions of
the forelimb sensorimotor areas revealed decreased motor output
in the infarcted area and spatial displacement of sensory and
motor maps (Harrison et al., 2013). While strokes in sensory
cortex caused the sensory map to move into the M1, a stoke in
the M1 lead to a compensatory increase in peri-infarct cortical
motor output, but did not affect the position or excitability
of the sensory maps. In vivo 2-photon calcium or voltage sen-
sitive dye imaging furthermore opens up new possibilities to
study the reorganization of complex neuronal networks and their
functional relevance for stroke recovery (Winship and Murphy,
2008; Stetter et al., 2013). Anatomically, different studies have
demonstrated that map-shifts and re-mapping can be accom-
panied by axonal sprouting (Carmichael, 2003), and dendritic
spine turnover (Brown et al., 2008, 2009, 2010). Using different
tracing techniques, Starkey et al. (2012b) could show which
neurons take over when functional map shifts occur: if the fore-
limb M1 in rats was destroyed, neurons in the hindlimb area
took over to enable functional recovery of the forelimbs. This
functional shift was based on sprouting of new axon branches
from hindlimb corticospinal fibers into the cervical spinal cord,
followed by retraction of the original lumbar projecting axon
and thus a conversion of a hindlimb into a forelimb projecting
neuron.
Animal studies have also provided first insights on underly-
ing molecular changes. A unilateral infarct is associated with a
number of growth related processes, in some cases bilaterally.
These events include the induction of inflammatory markers,
grow-promoting and inhibiting genes, cell-cycle regulatory genes
and genes involved in synaptogenesis, dendritic branching and
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neuronal sprouting as reviewed elsewhere (Li and Carmichael,
2006; Popa-Wagner et al., 2007).
Three major phases of stroke reaction and repair are often
distinguished (Cramer and Crafton, 2006): the first epoch is
the acute reaction to the injury and takes place in the initial
hours when modifications become apparent in blood flow, edema,
metabolism and inflammation. A second epoch is related to
repair, starts in the first days post stroke and is on-going for
several weeks. During this epoch spontaneous recovery is seen and
endogenous repair related events reach their peak levels. The third
epoch begins weeks to months after stroke when spontaneous
recovery has reached a plateau and represents a stable but still
modifiable chronic phase.
On the molecular level stroke induces neuronal growth-
promoting genes in sequential waves post insult to initiate axonal
sprouting in the peri-infarct cortex, as initially shown in a rat
somato-sensory cortex (barrel field) infarct model (Carmichael
et al., 2005): in the early phase immediate early genes and growth
related mRNAs such as SPRR1 are induced 3–7 days after stroke.
Typical growth cone constituents such as GAP43, CAP23 and
MARCKS as well as the transcription factor c-Jun are expressed
from day 3 onward. Subsequently, the cell adhesion molecule
L1, cyclin-dependent kinase inhibitor p21 and embryonic tubulin
isoform alpha1 tubulin are induced, followed by the expression
of cytoskeletal reorganization genes such as SCG10 and SCLIP.
This pattern of growth gene expression described is unique
for axonal sprouting as a stroke response compared to expres-
sion profiles in neuronal development, peripheral or other CNS
injuries (Li et al., 2010). Furthermore, in an early response to
stroke (Mattson, 2008; Carmichael, 2012), several neurotrophic
factors such as brain-derived neurotrophic factor (BDNF), nerve
growth factor (NGF) and neurotrophin 3 (NT-3) as well as
fibroblast growth factor (FGF)-2 and insulin-like growth factor
(IGF-1), epidermal growth factor (EGF) and glial cell line-derived
neurotrophic factor (GDNF) are up-regulated. Each neurotrophic
factor species shows a different temporal and cellular distribution
pattern (Abe, 2000): while GDNF is mainly expressed by neurons,
CNTF induction was predominantly observed in astroglia of the
marginal region and VEDF gene expression was found in both
non-neuronal and neuronal cell types after stroke.
Axonal sprouting not only requires the induction of growth-
promoting programs within perinfarct neurons, but also a
reduction in the growth inhibitory environment (Carmichael,
2006): axonal growth inhibition in the adult CNS is mediated
through three general classes of proteins: myelin associated pro-
teins (Nogo-A, myelin-associated glycoprotein, oligodendrocyte
myelin glycoprotein), extracellular matrix proteins (e.g., chon-
droitin sulfate proteoglycans) and repulsive cues for growth cones
known mainly from development (e.g., ephrins, semaphorins).
Interestingly, messenger RNAs for the chondroitine sulfate pro-
teoglycans aggrecan, phosphacan and versican were found to
be induced later after stroke than the early and middle phase
of the growth-promoting gene expression. A small number of
growth inhibitory proteins including Nogo-A (Jiang et al., 2009),
ephrin A5, semaphoring IIIa and neuropilin 1 are induced in
the early phase, however, but down-regulation of Nogo receptor
components were also seen (Li et al., 2010).
Not only a temporal expression pattern of growth promoting
and inhibiting genes can be detected, but also the spatial dis-
tribution plays a role to induce the brain’s self-repair processes
at the right location: axonal sprouting e.g., in the peri-infarct
cortex takes place in a distinct environment close to but larger
than the glial scar. Thus, within the glial scar representing the
wall that separates the stroke core from the surviving per-infarct
tissue both, growth-promoting and growth inhibiting factors are
induced while the growth-permissive and peri-infact cortex shows
a reduction of the levels of growth inhibiting molecules such
as chondroitin sulfate proteoglycans. In contrast, neurotrophins
such as BDNF are highly up-regulated in the growth-permissive
penumbra und repressed in the stroke core (Lanfranconi et al.,
2011).
Taken together, the data on the time and space dependent
processes of intrinsic repair mechanisms after stroke suggest a
critical period or time window, in which the CNS recruits fac-
tors for plasticity that enhance functional recovery. One of the
most crucial questions that has to be addressed from a clinical
perspective is whether this period characterized by map shifts,
fiber growth and major functional and structural changes is also
the time window in which rehabilitative interventions should be
initiated. We now give an overview on rehabilitative and repair
strategies with an emphasis on timing, kind and intensity.
STRATEGIES TO ENHANCE PLASTICITY AFTER STROKE
GROWTH AND PLASTICITY ENHANCING TREATMENTS
Since the discovery of nerve growth factors and factors that pre-
vent neuronal outgrowth and survival, it became a goal in exper-
imental animal studies to apply or induce growth-promoting
factors and inhibit the inhibiting ones. Several preclinical studies
have examined various growth factors, hormones and cytokines
with the aim to enhance motor rehabilitation—including promi-
nent candidates such as NGF, glia (GDNF) and BDNF, IGF,
erythropoietin and the granulocyte colony-stimulating factor. All
have met with variable levels of success in animal models; some
initial clinical studies have started (The BDNF study group (Phase
III), 1999; Nagahara and Tuszynski, 2011).
In adult rats with large strokes, the administration of BDNF
resulted in improved recovery rates (Schäbitz et al., 2004), while
the beneficial effect of rehabilitation on the improvement of
forelimb function was prevented in animals treated with a BDNF
antisense oligonucleotide (Ploughman et al., 2009). The transla-
tion of these results into clinical trials remains challenging and
is a matter of safety concerns: in the case of BDNF applied as
a neuro-protective agent after stroke, the administration of very
large quantities would be necessary as well as repeated dosing to
overcome the limited amount of protein that reaches the CNS,
even with transient disruption of the blood-brain barrier after
stroke. The adverse effects of these high dosages have not been
extensively studied in animal models (Nagahara and Tuszynski,
2011). Furthermore, the largest clinical trial of erythropoietin
therapy revealed that, compared with placebo, erythropoietin
administration was associated with an increased risk of mortality
in patients with acute stroke (Ehrenreich et al., 2009).
Other experimental approaches to enhance the intrinsic regen-
eration ability of CNS axons include injecting cAMP analogs to
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influence intracellular signaling pathways (Hannila and Filbin,
2008), knock down of the protein synthesis inhibitor PTEN (Liu
et al., 2010) or blocking the small GTPase RhoA (Ellezam et al.,
2002).
Promising results have also been gained if inhibition of neu-
ronal plasticity and outgrowth was decreased either by: (1) digest-
ing growth restricting ECM proteoglycans with enzymes such
as chondroitinase ABC; (2) by blocking the growth inhibitory
protein Nogo-A; or (3) by grafting growth permissive cells.
The bacterial enzyme chondroitinase ABC digests the gly-
cosaminoglycan chains of the chondroitin sulfate proteoglycans
(CSPGs) which are part of the extracellular matrix and usually
up-regulated in astrocyctes and oligodendrocytes after CNS injury
(García-Alías and Fawcett, 2012). Chondroitinase ABC treatment
reduces scar formation and enhances axonal regeneration and
sprouting as first shown in several studies after experimental
spinal cord injury (Moon et al., 2001; Bradbury et al., 2002; Huang
et al., 2006). After stroke, chondroitinase ABC administration
promoted functional recovery (Hill et al., 2012; Starkey et al.,
2012a). Furthermore, Soleman et al. (2012) could demonstrate
that delayed chondroitinase ABC microinjections into the cervical
spinal cord induce localized plasticity of the forelimb sensori-
motor spinal circuitry without effects on the cortical peri-infarct
region.
Inhibition of Nogo-A signaling in animal models of stroke
The well-studied protein Nogo-A, a transmembrane protein of
about 1200 amino acids including a C-terminal 200 amino acid
reticulon (RTN) domain, is involved in several cellular and
molecular events contributing to the failure of CNS axons to
sprout and reconnect after CNS injury. Function-blocking anti-
bodies against Nogo-A, Nogo receptor (NgR1)-blocking pep-
tides, antibodies against the Nogo receptor subunit Lingo-1, or
pharmacological blockade of the signal transducer RhoA and
ROCK have been administered in various laboratories in dif-
ferent stroke and spinal cord injury models in rodents and
primates (Pernet and Schwab, 2012 for review). Enhancement
of behavioral recovery in a variety of sensory-motor tasks as
well as anatomical evidence of fiber growth, increased plasticity
and re-organization within the cortex, brain stem and spinal
cord have been reported (Zörner and Schwab, 2010 for review).
Despite different approaches to interrupt Nogo-A signaling, a
high degree of similarity in terms of functional recovery and
hardware changes in the CNS was found among research groups
and injury models. Acute intrathecal anti-Nogo-A antibody infu-
sion over 2 weeks after stroke, with an application starting early
after incident (Wiessner et al., 2003; Tsai et al., 2007), or delayed
application starting 9 weeks after stroke in adult rats (Tsai et al.,
2011) significantly improved forelimb function and was corre-
lated with a significant increase of midline crossing corticospinal
fibers originating in the unlesioned sensorimotor cortex. Robust
sprouting of new projections from contralesional brain regions
into subcortical structures as well as functional reorganization of
contralateral sensorimotor areas were reported after anti-Nogo-
A immunotherapy in rats (Markus et al., 2005; Cheatwood et al.,
2008). Those newly sprouting cortico-efferent axons terminated
in the red nucleus, pontine nuclei and spinal cord. A similar
effect was found by down-regulation of the Nogo receptor NgR
using adenovirus-mediated RNA interference (Wang et al., 2010)
or NgR or Nogo-A/B knockout mice (Lee et al., 2004). Anti-
Nogo-A immunotherapy was also associated with increases in
dendritic length, complexity, and spine density, both in the
lesioned and contralesional hemisphere (Papadopoulos et al.,
2006). Functional MR-imaging 8 weeks after unilateral MCAO
revealed adaptations in the somatosensory system of rats in the
anti-Nogo-A antibody treatment group (Markus et al., 2005).
Nevertheless anti-Nogo-A immunotherapy is not neuroprotective
in the sense that it would reduce stroke lesion size as reported
for anti-MAG immunotherapy (Irving et al., 2005). This opens
the therapeutic window for anti-Nogo-A immunotherapy in the
subacute and even chronic phase.
The described in vivo experiments represent essential
preclinical tests to validate the efficiency and safety of intrathecal
Nogo-A antibody administration. Three different anti-Nogo-A
antibodies (IN-1, 11C7, 7B12) have proved efficient in enhancing
axonal regeneration and outgrowth both in vitro and in vivo.
In collaboration with Novartis Pharma, a human anti-human
Nogo-A antibody has been developed and tested in extensive
toxicological studies with intrathecal antibody application in
rodents and primates. In a Phase I clinical trial1 with 52 acutely
injured para- and tetraplegic patients in Europe (European
Multicenter Study about Spinal Cord Injury, EMSCI2) and
Canada pharmacokinetics, safety, tolerance and dosing of
intrathecal delivery of the antibody were investigated. The
tolerance has been excellent without any adverse effects ascribed
to the anti-Nogo-A antibody (Abel et al., 2011). A placebo-
controlled Phase II clinical trial is currently in preparation.
Anti-Nogo antibodies are also in clinical trials or in preparation
for clinical trials for other neurological indications such as
multiple sclerosis and amytrophic lateral sclerosis (ALS). For
ALS GlaxoSmithKline (GSK) has also developed a humanized
anti-Nogo-A antibody (GSK1223249). In a Phase I clinical
trial, the intravenous injections of GSK1223249 were well
tolerated by the 76 patients enrolled in the study (Pradat et al.,
2011).
Several additional molecules restricting axonal growth in vitro
have been identified including ephrins, netrins, semaphorins
and oligodendrocyte myelin glycoprotein (OMgp; Schwab, 1990,
2010; Schwab et al., 1993). Their role in vivo after stroke has
to be evaluated. How much growth and plasticity of the adult,
stroke-injured CNS can be enhanced by single or combined
manipulations of growth promoting or inhibitory mechanisms,
and if there is a danger of chaotic growth and formation of wrong
connections is currently unknown.
Finally, grafting growth permissive cells, such as bone-marrow
mesenchymal cells, cord blood cells, fetal cells and embryonic
cells as a form of restorative therapy have been studied in animals
(Chopp and Li, 2002). E.g., cultivated bone-marrow stromal cells
from donor rats were stereotactically implanted into the peri-
infarct area in rats resulting in significant recovery of somatosen-
sory behavior. In a first small study, 5/30 stroke patients who
1http://clinicaltrials.gov/ct2/show/NCT00406016
2www.emsci.org
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received autologous bone-marrow mesenchymal cell transplanta-
tion showed beneficial effects in clinical stroke scores (Bang et al.,
2005). Such cell-based therapies could influence endogenous
neurogenesis, axonal sprouting and synaptogenesis in ischemic
brain tissue (Zhang and Chopp, 2009), although their effects may
be primarily immune-modulatory or neurotrophic. More detailed
and systematic studies are certainly needed.
REHABILITATIVE TRAINING IN CLINICAL AND EXPERIMENTAL STUDIES
The brain, including the motor system, learns by repetition
and training. Many basic mechanisms, however, are still poorly
understood, and rehabilitative training is largely evidence-based
medicine (European Stroke Organisation (ESO) Executive
Committee; ESO Writing Committee, 2008). Nevertheless there
are no generally accepted guidelines and no definite recommen-
dations concerning the timing, kind and intensity of rehabilita-
tive training. Clear end point data and randomized controlled
clinical trials are often lacking. Furthermore, stroke recovery is
a complex process that probably occurs through a combina-
tion of restoration, substitution and compensation of functions.
For this reason it has been also difficult to translate results
from rehabilitative studies in animals to recommendations for
rehabilitative schedules in human stroke patients. A major-
ity of clinical studies has been conducted in chronic stroke
patients (> 6 months after the stroke) as recruitment of these
patients was easier and baseline performance had stabilized
(Krakauer et al., 2012). These circumstances lead to functional
outcome measurements probably gained largely from compen-
satory techniques to improve skills for daily living. In contrast,
animal studies had a stronger focus on enhancing impairment
with more or less detailed analysis how much of the func-
tional recovery was restoration of baseline (motor) function or
compensation. Furthermore, the time courses of motor recov-
ery differ among animal and human studies: While recovery
in rodent models reaches its maximum around 4 weeks after
stroke, human stroke survivors complete most of their recovery
within 3 months (Dimyan and Cohen, 2011; Krakauer et al.,
2012).
Early vs. delayed training
A consensus exists that the effects of early training, whereby
“early” should be starting at 1–2 weeks in animals, not earlier (see
below), exceed effects of delayed training in terms of functional
recovery in both, animals and humans (Nudo, 2006; Murphy and
Corbett, 2009; Langhorne et al., 2010; Krakauer et al., 2012).
In animal studies, behavioral training after ischemic injury is
most effective for restoring behavioral performance, peri-infarct
neurophysiological maps and enhanced neuroanatomical changes
in the ipsi- and contralesional hemisphere when introduced
within the first week of injury (Nudo, 2006). In a rat MCAO
stroke model it was demonstrated that functional outcome and
dendritic branching patterns in the contralesional hemisphere
were restricted when rehabilitative training was initiated 14 and
30 days post insult (Biernaskie et al., 2004). In another study
by Hsu and Jones (2005), rats were trained in a skilled forelimb
reaching tasking starting 4 or 25 days post stroke. Reaching per-
formance was significantly enhanced in the early trained group.
In a small ischemic insult in M1 in squirrel monkeys delayed
training resulted in a large decrease in spared hand representation
during the spontaneous recovery period that persisted following
the delayed training (Barbay et al., 2006).
Concerns about initiating therapy too early following stroke
arose from studies where lesion size and cell death rate were seen
to be exaggerated after early excessive use of the impaired forelimb
in rats while the unimpaired forelimb was casted (Kozlowski et al.,
1996). One cause for increased lesion size following early excessive
limb training might be NMDA-mediated excitotoxicity in the
already hyperexcitable peri-infarct region (Humm et al., 1999). In
closer resemblance to clinical practice were animal studies, where
training or enriched rehabilitation was initiated a few days after
stroke. In these cases early intervention (1–3 days post stroke)
again was associated with increased cell-death but also with much
improved motor performance on the long-term (Risedal et al.,
1999; Farrell et al., 2001). Here, neuronal cell death may be part
of a pruning effect in which non- or dysfunctional neurons are
eliminated early due to a use-dependent selection. In summary,
the overall consensus from animal data is that initiating rehabili-
tative training 5 or more days after stroke is mostly beneficial and
has no adverse effects (Krakauer et al., 2012).
Constraint-induced movement therapy (CIMT), robot assisted
training and electrical devices to stimulate the rehabilitation
process
For human stroke patients two advanced rehabilitative
approaches have proven beneficial for functional outcome:
constraint-induced movement therapy (CIMT) and robot-
assisted training for upper limb function (Langhorne et al., 2009;
Liao et al., 2012; Mehrholz et al., 2012). Extensive preclinical
studies in rodents and primates have preceded both rehabilitative
strategies (Taub et al., 2002). When somatic sensation is surgically
abolished from a single forelimb in a monkey, the animal avoids
the usage of this forelimb in the free situation, but monkeys
can be induced to use the de-afferented extremity by restricting
movement of the intact limb continuously for a period of days.
This concept was successfully brought into the clinics when
chronic stroke patients wore a sling or cast on their less affected
arm during 90% of their waking hours for 14 days (Taub et al.,
1993). These patients showed a significant increase in the skill
and quality of movement as measured by two laboratory tests
and a much larger increase in real-world arm use over the
period of these 2 weeks than the unrestricted control group.
Two studies addressed the question of intensity and timing for
CIMT: In the VECTORS study (Dromerick et al., 2009), 52
stroke patients were randomized at about 10 days post stroke
to two levels of intensity of CIMT or standard upper extremity
therapy. Intense meant 3 h of CIMT vs. 2 h of shaping therapy.
After 90 days the motor outcome was worse for the more
intensive CIMT group, although there had been no difference
at 30 days. This result reflects the fact that too intensive CIMT
can turn into an adverse situation for both the patient and
the therapist. In the much larger EXCITE study (Wolf et al.,
2006) patients started CIMT therapy 3–9 months post stroke
and showed greater motor recovery than the usual care group.
In addition Lang et al. (2013) revealed that improvements
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in existing motor abilities were possible with both early (3–9
months post stroke) and delayed (15–21 months post stroke)
application of CIMT. However, significant reacquisition of the
ability to complete tasks was only detected with early CIMT
treatment.
A number of arm and also hand training robots have been
developed recently with the aim to allow very intense training
without continuous, costly physiotherapy assistance. In the most
modern set-ups, training devices are combined with interactive
video games that can boost the motivation of the patient for the
training and facility e.g., precision movements (e.g., grasping eggs
and putting them into a basket). The number of well controlled
and standardized outcome studies is still very limited. How-
ever, differences are discriminated between recovery of specific
movements under “laboratory conditions” and functional gains
for daily life activities (Mehrholz et al., 2012). Such studies are
needed to exactly know the specific advantages (and potential
drawbacks) of robot assisted rehabilitation in stroke (Aisen et al.,
1997; Balasubramanian et al., 2010; Mehrholz et al., 2012).
Therapeutic approaches which directly stimulate the PNS or
CNS electrically or by magnetic pulses may enhance neuroplastic-
ity during poststroke rehabilitation (Dimyan and Cohen, 2011).
Numerous research groups have examined the stimulation of the
CNS, specifically the primary M1, by noninvasive approaches
such as TMS and direct current stimulation as well as experi-
mentally in animals by the implantation of electrodes. Several
studies showed that an increase of the excitability in the stroke-
affected ipsilesional M1 by electrical devices resulted in improved
motor outcome (Hummel et al., 2005; Malcolm et al., 2007;
Ameli et al., 2009; Koganemaru et al., 2010). The mechanisms
of action of these techniques are under investigation but might
involve changes in synaptic activity, gene expression and increases
in neurotransmitter, receptor and neurotrophin levels (Dimyan
and Cohen, 2011) or even enhanced fiber sprouting (Martin,
2012). Understanding these mechanisms may provide the basis
for novel approaches using closed-loop brain machine interfaces
(BMIs) that define optimal stimulation parameters from a priori
developed experimental models and correctly modulate ionic
currents and extracellular electric fields to provoke and guide
plastic changes of the CNS (Gonzalez Andino et al., 2011).
COMBINATION OF DIFFERENT REPAIR AND REHABILITATION
STRATEGIES
To maximize the effectiveness of rehabilitative therapies after
stroke, it is critical to define when the brain is most responsive
to sensorimotor input or extrinsic application of plasticity pro-
moting reagents. This becomes particularly important if different
rehabilitative approaches are combined.
In one of the first proof of concept studies for a critical
period of heightened neuroplasticity, stroke rats were exposed
to an enriched environment in combination with daily sessions
of grasping training. The most significant gains in the recovery
of forelimb reaching ability were achieved when rehabilitation
was initiated early, i.e., 5 days after stroke as compared to 14
and 30 days after stroke. Recovery was associated with increased
dendritic branching of layer V M1 neurons in the unlesioned
hemisphere—a response that was not detected when rehabilita-
tion was delayed by 30 days (Biernaskie et al., 2004).
A few recent studies in which regenerative therapies and
rehabilitation have been combined have been conducted since
then. These experiments suggest that designing the combination
and their temporal pattern of administration are not going to
be trivial (García-Alías and Fawcett, 2012; Starkey and Schwab,
2012). The different experiments have revealed a beneficial com-
binatorial effect, a detrimental effect, no effect at all, or an effect
that depends on the relative timing of plasticity treatment and
rehabilitation.
Beneficial effects were described in spinal cord injury rat
models when agents against inhibitory molecules in the CNS
were combined with growth promoting reagents: García-Alías
et al. (2011) reported that the combination of Chondroitinase
ABC with neurotrophin NT-3 and an increased expression of the
NR2D subunit of the NMDA receptor resulted in better body
stability and interlimb coordination compared with the single
treatment groups. The behavioral data were correlated with the
highest number of sprouting axons in the spinal cord and multi-
synaptic responses in the motor-neurons. Similar results could be
found if anti-Nogo-A antibodies were combined with NT-3 and
the NMDA-NR2D subunit (Schnell et al., 2011). Furthermore, the
combinatorial treatment of acutely applied anti-Nogo-A antibody
followed by delayed Chondroitinase ABC treatment starting 3
weeks after spinal cord injury, and forelimb grasp training starting
at 4 weeks was much more effective in terms of functional recov-
ery, sprouting and axonal regeneration than the single treatments
(Rehme et al., 2011). In rats with large cortical strokes, inosine,
a substance which was shown to improve fine motor control
after stroke (Zai et al., 2009), augmented the effects of the Nogo
receptor blocker NEP1-40 in the restoration of skilled reaching
abilities in rats. Similar functional improvements were seen when
inosine was combined with environmental enrichment (Zai et al.,
2011).
Several recent experiments—mainly in spinal cord injury—
have combined growth-promoting agents with rehabilitative
training with somewhat different results: García-Alías et al. (2009)
investigated whether chondroitinase-induced plasticity combined
with physical rehabilitation promotes recovery of manual dexter-
ity in rats with cervical spinal cord injury. While CSPG digestion
combined with forelimb-specific rehabilitation lead to improved
manual dexterity, animals treated with chondroitinase ABC in
combination with environmental enrichment improved in ladder
walking but performed much worse in skilled forelimb tasks than
untreated control animals. In a second investigation by Maier
et al. (2009) adult rats with large but incomplete cervical spinal
cord injury received anti-Nogo A antibodies and simultaneous
daily forced treadmill training. The simultaneous rehabilitative
therapy clearly worsened the functional outcome compared with
either treatment alone. When the forced treadmill training was
delayed, however, for 2 weeks after the end of the antibody
treatment a very good functional outcome was obtained (Marsh
et al., 2011). In contrast to these results in spinal cord injured
rats, combination of Nogo receptor blockade with skilled forelimb
training in stroke lead to a greater degree of recovery than when
either of the treatments were applied alone (Fang et al., 2010).
Frontiers in Human Neuroscience www.frontiersin.org June 2014 | Volume 8 | Article 381 | 7
Wahl and Schwab Finding an optimal rehabilitation paradigm
No additive or adverse effects were reported by Boyce et al.
(2007) when neurotrophins were combined with rehabilitative
training in spinal cord injured cats. Administration of pharma-
cological neuromodulators such as amphetamine and cholinergic
agonists in combination with rehabilitative training are a matter
of debate: early animal research had suggested a beneficial effect
of amphetamine in recovery of motor function after stroke which
could not be sufficiently reproduced in recent human and animal
studies (Krakauer et al., 2012). Only for the anti-depressant fluox-
etine, a serotonin-selective reuptake inhibitor, which was applied
from 9 days post stroke to 3 months in a human stroke study,
an impressive degree of increased motor recovery was found
when combined with rehabilitative training (Chollet et al., 2011).
For all these studies and their quite diverse outcomes, better
knowledge of the neurobiological phenomena and mechanisms
triggered by the injury, the spontaneous reaction of the nervous
tissue to it, and by the different pharmacological and behavioral
interventions is urgently required.
FUTURE DIRECTIONS FOR DESIGNING OPTIMAL
REHABILITATION SCHEDULES
How can we better understand the neurobiology of rehabilitation?
What can we learn from the above mentioned animal and clin-
ical studies to improve current rehabilitation schedules for the
best possible recovery after stroke? The presence of critical time
windows for the application of growth and plasticity promoting
agents and of training-dependent plasticity suggests that careful
consideration of rehabilitation onset times, tailored training to
the type and extent of stroke and the patient’s history are required.
Potential future rehabilitation schedules after stroke may therefore
include the following “3 step model” (Figure 1):
1. Determination of the metabolic and plastic status of the brain
by using state-of-the-art imaging technologies and metabolic
markers
2. Enhancement of the plastic status of the brain by the applica-
tion of growth and plasticity-promoting factors
3. Selection and stabilization of newly formed functional connec-
tions by rehabilitative training
One obstacle of the implementation of the optimal restorative
therapies is the heterogeneity of stroke as injury location and size
differ widely from one patient to another. The ability to assign
the right therapy to the right patient would maximize treatment
effects. Although clinical scores and a number of imaging meth-
ods exist for evaluating the state of the central nervous system and
its function after stroke as reviewed elsewhere (Burke and Cramer,
2013), these approaches are often insensitive, cost intensive and
have logistical difficulties. Nevertheless, neuroimaging is not only
essential for the establishment of acute stroke diagnosis but can
also serve as a powerful tool for the characterization of disease
FIGURE 1 | Schematic overview of the “3 step model”—as a possible
roadmap for designing future rehabilitation schedules: (1) determination
of the metabolic and plastic status of the brain by using state- of the art
imaging technologies (image taken by the Akashi Municipal Hospital, Japan)
and biomarker profiles in the blood and CSF; (2) enhancement of intrinsic
repair and plasticity mechanisms in the ispi- and contralesional hemisphere as
well as the spinal cord by application of growth and plasticity-promoting
factors such as anti-Nogo-A antibody or Chondroitinase ABC; and (3)
selection and stabilization of newly formed functional connections and
pruning of non-functional ones by rehabilitative training.
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progression and monitoring of the response to rehabilitative
interventions. Diffusion-weighted imaging (DWI) and perfusion-
weighted MRI (PWI) are widely available MRI modalities that
provide valuable information about the tissue characteristics of
the ischemic core but also of the tissue at risk in the penumbra
(Merino and Warach, 2010; Fisher and Bastan, 2012). Further
work is needed to optimize the characterization of penumbra
imaging for patient triage into adjusted treatment groups. In the
near future we expect to learn if penumbra imaging or other
early imaging features provide predictive value of critical time
windows in which therapeutic interventions should be initiated
or maintained and allow stratification of patients into groups for
specific types of therapies.
Biomarker profiles in blood and cerebrospinal fluid (CSF)
samples could bring a tremendous advance and are currently a
focus of genomic and proteomic profiling studies and of systems
biology in several laboratories (Stuart et al., 2010; Hemphill
et al., 2011; Whiteley et al., 2012). In this regard, a biomarker
or a specific combination and profile of biomarkers may not
only speed up diagnosis and initiation of acute stroke treatment
but may also help to classify and categorize patient groups for
prediction of outcome and target the right rehabilitative approach
to those stroke patients who would benefit the most.
Why do we suggest a temporal sequence of first enhancing the
plastic state by growth promoting agents followed by a phase of
rehabilitative training in our “3 step model”?
The current data suggest that the CNS reacts to the injury by an
activation of growth and plasticity mechanisms which, however,
seem to also represent a vulnerable phase in which forced activity
can be harmful: this phase includes a period of GABA-mediated
tonic inhibition, which may also be necessary in the first days
after the stroke to limit an expansion of the infarct size (Clarkson
et al., 2010), as well as homeostatic plasticity mechanisms, which
ensure that neurons receive an balanced amount of synaptic input
(Murphy and Corbett, 2009). Intrinsic growth and plasticity as
well as exogenous enhancement of growth will lead to the forma-
tion of a large number of new connections within and between
different areas of the injured CNS. In analogy to the situation in
early postnatal development, many of these connections may be
weak and imprecise. The functionally meaningful ones will now
have to be selected and stabilized, while the malfunctional ones
should be pruned, in the next, activity-dependent phase of the
recovery process.
In the last step of recovery that is based mainly on rehabilitative
training the spared and the new circuitry of the CNS is shaped by
selection and stabilization of functional connections and pruning
of the non-functional ones. Hebbian learning rules might play
a crucial role in this step in the sense that Hebbian plasticity
mechanisms redistribute synaptic strength to favor the wiring
of pathways that are coincidently active (Murphy and Corbett,
2009). Motor learning in development is a very protracted pro-
cess, requiring huge numbers of repetitions over a period of many
weeks and months. Much too less is known today on the optimal
time and intensity requirements for rehabilitation learning. To
distinguish optimal rehabilitation schedules from less beneficial
ones, strict criteria for functional outcome have to be defined that
discriminate compensation and substitution from real restoration
of previously impaired function. Much remains to be learned and
applied in this fascinating and medically most important field of
stroke rehabilitation at the interface between basic neuroscience
and clinical neurology.
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Asynchronous therapy restores motor
control by rewiring of the rat
corticospinal tract after stroke
A. S. Wahl,1,2*W. Omlor,2 J. C. Rubio,3 J. L. Chen,2 H. Zheng,3 A. Schröter,4 M. Gullo,1,2
O. Weinmann,1,2 K. Kobayashi,5 F. Helmchen,2 B. Ommer,3 M. E. Schwab1,2*
The brain exhibits limited capacity for spontaneous restoration of lost motor functions
after stroke. Rehabilitation is the prevailing clinical approach to augment functional
recovery, but the scientific basis is poorly understood. Here, we show nearly full recovery
of skilled forelimb functions in rats with large strokes when a growth-promoting
immunotherapy against a neurite growth–inhibitory protein was applied to boost the
sprouting of new fibers, before stabilizing the newly formed circuits by intensive
training. In contrast, early high-intensity training during the growth phase destroyed
the effect and led to aberrant fiber patterns. Pharmacogenetic experiments identified
a subset of corticospinal fibers originating in the intact half of the forebrain,
side-switching in the spinal cord to newly innervate the impaired limb and restore
skilled motor function.
S
troke is a major cause of severe disability
in the elderly population, and recovery
after large strokes is limited (1, 2). Current
strategies to improve long-term outcome
in humans include mostly rehabilitative
training and, in experimental models, electri-
cal stimulation and pharmacological interven-
tions (3). However, all of these treatment options
have had only limited success thus far (4, 5).
Here, we show that rehabilitative training, if
preceded by a nerve growth–promoting anti-
body therapy, almost completely restored skilled
forelimb functions after cortical strokes in adult
rats. Sequential application of the treatments
was essential: When growth promotion by
blockade of the neurite growth–inhibitory pro-
tein Nogo-A was simultaneously applied with
intensive forced-use training of the forelimb
during the first 2 weeks after the stroke, func-
tional outcome was poorer compared with train-
ing, immunotherapy alone, or no treatment at
all (6). Anatomically, Nogo-A neutralization pro-
moted growth of corticospinal fibers from the
intact forebrain motor cortex across the mid-
line of the cervical spinal cord. In rats with sim-
ultaneous antibody treatment and training, fiber
branching was abundant with anatomically ab-
errant terminations. In contrast, in animals trained
for forelimb function subsequent to antibody
treatment, axonal fibers originally terminating
in the intact spinal hemicord crossed the mid-
line and innervated the ventral motor regions
of the spinal hemicord that had lost its input
from the motor cortex. To prove the functional
relevance of these newly grown, “side-switched”
descending corticospinal tract (CST) fibers, we
selectively and temporarily blocked these fibers
by two different pharmacogenetic techniques,
both of which suppressed the restored forelimb
function. Our results demonstrate that a sequen-
tial strategy of first promoting fiber growth to
enhance the low endogenous plastic potential
of the brain and spinal cord, followed by reha-
bilitative training–induced selection and stabili-
zation of functionally meaningful connections
can lead to much higher levels of functional
restoration after the formation of large brain
lesions than currently obtained in conventional
rehabilitation medicine.
Success of rehabilitation depends
on timing
We compared four different therapy and reha-
bilitation schedules for promoting functional
recovery of fine motor skills of forelimbs in a
thrombotic stroke model in rats. Using the well-
established technique of photothrombosis (6), we
induced blood vessel blockade by multiple micro-
thrombi, which destroyed >90% of the sensory-
motor cortex of adult rats. Rats were then treated
with intrathecal anti-Nogo-A or control antibody
for 2 weeks (6, 7). In addition, we trained rats in-
tensely in skilled forelimb reaching (100 reaches
per day), either simultaneously with antibody
application (parallel groups) or during the 2 weeks
after antibody treatment (sequential groups)
(Fig. 1A). To avoid a training effect of testing
itself, we did not reassess the sequential groups
(anti-Nogo-A/sequential and control sequential)
during the first 2 weeks after lesion formation.
When the growth-enhancing anti-Nogo-A treat-
ment was followed by the rehabilitative train-
ing (anti-Nogo-A/sequential group), animals
improved their performance from day 16 post-
stroke onwards, and their skilled reaching abil-
ities almost completely recovered [reaching 86.3 T
2.0% of prestroke level; significantly better than
all other groups; P < 0.001, two-way repeated
measures analysis of variance (ANOVA) with
post hoc Bonferroni] (Fig. 1, A and B). This group
also performed best in two skilled forelimb
use tasks tested at the end of the experiment
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[Montoya staircase grasping: success rate 34.1 T
5.1% (Fig. 1C); horizontal ladder crossing: suc-
cess rate 65.8 T 3.7% (Fig. 1D)]. As animals had
not been exposed to these tasks before, these re-
sults indicate a generalization of the recovery of
forelimb function in the sequential training group
that is transferable to nontrained motor skills.
In contrast to these results, rats receiving inten-
sive forelimb training concurrently to the anti-
Nogo-A antibody treatment (anti-Nogo-A/parallel
group) performed worse than all other groups in
the single-pellet grasping task (success rate
10.0 T 5.2%) (Fig. 1, A and B). In the tasks eval-
uated at the end of the experiment, these ani-
mals showed either no significant improvement
(Fig. 1C) or a tendency to decline over the course
of trials (P = 0.1, two-way repeated measures
ANOVA with post hoc Bonferroni) (Fig. 1D). The
control antibody-treated groups reached low
levels of recovery (35 to 40% success rate in pellet
grasping) (Fig. 1, A to D), with an early training
effect visible in the group trained during the
first 2 poststroke weeks (control/parallel)
(Fig. 1A). Final success scores did not corre-
late with stroke volume, as determined ex vivo
from either whole-brain magnetic resonance
images (r = 0.04, Spearman correlation) (Fig.
1F) or histological Nissl stains (fig. S1), suggest-
ing no specific neuroprotective effect by any of
the four therapeutic schedules. We conclude
that applying a nerve fiber growth-promoting
cellular therapy and rehabilitative physical train-
ing in sequence delivers greater functional recov-
ery than when the same protocols are applied
concurrently.
Rehabilitative schedules induce distinct
neuronal fiber patterns
We investigated the neuroanatomical corre-
lates of functional recovery by labeling the intact,
contralesional CST, which normally innervates
the spinal cord half opposite to the one that
has lost its cortical input, with only few fibers
crossing the spinal cord midline. Each of the
four experimental groups presented a distinct
rehabilitation-induced pattern of fiber sprout-
ing in the cervical spinal cord (Fig. 2C). We
counted labeled fibers originating in the cortex
of the intact side opposite to the stroke and
crossing the midline of the spinal cord (Fig.
2A). We also quantified their elongation and
branching within the gray matter of cervical
spinal cord, that is, the cord region containing
the motor control circuits of the forelimb and
paw (Fig. 2, A and B). The greatest number of
midline-crossing fibers was seen in the anti-Nogo-
A/sequential treatment group, which also had
the best functional outcome. In contrast, the anti-
Nogo-A/parallel group, showed extensive branch-
ing of the midline crossing corticospinal fibers
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Fig. 1. Timing matters when a growth-promoting anti-Nogo-A immu-
notherapy is combined with training. (A) Success rates in the single-pellet
grasping task at baseline (intact, trained), 2 days after a large, unilateral
photothrombotic stroke to the sensorimotor cortex of the preferred paw, and
during training and retesting sessions until 4 weeks post-insult. The anti-
Nogo-A/sequential group showed significant improvement compared with all
other groups, whereas the performance of the anti-Nogo-A/parallel group was
significantly worse (anti-Nogo-A/parallel, n = 16; control/parallel, n = 8; anti-
Nogo-A/sequential, n = 16; and control/sequential, n = 9). (B) Recovery rates
expressed as success rates of the last testing session normalized to baseline
performance (100%). n.s., not significant. (C and D) Animals in the anti-
Nogo-A/sequential group also performed significantly better in grasping
tasks, such as the Montoya staircase test (C) or the horizontal ladder
crossing task (D), introduced after the completion of the rehabilitation
schedules for three consecutive trials. In (A) to (D), data are presented as
means T SEM. Statistical evaluation was carried out with two-way ANOVA
repeated measure, followed by Bonferroni post hoc test. Asterisks indicate
significances: *P < 0.05, **P < 0.01, ***P < 0.001. (E) Representative picture
of an ex vivo magnetic resonance image stack for three-dimensional stroke
reconstruction. (F) There was no correlation between stroke volume and end-
point success rate in the single-pellet grasping task among all rehabilitation
groups (r = 0.04, Spearman correlation).
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(Fig. 2B) (P < 0.05, two-way repeated measures
ANOVA with post hoc Bonferroni).
A quantitative analysis of the distribution
and density of ipsilaterally projecting cortico-
spinal fibers using pattern-recognition algo-
rithms to analyze both single corticospinal
fibers and related fiber-growth parameters (see
supplementary materials and methods) con-
firmed overshooting fiber growth and aber-
rant termination patterns in the anti-Nogo-A/
parallel group. In the anti-Nogo-A/sequential
group, midline-crossing, sprouting corticospinal
fibers displayed a radial organization with few
branches and a preference for the premotor
and motor spinal cord (laminae 6 to 9) (Fig. 2,
D and G). In contrast, fibers in the anti-Nogo-A/
parallel group appeared less organized with
more than double the number of branches and
a different laminar distribution including the
dorsal, predominantly sensory laminae 1 to 5.
We also assessed the connectivity of the ipsi-
laterally projecting corticospinal fibers by quan-
tifying the density of axonal boutons recognized
morphologically in the premotor interneuron
lamina 7: We detected a significantly higher
bouton density in the anti-Nogo-A/parallel group
compared with the anti-Nogo-A/sequential group
(Fig. 2H) (P < 0.05, Student’s t test, two-tailed,
unpaired). The anti-Nogo-A/parallel group showed
a greater tendency of axons to grow beyond the
gray matter–white matter boundary, as well as a
highly aberrant growth pattern (Fig. 2, H and I).
In the medio-ventral funiculus, such fibers are
probably intermixed with sprouts of the small,
uncrossed ipsilateral CST.
Nerve cells from the intact forebrain
cortex are responsible for recovery
Our results suggest that the recovery of rat fore-
limb function after stroke in the anti-Nogo-A/
sequential group originates from extensive and
precise reinnervation of the stroke-denervated
spinal hemicord by midline-crossing fibers from
the intact motor cortex and CST. We tested this
hypothesis in the animals of the anti-Nogo-A/
sequential group, all of which showed excellent
functional recovery, by using two different ex-
perimental approaches for inducible, selective,
and reversible inactivation of the ipsilaterally
projecting corticospinal fibers on the long and
short term, respectively. For long-term blockade,
we used a virus to deliver a doxycyclin-inducible
tetanus toxin to temporarily inactivate the syn-
aptic release mechanism (8). We injected the
highly efficient retrograde gene transfer lenti-
vector HiRet carrying enhanced tetanus neu-
rotoxin light chain (eTeNT) with an enhanced
green fluorescent protein (EGFP) downstream
of a tetracycline-responsive element (TRE) into
the stroke-denervated side of the cervical spi-
nal cord at level C5-C6, and we injected the
adeno-associated serotype 2.2 (AAV2) vector
carrying the reverse tetracycline transactivator
(rtTAV16, Tet-on) into the contralesional, intact
premotor and motor cortex (n = 6 animals)
(Fig. 3, A and B). Only cortical neurons with
axons projecting to the stroke-denervated spinal
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Fig. 2. Corticospinal tract sprouting depends on timing of rehabilitative training correlating with
functional recovery. The four rehabilitation schedules (anti-Nogo-A/parallel, n = 10; control/parallel, n = 8;
anti-Nogo-A/sequential, n = 10; and control/sequential, n = 8) differently influenced the sprouting of
corticospinal fibers from the intact side of the spinal cord across the spinal cord midline (M). (A) Low- and
high-magnification micrographs of biotinylated dextran amine (BDA)–labeled corticospinal fibers in intact
spinal hemicord (left) growing into the stroke-denervated hemicord (right; inset) at spinal cord level C4. D1 to
D4: Lines for intersection counts with corticospinal fibers. Scale bar, 200 mm. (B) Fibers crossing the midline
(M) and branching in the gray matter at distances D1 to D4 were counted and normalized to the number of
BDA-positive labeled fibers in the main tract. (C) Micrographs showing different sprouting patterns of
corticospinal fibers from the ipsilateral cortex in the denervated cervical spinal cord (C4) in lamina 7 in the
different treatment groups. Scale bars, 200 mm. (D) Combining anti-Nogo-A immunotherapy with simul-
taneous training (anti-Nogo-A/parallel) results in a significantly higher density of ipsilateral CST fibers in
the stroke-denervated cervical spinal cord than does anti-Nogo-A/sequential treatment. (E) The most
significant difference in fiber density between anti-Nogo-A/parallel and anti-Nogo-A/sequential animals
was detected in lamina 6/7 and lamina 9 of the denervated cervical hemicord. Lamina 7 was also
significant for increased fiber branching (F) (branching index = branches per fiber per BDA-positive fibers
in the intact CST) and bouton numbers (G) in the anti-Nogo-A/parallel group. (H and I) Significantly
more fibers cross the gray matter–white matter boundaries in the dorsolateral (labeled with “A”), the
ventrolateral (label “B”), and the ventro-medial funiculus [label “C,” scheme shown in (H)] in the anti-
Nogo-A/parallel group. Data are presented as means T SEM. Statistical evaluation was carried out with
two-way ANOVA repeated measure, followed by Bonferroni post hoc (B) and Student’s t test (two-tailed,
unpaired) (D to G and I). Asterisks indicate significances: *P < 0.05, **P < 0.01, ***P < 0.001.
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cord would contain both transgenes and ac-
tivate tetanus toxin in response to doxycycline.
We applied the same procedure in four con-
trol animals, except these animals received
injections of the HiRet lentivector coding for
EGFP only.
After recovery from the surgery and the reas-
sessment of regained grasping skills, doxycycline
was orally administered for 2 weeks (Fig. 3, A
and C). In the experimental group grasping per-
formance declined within a few days, reaching
a very low level from day 7 after doxycycline
initiation (P < 0.05, statistical comparison TeNT
versus control group, two-way repeated mea-
sures ANOVA with post hoc Bonferroni) (Fig.
3C).When the drug administration was ceased,
the lost fuction was regained within 2 weeks.
All animals again showed a loss of skilled food-
pellet grasping movements when oral doxycy-
cline intake was restarted for a second time
over the course of another 3 weeks (Fig. 3C). No
deterioration of the poststroke recovered skilled
grasping was observed in control animals (EGFP
instead of eTeNT) under the same dosage of
doxycycline and within the same time frame
(98.1 T 0.9% of pre-doxycycline grasping per-
formance). As the retrogradely transported
virus was EGFP-tagged, corticospinal neurons
projecting to the ipsilateral cervical spinal cord
segments C5 and C6 could be quantified. These
neurons were concentrated in layer five of a
specific region of the rostral, premotor, and pri-
mary (M1) forelimb motor cortex (3.7 T 0.2 mm
anterior to bregma). In the center of the labeled
region, 41.4 T 5.6% of Nissl-positive cells of
layer five contained the transgene (Fig. 3, D
and E). These results demonstrate thatmidline-
crossing corticospinal fibers from the intact hem-
isphere opposite to the stroke lesion anatomically
and functionally switch sides, which is crucial for
the recovery of skilled forelimbmovements. These
fibers maintain their new function, even if they
are functionally blocked for weeks. Evidently,
their role cannot be compensated by other cor-
tical or subcortical motoneuronal pathways in
the injured system.
Temporally blocking rewired
corticospinal fibers results in decline
of regained function
For short-term reversible inactivation of the
midline-crossing corticospinal fibers, we used
a pharmacogenetic approach involving virus-
mediated gene transfer to express engineered
Gi/o-coupled DREADD receptors (“designer re-
ceptor exclusively activated by designer drug”).
These receptors are only activated by the other-
wise pharmacologically inert synthetic ligand
clozapine-N-oxide (CNO), resulting in increased
intracellular Gi/o-mediated signaling, which
leads to membrane hyperpolarization and si-
lencing of the infected neurons (9–11). We used
only rats that had undergone the treatment
schedule of growth promotion by anti-Nogo-A
antibodies, followed by another 2 weeks of re-
habilitative training. The virus injections started
at the end of the training period (fig. S2A). To
selectively manipulate the corticospinal fibers
projecting from the intact, contralesional motor
cortex to the denervated cervical spinal cord,
we first injected an AAV2.9 vector carrying the
Cre sequence into segments C5 and C6 of the
stroke-denervated cervical spinal cord, followed
by injections of the Cre-dependent AAV2.1 vec-
tor carrying the Gi/o-coupled DREADD (hM4Di)
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functional recovery after stroke. (A) Experimental schedule. All animals had anti-Nogo-A immuno-
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forelimb functions. (B) Schematic diagram of vector injections into the contralesional motor cortex
(AAV2.2-CMV-rtTAV-16) and stroke-denervated cervical spinal cord (HiRet-TRE-EGFP-TeNT or HiRet-
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receptor into the contralesional pre- and senso-
rimotor cortex (n = 6) (fig. S2B). The DREADD
receptor hM4Diwas taggedwithmCherry, which
allowed neuroanatomical confirmation that only
double-infected cells expressed the hM4Di re-
ceptor (fig. S2C): We found mCherry-positive
cells concentrated in layer five of the same re-
gion of the contralesional premotor and motor
cortex (3.7 T 0.2 mm anterior to bregma), as in
the tetanus toxin experiment. A portion of Nissl-
positive layer five cells in this region (31.6 T 2.4%)
were positive for mCherry (Fig. 4, A and B),
with very limited numbers of mCherry-positive
cells outside of this area. In control animals that
received injection of the Cre-dependent AAV2.1-
hM4Di vector in the contralesional cortex without
AAV-Cre virus injection in the spinal cord, only
4.3 T 0.5% of Nissl-positive cells in layer five
were positive for mCherry, indicating low back-
ground noise (n = 4) (Fig. 4A).
Three weeks after virus injection, both hM4Di/
+Cre and control hM4Di/–Cre animals performed
at >80% success rate in single-pellet grasping
(Fig. 4C). Animals were then injected intraperi-
toneally with the channel-activating drug CNO.
Control animals showed no change in reaching
and grasping abilities over the 50 min of obser-
vation time. However, animals of the hM4Di/+
Cre group lost their grasping abilities over 10 to
30 min, with performance declining to 38.9 T
6.0% success rate, which is significantly lower
compared with the control group (Fig. 4C) (P <
0.001, two-way repeated measures ANOVA with
post hoc Bonferroni). The defective movements
were characterized by a specific failure to target
the paw to the pellet and to close the paw around
the pellet (Fig. 4D), but with little modifications
in overall grasping trajectories (fig. S3). The
abatement of distal motor functions was con-
firmed by performing discriminative classifica-
tion based on a nonparametric representation
(12) of paw posture and its change over time
(P = 0.02, grasps at baseline versus after 30min
CNO, Kolmogorov-Smirnov test). This mainly
distal impairment may also be due to the fact
that only the cervical segments C5 and C6 were
injected with the Cre virus. These functional
defects were fully reversible, with performance
Fig. 4. Short-term
reversible blockade
of ipsilateral
corticospinal fibers
abolishes recovered
grasping function
and forelimb EMGs.
(A and B) Quantification
of mCherry-positive
cells in percentage of
Nissl-positive cells in
layer five of contrale-
sional premotor (M2)
and motor cortex (M1),
3.7 mm anterior
to bregma in the
hM4Di/+Cre group
(n = 6) and the hM4Di/
–Cre control group
(n = 4) (A), and the
illustration of its location
using Neurolucida
software reconstruction
(B). (C) Activation of
the DREADD receptor
in the hM4Di/+Cre
group induced a rapid
and massive but fully
reversible impairment
of grasping
performance 10 to
40 min after CNO
application. Reaching
success rates were
unchanged in the
control hM4Di/–Cre
CNO-treated group
over the same time
frame. (D) CNO
application disturbed
fine motor function
of closing the paw around the pellet in the hM4Di/+Cre group (P = 0.02,
Kolmogorov-Smirnov test): The figure shows the spatial probability den-
sities for the location of hand closure relative to the sugar pellet during
grasping at baseline and after CNO application. “x” represents the po-
sition of the sugar pellet relative to the forelimb position during grasping.
Scale bar, 10 mm. (E) CNO application leads to a decrease of EMG re-
sponses in the hM4Di/+Cre group (n = 5) after ICMS of the contrale-
sional motor cortex compared with ICMS stimulation at baseline and
30 min after CNO application in control animals (n = 3). Heat maps of
the cortical stimulation grid are shown (60 stimulation points, 80 mA, +3
to –3 mm anterior-posterior and 1 to 3.5 mm medio-lateral relative to
bregma). Each stimulation point is color coded with the mean value of
EMG response for a muscle group (wrist, elbow, shoulder) at this stim-
ulation point (in millivolts) normalized to the mean of all stimulation
points at the baseline. Data are presented as means T SEM. Statistical
evaluation was carried out with two-way ANOVA repeated measure,
followed by Bonferroni post hoc test. Asterisks indicate significances:
***P < 0.001.
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returning to preinjection levels ~40 to 50 min
after the CNO injection (Fig. 4, C and D).
Pharmacogenetic inhibition of regained
EMG activity
We confirmed the CNO-specific blockade of neu-
ronal firing of ipsilaterally projecting, partially
midline-crossing corticospinal fibers of the intact,
contralesional motor cortex by electrophysiology
using intracortical microstimulation (ICMS) at
the end of the behavioral testing:We used a 5-by-
12–point stimulation grid (positioned at +3 to
–3 mm anterio-posterior and 1 to 3.5 mmmedio-
lateral relative to bregma) (fig. S4A) and electro-
myogram (EMG) recordings of wrist, elbow, and
shoulder muscles of the impaired paw as read-
outs (fig. S4B). In all animals, each cortical po-
sition within the exploration grid was stimulated
twice, first as baseline stimulation, then again
30 min after CNO injection. In all hM4Di/–Cre
control animals, the EMG responses at baseline
and 30 min after CNO injection were not sig-
nificantly different for the 60 stimulation points
[for wrist, 95% confidence interval between
baseline and 30 min CNO was for animal one:
0 (0 to 0.001), animal two: 0 (0 to 0), animal
three: 0 (0 to 0.001); one-sample Wilcoxon signed
rank test] (Fig. 4E and fig. S4C). In contrast, in
four out of five hM4Di/+Cre animals, the ICMS-
evoked EMG responses significantly decreased
30 min after CNO injection compared with
baseline [for wrist, 95% confidence interval was
for animal one: –0.002 (–0.002 to –0.001), animal
two: –0.004 (–0.005 to –0.003), animal three:
–0.002 (–0.002 to –0.002), animal four: 0 (0 to
0.001), animal five: –0.012 (–0.016 to –0.009);
one-sample Wilcoxon signed rank test] (Fig. 4E
and fig. S4D). Calculating the mean EMG re-
sponse for every stimulation point in hM4Di/+Cre
animals versus hM4Di/–Cre controls revealed a
significant decline of EMG responses in wrist and
elbow muscles in the hM4Di/+Cre group 30 min
after CNO application compared with controls
(P < 0.05, Mann-Whitney test) (Fig. 4E). No
significant abatement of EMG responses oc-
curred in shoulder muscles of hM4Di/+Cre ani-
mals (P = 0.4,Mann-Whitney test) (Fig. 4E). CNO
application resulted in the largest difference in
EMG responses of wrist recordings when premo-
tor and rostral forelimb areas of the contralesional
motor cortex were stimulated in the hM4Di/+Cre
group compared with controls (fig. S2D). These
areas also expressed the highest concentration of
mCherry-expressing cells (Fig. 4A).
Discussion
Our study shows that in a rat model of large
forebrain cortex strokes, timing of rehabilita-
tive training relative to timing of a nerve fiber
growth-promoting therapy affects the recovery
of lost motor function and the pattern of fiber
sprouting. When rats received their first anti-
Nogo-A immunotherapy followed by 2 weeks
of specific, intense rehabilitative training, fore-
limb function was almost fully restored (Fig. 1, A
and B), indicating a far more extensive recovery
rate relative to stroke size than previously obtained
by training (13–15) or growth-promoting therapy
alone (6, 16). Not only did these animals out-
perform the other rehabilitation groups in the
single-pellet grasping task, but they were also
able to better transfer their regained skills to
novel forelimb tasks (15). The behavioral recov-
ery was associated with crossing of CST fibers
from the lesion-spared, intact motor cortex to
the stroke-denervated side of the spinal cord.
This observation is supported by various stroke
and spinal cord injury models (15–19) that relate
midline-crossing corticospinal fibers to func-
tional outcome. Our analysis shows that not only
the quantity of newly out-sprouting cortico-
spinal fibers is relevant but also their termina-
tion pattern: Intensive training, when applied
too early, induced hyperinnervation and aber-
rant growth even beyond the gray matter–white
matter boundary and into dorsal sensory lami-
nae. Such widespread sprouting may result in
wrong circuit connectivity involving cervical in-
terneurons, V2a propriospinal neurons, andmoto-
neurons, thus impairing grasping function, for
example, by coactivation of agonistic and antago-
nistic muscles (20, 21).
Our data suggest the presence of critical time
windows during which the brain is most respon-
sive to the application of growth-promoting agents
and to training-dependent plasticity. A correct,
timed sequence of interventions is required to
maximize the effectiveness of rehabilitative ther-
apies after stroke. In a first step, suppression of
the action of the endogenous growth-inhibitory
factor Nogo-A by immunotherapy may diminish
constraints on lesion-induced structural plasticity
throughmechanisms such as neurotrophic factors,
modified electrical properties of motoneurons,
alteration in neuronal energy balance (22), and
recruitment of new circuits leading to hyper-
excitability and prolonged responses to external
stimuli (1). In analogy to development, many of
these newly formed connections may be weak and
imprecise. Training in a second stepmay then help
to shape the spared and new circuits by selection
and stabilization of functional connections and
pruning of the nonfunctional ones. This second
step might involve Hebbian learning rules, in the
sense that Hebbian plasticity redistributes syn-
aptic strength to favor functionally relevant path-
ways that are coincidently active (1). The high
degree of recovery of important, cortically con-
trolled motor functions in rats with large ische-
mic strokes, as demonstrated here, points to a
possible avenue to explore growth-inhibitor block-
ade in combination with rehabilitative training
as a treatment strategy for humans with motor
cortex stroke. Antibodies against Nogo-A are cur-
rently used in clinical trials in humans for amy-
otrophic lateral sclerosis, multiple sclerosis, and
spinal cord injury (www.clinicaltrials.gov). Care-
ful consideration of rehabilitation onset times—
particularly with regard to windows of sprouting
and circuit plasticity, but also vulnerability of
the injured brain—and tailored training adapted
to the type and extent of stroke and the patient’s
history will be essential for future approaches in
the clinic (2, 23).
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